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Abstract  
Extracellular adenosine 5′-triphosphate (ATP) is an agonist for the P2Z receptor 
of human leukaemic lymphocytes and opens a Ca2+-selective ion channel, which 
also conducts Ba2+, Sr2+ and the small fluorescent dye, ethidium+. A wide range 
of receptor agonists, many of which raise cytosolic [Ca2+] activate phospholipase 
D (PLD). In the present study, it was shown that both ATP and 3′-O-(4-
benzoylbenzoyl)-ATP (BzATP) stimulated PLD activity in a concentration-
dependent manner, and the inhibitory effects of suramin, oxidised ATP, 
extracellular Na+ and Mg2+ suggested that the effect of these agonists is mediated 
by P2Z receptors.  
 
The role of divalent cations in ATP-stimulated PLD activity was investigated. 
Several agonists (eg ATP, thapsigargin, ionomycin) stimulated a rise in cytosolic 
[Ca2+] in human lymphocytes, but only ATP and ionomycin stimulated PLD 
activity. When Ca2+ influx was prevented by EGTA, the majority of ATP-
stimulated and all of ionomycin-stimulated PLD activity was inhibited. 
Preloading cells with the Ca2+ chelator, BAPTA, reduced cytosolic [Ca2+] and, 
paradoxically, ATP-stimulated PLD activity was potentiated. ATP-stimulated 
PLD activity was supported by both Ba2+ and Sr2+ when they were substituted for 
extracellular Ca2+. Furthermore, both ATP-stimulated PLD activity and ATP-
stimulated 133Ba2+ influx showed a linear dependence on extracellular [Ba2+]. 
Thus it was concluded that ATP stimulated PLD activity in direct proportion to 
the influx of divalent cations through the P2Z ion channel and this PLD activity 
was insensitive to changes in bulk cytosolic [Ca2+].  
 
The calmodulin (Ca2+/CaM) inhibitor, trifluoperazine (TFP) inhibited ionomycin- 
stimulated and ATP-stimulated PLD activity, as well as ATP-stimulated 
apoptosis.  TFP had no effect on the increased basal PLD activity observed after 
brief exposure of cells to ATP.  However, TFP inhibited ATP-stimulated Ca2+, 
Ba2+ and ethidium+ fluxes, at concentrations below those which inhibit 
Ca2+/CaM-dependent enzymes, suggesting that TFP, in this system, inhibits the 
P2Z receptor. 
 
Similarly, the isoquinolinesulphonamide, KN-62, a selective inhibitor of 
Ca2+/CaM-dependent protein kinase II (CaMKII), prevented ATP-stimulated 
apoptosis, but was without effect on the increased basal PLD activity, which 
follows brief exposure of cells to ATP. In addition, KN-62, and an analogue, 
KN-04, which has no effect on CaMKII, potently inhibited ATP-stimulated Ba2+  
 
 
 
 
 
 
 
 xviii
 
 
influx (IC50 12.7 ± 1.5 and 17.3 ± 2.7 nM, respectively), ATP-stimulated 
ethidium+ uptake (IC50 13.1 ± 2.6 and 37.2 ± 8.9 nM, respectively), ATP-
stimulated phospholipase D activity (50% inhibition 5.9 ± 1.2 and 9.7 ± 2.8 nM, 
respectively) and ATP-induced shedding of the surface adhesion molecule, L-
selectin (IC50 31.5 ± 4.5 and 78.7 ± 10.8 nM, respectively). They did not inhibit 
phorbol ester- or ionomycin-stimulated PLD activity or phorbol ester-induced L-
selectin shedding. Neither KN-62 nor KN-04 (both 500 nM) have any effect on 
UTP-stimulated Ca2+ transients in fura-2-loaded human neutrophils, a response 
which is mediated by the P2Y2 receptor.  Thus, KN-62 and KN-04 are almost 
equipotent as P2Z inhibitors with IC50s in the nanomolar range, indicating that 
their actions cannot be due to CaMKII inhibition, but rather that they are potent 
and direct inhibitors of the P2Z receptor. 
 
Extracellular ATP-induced shedding of L-selectin from lymphocytes into the 
medium is a Ca2+-independent response. L-selectin is either cleaved by a 
metalloproteinase or a PLD with specificity for glycosylphosphatidylinositol 
(GPI). The novel hydroxamic acid-based zinc chelator, Ro-31-9790 blocks ATP-
induced L-selectin shedding, but was without effect on ATP-induced Ba2+ influx 
or ATP-stimulated PLD activity. Furthermore, another zinc chelator, 1,10-
phenanthroline, an inhibitor of a GPI-PLD, potentiated rather than inhibited 
ATP-stimulated PLD activity, suggesting that ATP-induced L-selectin shedding 
and ATP-stimulated PLD activity are independent of each other. 
 
Although extracellular ATP is the natural ligand for the lymphocyte P2Z 
receptor, it is less potent than BzATP in stimulating Ba2+ influx. Concentration-
response curves for BzATP and ATP gave EC50s 15.4 ± 1.4 μM and 85.6 ± 8.8 
μM, respectively, for agonist-stimulated ethidium+ influx. The maximal response 
to ATP was only 69.8 ± 1.9% of that for BzATP. The above response curves 
were sigmoid with Hill coefficients 3.17 ± 0.24 and 2.09 ± 0.45 for BzATP and 
ATP respectively, suggesting greater positive cooperativity for BzATP than for 
ATP in opening the P2Z-operated ion channel. A rank order of agonist potency 
of BzATP > ATP = 2MeSATP > ATPγS was observed for agonist-stimulated 
ethidium+ influx, while maximal influxes followed a rank order of BzATP > ATP 
> 2MeSATP > ATPγS. When ATP (300 -1000 μM) was added simultaneously 
with 30 μM BzATP (EC90), it reduced both ethidium+ and Ba2+ fluxes by 30 - 
40% relative to values observed with BzATP alone. KN-62, previously shown to 
be a specific inhibitor of the lymphocyte P2Z receptor, was a less potent 
antagonist of BzATP-induced fluxes than ATP, when maximal concentrations of  
 
 
 
 
 
 
 xix
both agonists (50 and 500 μM respectively) were used. However, when BzATP 
(18 μM) was used at a concentration equiactive with a maximally effective ATP 
concentration, KN-62 showed the same inhibitory potency for both agonists. The 
ecto-ATPase antagonist, ARL-67156, inhibited both ATP- and BzATP-
stimulated Ba2+ influx, suggesting that the lower efficacy of ATP compared with 
BzATP was not due to preferential hydrolysis of ATP. Thus, the natural ligand, 
ATP, is a partial agonist for the P2Z receptor while BzATP is a more efficacious  
agonist. Moreover the competitive studies show that only a single class of P2-
receptor (P2Z class) is expressed on human leukaemic lymphocytes. 
 
Both ATP- and BzATP-stimulated PLD activity were significantly inhibited (P < 
0.05) when cells were suspended in iso-osmotic choline Cl medium. Choline+ 
was found to be a permeant for the P2Z ion channel, since ATP induced a large 
uptake of [14C]choline+ (60 to 150 μmol/ml intracellular water) during a 5 min 
incubation, which remained in the cells for several hours, and ATP was used to 
load cells with these levels of choline+. Intracellular choline+ inhibited ATP-, 
BzATP-, PMA- and ionomycin-stimulated PLD activity. Brief exposure of 
lymphocytes to ATP increased the subsequent basal rate of ethidium+ uptake, and 
this was prevented by intracellular choline+. It is proposed that P2Z-mediated 
Ca2+ influx in lymphocytes activates PLD leading to significantly changes of the 
phospholipid composition of the plasma membrane, which subsequently 
produces a permeability lesion, which in turn contributes to cell death.  
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Adenosine triphosphate (ATP) is an important energy storage chemical inside all 
cells. ATP can also affect many cells when present on the outside. Cells only 
respond to ATP if they have special receivers on their surface, called receptors. 
There are three major types of receptors for ATP. Human lymphocytes, a type of 
white blood cell, have one type, called P2Z. In the present study, it was shown 
that when ATP was added to the outside of lymphocytes, it attached to the P2Z 
receptor and opened a channel through which tiny amounts of calcium entered 
the cell. This inflow of calcium switched on an enzyme called phospholipase D, 
thus passing on the chemical message inside the cell. 
 
The function of the P2Z receptor and phospholipase D is unknown, but evidence 
from this study suggested that ATP, through its action on phospholipase D, 
produces a delayed leakiness of the cell boundary, which may ultimately lead to 
death of the cell. The communication between lymphocytes and ATP probably 
occurs infrequently in the body at sites where lymphocytes are normally removed 
or where there is blood vessel damage, since it was found that ATP, the natural 
communication molecule for the lymphocyte P2Z receptor was much less 
effective than a similar synthetic ATP derivative. 
 
The most significant aspect of this study was the discovery of two new and 
potent inhibitors for the P2Z receptor, KN-62 and KN-04, which have no effect 
on the other two types of ATP receptor. These inhibitors are several hundred 
times more potent than currently available inhibitors, which also do not 
discriminate between the different receptor types. This discovery will aid in 
delineating the functions of different ATP receptors on cells containing both the 
P2Z and other ATP receptors. 
 
Name: CAROLINE GARGETT 
Signed: .....................................................Date: ................................... 
Supervisors: Professor James S. Wiley and Dr. Jean Cornish 
 
 
 
 
 
 
 
 
 
 Introduction 
 
 
 
 
 
1.1 History of P2-Receptors 2 
1.2 Source and Metabolism of Extracellular ATP 3 
1.3 P2-Receptor Classification 6 
1.4  Functions of P2X and P2Y Receptors 15 
1.5 Signal Transduction by P2-receptors 17 
1.6  The P2Z receptor 21 
1.7 Phospholipase D 36 
1.8 Aims of This Study 46 
 
  
2
 
1.1 History of P2-Receptors 
Pharmacological activity of extracellular adenine nucleotides was first noted in 
1929, when Drury and Szent-Györgyi reported on their potent inhibitory actions 
on the mammalian heart. Subsequently, numerous reports appeared describing 
the effects of adenosine and ATP on the cardiovascular system, which have been 
summarised by Green and Stoner (1950). Later, Berne (1963) proposed that 
adenosine was the physiological mediator of coronary vasodilatation under 
conditions of myocardial hypoxia. The first suggestion that extracellular ATP 
may be a neurotransmitter was made by Holten (1959), who showed that ATP 
released from sensory nerves caused vasodilatation of the rabbit ear artery. 
In the early 1960’s, it was recognised that there was a component of 
neurotransmission in the autonomic nervous system which was neither 
cholinergic nor adrenergic (Burnstock et al, 1963; Martinson and Muren, 1963). 
Later, Burnstock et al (1970) reported evidence which suggested that ATP was 
synthesised, stored and released from nonadrenergic, noncholinergic (NANC) 
nerves innervating intestinal smooth muscles, and proposed that ATP released 
from NANC fibres was responsible for “purinergic” transmission (Burnstock, 
1972). ATP was first proven to be a neurotransmitter when the release of 
[3H]ATP from NANC nerves supplying the guinea pig taenia coli was blocked 
by tetrodotoxin (Su et al, 1971). 
As evidence of the diverse roles of extracellular ATP accumulated, Burnstock 
(1978), on the basis of a detailed analysis of the available literature, proposed 
that there were two groups of purinoceptor. He suggested that those receptors 
which were stimulated by adenosine, competitively antagonised by the 
methylxanthines and which modulated cellular cyclic adenosine 5′ 
monophosphate (cAMP) levels should be designated P1 purinoceptors. Those 
which responded to ATP, were unaffected by methylxanthines, did not regulate 
cAMP levels and resulted in prostaglandin synthesis, he named P2 purinoceptors 
(Burnstock, 1978). The concept that extracellular ATP activated specific P2 
purinoceptors and was a cotransmitter in a wide variety of tissues was 
subsequently reported by many groups (Burnstock 1990). 
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1.2 Source and Metabolism of Extracellular ATP 
1.2.1 Source of extracellular ATP 
Extracellular ATP is normally maintained at extremely low levels. The main 
potential source of extracellular ATP is the cytosol, since all cells contain 1 - 5 
mM ATP. In some cells, adenine nucleotides are packaged together with 
neurotransmitters and other local mediators in secretory granules, where 
concentrations of ATP approximate 100 mM. In the cytosol, ATP exists as 
MgATP2-, a charged and relatively large molecule, which cannot permeate the 
plasma membrane (Gordon, 1986; Dubyak & El-Moatassim, 1993).  
There are three mechanisms whereby the level of extracellular ATP is transiently 
raised (Figure 1.1). Firstly, by leakage of high concentrations of cytosolic ATP 
from lysed cells at sites of vascular and tissue damage. Secondly, by exocytosis 
of ATP from secretory vesicles of neurone terminals into the synaptic cleft or 
neuromuscular junction (Burnstock et al, 1970), or by release of storage granules 
containing ATP from activated platelets (Meyers et al, 1982) and adrenal 
chromaffin cells (Rojas et al, 1985) into the bloodstream or release into the 
surrounding extracellular space from activated mast cells (Osipchuk & Calahan, 
1992). Thirdly, by release of cytosolic ATP during cellular hypoxia or shear 
stress associated with altered hydrodynamic blood flow, in the absence of plasma 
membrane damage or cytolysis (Gordon, 1986; Dubyak & El-Moatassim, 1993). 
For example, vascular endothelial cells release ATP when activated by various 
agonists, including ATP, or under conditions of turbulent blood flow (Hassessian 
et al, 1993). Similarly, hypoxic erythrocytes and cardiac myocytes, and 
fibroblasts under conditions of shear stress have been shown to release 
endogenous ATP (Forrester, 1990: Grierson & Meldolesi, 1995). Recently, it has 
been proposed that ATP is extruded from cells via P-glycoprotein, the multidrug 
resistance channel, as well as the cystic fibrosis transmembrane conductance 
regulator (CFTR) of airway epithelium (Abraham et al, 1993; Reisen et al, 
1994), although confirmatory studies are lacking. Both transport proteins belong 
to the ATP binding cassette family of proteins (Al-Awqati, 1995). ATP from 
these sources can thus result in transient, but physiologically significant 
accumulation of the nucleotide at sites of turbulent blood flow, thrombus 
formation in the vasculature, tissue trauma, infection and inflammation, while 
even higher levels are reached in synaptic clefts of neuronal and neuromuscular 
junctions. These pericellular concentrations are likely to reach nM to μM levels  
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(Gordon, 1986). Although difficult to quantitate, the concentration of 
extracellular ATP has been estimated to reach 50 μM at the site of thrombus 
formation (Dubyak & El-Moatassim, 1993). In the alveolar lining fluid, 
extracellular ATP reaches approximately 1 mM (Rice et al, 1989). The local 
concentration of extracellular ATP will not only depend on the amount released 
from cells, but also on how rapidly ATP is diluted in rapidly flowing blood or 
degraded by ubiquitous ecto-ATPases and ecto-nucleotidases (Dubyak & El-
Moatassim, 1993). However, it  
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Figure 1.1  Source and metabolism of extracellular ATP 
Adapted from Dubyak & El-Moatassim (1993). 
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does seem plausible that extracellular ATP may transiently reach significant 
concentrations in many locations of the body. 
1.2.2 Metabolism of Extracellular ATP 
Ecto-enzymes, present on the surface of many cells and tissues (Pearson & 
Gordon, 1985), regulate the concentration of extracellular purine nucleotides. For 
example, almost all (99%) of a bolus of ATP was removed on first pass through 
perfused heart or lung (Ryan & Smith, 1971; Paddle & Burnstock, 1974). The 
half life of ATP in the circulation was less than 0.2 s while, in contrast, in 
extravasated blood it was approximately 10 min (Ryan & Smith, 1971, Trams et 
al., 1980). 
Extracellular ATP is sequentially hydrolysed by ecto-ATPase, ecto-ADPase and 
ecto-5′-nucleotidases (Figure 1.1). These are separate enzymes with different 
kinetic parameters (apparent Km, Vmax) (Pearson & Gordon, 1985; Zimmerman, 
1992), distinct from the Ca2+-ATPase and non-specific phosphatases, which do 
not contribute to metabolism of extracellular ATP at the cell surface (Gordon, 
1986). Ecto-ATPase has broad nucleotide specificity, hydrolysing UTP, GTP, 
CTP as well as ATP, is activated to the same extent by either Ca2+ or Mg2+ and is 
not inhibited by vanadate (Dubyak & El-Moatassim, 1993). Ecto-5′-nucleotidase, 
a disulphide-linked dimer of two glycosylphosphatidylinositol (GPI) -anchored 
subunits, catalyses the hydrolysis of AMP to adenosine. ATP and ADP regulate 
ecto-5′-nucleotidase by a feed-forward inhibitory mechanism which limits 
adenosine formation and prevents P1-receptor activation (Figure 1.1) 
(Zimmerman, 1992). Many cells express these enzymes at variable levels of 
activity, including neurones and leukocytes (Zimmerman, 1992; Ziganshin et al, 
1994a), with B lymphocytes showing higher ecto-ATPase and ecto-5′-
nucleotidase activity than T lymphocytes (Barankiewicz et al., 1988). Recently, 
CD39, a marker expressed on activated lymphocytes, was identified as a major 
ecto-apyrase (ATP/ADPase) (Wang & Guidotti, 1996). Extracellular ATP may 
also be a substrate for ecto-protein kinases present on some cell types, including 
NK lymphocytes (Myers & Kang, 1990) and aortic endothelial cells (Pirotton et 
al, 1992). 
Rapid enzymic degradation of ATP/ADP terminates intercellular signalling via 
nearby P2 purinoceptors, analogous to the action of acetylcholinesterase on 
acetylcholine in the synaptic cleft. Unlike the degradation products of 
acetylcholinesterase, which have little biological activity, the final product of  
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ecto-ATPases and ectonucleotidases is adenosine, which is an agonist for P1 
purinoceptors. Adenosine generated in this manner may further modulate P2 
signalling responses, since activation of P1 purinoceptors on presynaptic 
membranes has an inhibitory effect on transmitter release (Burnstock, 1996). In 
addition, these enzymes provide a mechanism for producing adenosine, which 
can be transported into the cell and enter the salvage pathway, regenerating 
intracellular nucleotide pools (Bruns, 1990). The differential expression and 
relative activity of these ecto-enzymes on interacting cells, variously modulates 
the function of the P2 purinoceptors which may be expressed on these cells. 
1.3 P2-Receptor Classification 
1.3.1 The Problem of P2-receptor Classification 
The lack of selective antagonists for P2 purinoceptors has ensured that their 
classification primarily depended on relative agonist potencies. This 
classification must still be regarded as tentative rather than definitive (Fredholm 
et al, 1994). The original division of purinoceptors into the two groups, P1 and 
P2, proposed by Burnstock (1978) still stands, despite some modifications as 
more information has become available. In 1985, Burnstock and Kennedy 
delineated the P2 purinoceptors into two groups based on the nature of the 
response and their relative agonist potencies (Table 1.1). Those, where 
stimulation produced smooth muscle contraction with an agonist profile of α,β-
methylene ATP (α,β-meATP) > β,γ-meATP > ATP = ADP = 2-methylthio ATP 
(2MeSATP) and which were rapidly desensitised by α,β-meATP were termed 
P2X receptors, as exemplified in guinea pig bladder. Those inducing relaxation, 
and 2MeSATP > ATP >> α,β-meATP were termed the P2Y subtype, with 
guinea pig taenia coli a typical example (Burnstock & Kennedy, 1985). 
Exceptions to the above agonist profiles were soon found and thus Gordon 
(1986) added two more subtypes: the platelet P2T receptor, which responded to 
ADP and was inhibited by ATP and the P2Z subtype, which responded to ATP4- 
and formed large nonselective pores. Later the P2U subtype was added to the list, 
since it responded to the pyrimidine, UTP, at similar concentrations to ATP and 
ATP thiophosphate (ATPγS), (O’Connor et al, 1991; Dubyak, 1993). Yet another 
receptor subtype stimulated by diadenosine polyphosphates was termed P2D 
(Hilderman et al, 1991). As the structure of newly cloned receptor subtypes was 
elucidated and newer analogues of ATP were synthesised a revised classification 
  
7
 
system was proposed (Abbracchio & Burnstock, 1994; Fredholm et al, 1994) and 
is described in Section 1.3.4  
Several factors complicate the use of relative agonist potencies for receptor 
classification. Ubiquitous ecto-ATPases and ecto-nucleotidases rapidly remove 
ATP, ADP but not some synthetic ATP analogues during assay conditions. 
Furthermore, the degradation products can also interact with P2 receptors. Until 
recently, inhibitors of these ecto-enzymes were of low potency and reacted with 
P2-receptors (Ziganshin et al, 1994a), but with the use of the new ecto-ATPase 
inhibitor, ARL-67156 (Crack et al, 1995), the rank order of agonist potency of 
smooth muscle P2X receptor subtypes was redefined as 2MeSATP ≥ ATP > α,β-
meATP since 2MeSATP but not α,β-meATP was susceptible to ecto-ATPase 
degradation (Kennedy & Leff, 1995). A second complication is that agonists 
such as α,β-meATP may not attain temporal equilibrium because of receptor 
desensitisation. 
A third complication is the co-expression on most cell types of several P2-
receptor subtypes (Section 1.3.6.3). Thus the response of a given cell or tissue to 
any ATP analogue is the sum of the relative activities of those P2 receptor 
subtypes (O’Connor et al, 1991; Fredholm et al, 1994). 
As the purinoceptor subtypes are progressively being cloned and their structure 
determined, the IUPHAR Committee on Receptor Nomenclature and Drug 
Classification has recently recommended that only the two original P2X and P2Y 
classes of P2-receptor be retained, with subscripts used to indicate subtypes 
numbered sequentially in order of historical cloning of the gene (Fredholm et al, 
1994). The term P2-receptor has now replaced the term P2 purinoceptor to 
accommodate those receptors which respond to pyrimidine as well as purine 
nucleotides (Burnstock & King, 1996). This committee also recognised that the 
P2Z receptor may represent a third class. While this nomenclature will no doubt 
be revised again when truly selective antagonists become available, this 
classification has been useful for the presently cloned P2 purinoceptors, P2X1 to 
P2X7 and P2Y1 to P2Y7 (Tables 1.1 and 1.2) (Burnstock, 1996). 
1.3.2 Agonist Potency Profiles 
The latest rank order of agonist potencies for P2X1 to P2X7 and P2Y1 to P2Y7 are 
shown in tables 1.1 and 1.2. However, some relative potencies may change as 
ecto-ATPase activity (Section 1.3.1) is taken into account. Structures of some of 
these agonists are shown in Figure 1.4 
  
Table 1.1 Classification of the P2X receptors (ligand-gated ion channels) 
P2-Recep-
tor Subtype 
Rank Order of Agonist Potency Tissue Distribution Signalling Antagonists 
IUPHAR Classificationa   
P2X αβ-meATP≥βγ-meATP>ATP≥ADP 
>2MeSATP 
smooth muscle, brain, heart ligand-gated ion 
channel (Na+, K+, 
Ca2+) 
suramin, PPADS ANAPP3, 
desensitised by αβ-meATP 
Burnstockb     
P2X1 2MeSATP>ATP>αβ-meATP vas deferens & urinary bladder 
smooth muscle, thymus, spleen 
INa/K/Ca suramin, PPADS, ox-ATP 
desensitised by αβ-meATP 
P2X2 2MeSATP>ATP 
(αβ-meATP inactive) 
PC12 cells, sensory ganglia 
brain, some smooth muscles 
INa/K suramin, PPADS, ox-ATP, RB2 
P2X3 2MeSATP>ATP>αβ-meATP 
 
dorsal root ganglion cells INa/K/Ca suramin, PPADS,  
desensitised by αβ-meATP 
P2X4 ATP>2MeSATP>αβ-meATP 
(αβ-meATP inactive) 
neurones, widespread, 
excitable & non-excitable 
tissues 
INa/K/Ca reactive blue 2c 
suramin & PPADSd 
P2X5 ATPγS≥ATP≥2MeSATP 
(αβ-meATP inactive) 
peripheral sensory neurones INa/K/Ca suramin, PPADSe 
P2X6 2MeSATP=2-cl-ATP=ATP>ATPγS 
(αβ-meATP inactive) 
brain INa/K/Ca suramin & PPADS insensitivee 
P2X7 f BzATP> ATP>2MeSATP>ATPγS brain, microglia, macrophages INa/K/Ca ox-ATP 
aFredholm et al, (1994)  bBurnstock, (1996)      
cSoto et al, (1996)    
dhuman homologue (Garcia-Guzman et al, 1997) but the rat homologue is insensitive to both suramin and PPADS (Collo et al, 1996)  
eCollo et al, (1996) 
fIt is not known if the lymphocyte P2Z receptor is a P2X7. 
  
Table 1.2 Classification of the G-protein coupled P2Y receptors 
P2-Receptor 
Subtypea 
P2-Receptor 
Subtypeb 
Rank Order of Agonist Potency Tissue Distribution Signalling Antagonists 
P2Y P2Y1c 2MeSATP>ATP≥ADP 
(UTP inactive) 
smooth muscle, brain, endothelial 
cells, endocrine & exocrine 
glandular cells, hepatocytes 
PI-PLCβ/IP3/Ca2+ suramin, reactive 
blue 2 (RB2), 
PPADSd 
P2U P2Y2c ATP=UTP>>2MeSATP widespread, neurones, epithelia 
endothelial cells, neutrophils 
PI-PLCβ/IP3/Ca2+ suramin, RB2, 
PPADS insensitive 
P2Y P2Y3 ADP>UTP>ADP=UDP brain, spleen, kidney , lung PI-PLCβ/IP3/Ca2+ suramin, RB2e, 
P2Y P2Y4 UTP=UDP>ATP=ADP human placenta PI-PLCβ/IP3/Ca2+ suramin & PPADS 
insensitivef 
P2Y P2Y5 ATP>ADP>2MeSATP chicken lymphocytes nd nd 
P2Y P2Y6 UDP>>UTP >2MeSATP>ADP g rat aortic smooth muscle PI-PLCβ/IP3/Ca2+ suramin, RB2h 
P2Y P2Y7i ATP=ATPγS> MeSATP> 
β,γ-meATP>ADP=UTP 
heart, skeletal muscle, brain, liver PI-PLCβ/IP3/Ca2+ suramin 
P2T nd 2MeSADP>ADP platelets, megakaryocytes PI-PLCβ/IP3/Ca2+ 
cAMP, ?ion channel 
ATP, suramin,  
P2D/P4 nd diadenosine polyphosphates 
Ap4A> Ap5A> Ap6A 
neurones, chromaffin , endothelial 
cells 
? G-protein coupled 
↑Ca2+ 
 
nd: not determined  aFredholm et al, (1994) bBurnstock, (1996) 
c several P2Y1 and P2Y2 species homologues have been cloned with different agonist potency profiles. Shown are Webb et al, (1993) and Lustig 
et al (1993) for P2Y1 and P2Y2 respectively. 
dBrown et al, (1995)  eWebb et al, 1996 fCharlton et al, (1996b) g Nicholase et al (1997)  hChang et al, (1995)   
iAkbar et al (1996) 
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1.3.3  Antagonists of P2-receptors 
The lack of potent selective antagonists has been a major problem in P2-receptor 
research and classification (Fredholm et al, 1994).  
The best known inhibitor is suramin, a large naphthalene polysulphonic acid, 
originally synthesised for its trypanocidal activity (Voogd et al, 1993). Suramin 
was first used by Dunn & Blakely (1988) to inhibit α,β-meATP-induced 
contractile responses in mouse vas deferens as well as other P2X responses (Leff  
et al, 1990). While suramin was found to inhibit most native and cloned P2-
receptors (Tables 1.1 and 1.2), rather high concentrations are required and it does 
not discriminate between P2-receptor subtypes (Fredholm, et al, 1994). 
However, suramin has proven useful in defining newly cloned P2-receptors 
expressed in heterologous cells. Another problem with suramin is its lack of 
specificity, since at concentrations above 100 μM, it also inhibits receptors for 
several growth factors (eg bFGF, PDGF, IL-3) and a wide variety of hydrolytic 
and oxidative enzymes, including ecto-ATPase (Voogd et al, 1993; Crack et al; 
1995). 
PPADS (pyridoxalphosphate-6-azophenyl-2′,4′-disulphonic acid) was 
synthesised by Lambrecht et al (1992) and found to selectively inhibit P2X 
responses in rabbit vas deferens. Initial studies suggested that PPADS 
distinguished between P2X and P2Y receptors (Ziganshin et al, 1994b). 
However, while PPADS has no action at P2Y2 and P2Y4 receptors, it does 
antagonise P2Y1 receptors (Brown et al, 1995; Charlton et al, 1996a,b). The 
discriminatory ability of PPADS for P2Y1 and P2Y2 receptors should prove 
useful in examining P2-receptor mediated responses in endothelial cells, known 
to express both these receptors (O’Connor et al, 1991). PPADS has yet to be 
tested against some cloned P2Y receptors (Table 1.2).  
Reactive blue 2 (RB2), an anthraquinone sulphonic acid dye, has been proposed 
as a reasonably selective P2Y receptor antagonist (Manzini, et al, 1986). 
However, RB2 is difficult to use because its effect is critically dependent on 
concentration and length of exposure, its purity can be as low as 60% and it has 
limited specificity for P2-receptors (Fedan & Lamport, 1990).  
Several ATP analogues show antagonistic activity towards P2-receptors. 
ANAPP3 (arylazidoaminopropionyl-ATP) covalently binds to some P2X 
receptors when activated by visible light and produces irreversible inhibition. 
However, ANAPP3 is non specific, since it readily binds to many ATP-
metabolising proteins (Fedan & Lamport, 1990). 
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1.3.4 Cloning and Structure of P2-receptors 
Classification of P2-receptors is now based on information gained from cloning 
studies. While this information is yet incomplete, the P2X and P2Y receptors are 
structurally distinct, the former being an ion channel, the latter a G-protein 
coupled receptor. This correlates with signalling mechanisms elucidated in 
earlier functional studies (Burnstock, 1996).  
Protein amino acid sequences deduced from isolated cDNA clones for the P2X 
family of receptors suggest a structure of 2 transmembrane domains (M1 and 
M2) connected by a large extracellular loop (Figure 1.2a) (Brake et al, 1994; 
Valera et al, 1994). When these P2X receptors are transfected into heterologous 
cells they form ion channels, which have the properties of their native receptors 
(Brake et al, 1994; Valera et al, 1994). The subunit stoichiometry has not yet 
been determined, although kinetic data on native P2X receptors suggest at least 3 
subunits per receptor (Bean, 1990). Members of the P2X family share a 35-48% 
identity in their amino acid composition, each subunit containing approximately 
400 amino acids. Sixty seven of the ≈ 270 amino acids, which comprise the 
extracellular domain of the 7 P2X receptors are completely conserved, 10 of 
which are cysteine and 6 are lysine (North, 1996). Both the amino and carboxyl 
termini are intracellular, with the P2X7 having a particularly long carboxyl tail 
with approximately 200 extra amino acids (Surprenant et al, 1996). These 
features, together with several possible N-linked glycosylation sites on the 
extracellular domain suggest that P2X receptors have a structure related to the 
amiloride sensitive epithelial sodium channel, the inward-rectifier potassium 
channel and bacterial mechanosensitive channels (North, 1996). While there is 
evidence that the 2X1 and P2X2 channels form homopolymeric channels, it is 
likely that other members form heteropolymers (Lewis et al, 1995).  
The first two members of the P2Y receptor family were initially cloned in 1993 
(Webb et al, 1993; Lustig et al, 1993) and their deduced structures were typical 
of G-protein coupled receptors containing seven transmembrane α helices 
(Figure 1.2b). P2Y receptors showed closest homology (27%) to the thrombin 
and complement factor 5a peptide receptors, but bore little resemblance to 
adenosine receptors, confirming that P1 and P2 receptors are fundamentally 
different (Barnard, et al, 1994). Within the P2Y family there is diversity in 
structure, with approximately 35-40% homology between the members and no 
homology in the intracellular domains associated with G protein binding 
(Barnard, et al, 1996). 
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1.3.5 Ionotropic and G protein-coupled P2-receptors 
Receptors for neurotransmitters are either ionotropic or G protein-coupled. 
Ionotropic receptors mediate fast responses because they are coupled to ion 
channels which rapidly conduct cations on ligand binding. These include the 
nicotinic acetylcholine, GABAA, 5-HT3, glycine and most glutamate receptors. In 
contrast, G protein-linked receptors mediate slow responses because they 
stimulate cellular enzymes, in particular the phosphatidylinositol-specific 
phospholipase C (PI-PLC) signalling cascade producing two second messengers 
to transduce the signal (Section 1.5.2.2). Such receptors include the muscarinic 
acetylcholine, GABAB, and the majority of 5-HT receptors (Burnstock, 1996). 
Numerous studies indicate that extracellular ATP is a neurotransmitter (Section 
1.4.1). Both electrophysiological and cloning studies (Section 1.3.4) indicate that 
P2X receptors are ligand-gated ion channels, which conduct Na+ and Ca2+ from 
the extracellular medium. The P2X receptor structure, however, is unrelated to 
any of the other ionotropic receptors, placing P2X receptors into a separate 
family (North, 1996; Valera et al, 1994; Brake et al, 1994). The P2Z receptor is 
also a ligand-gated ion channel (Wiley et al, 1993). In contrast, the P2Y 
receptors are G-protein coupled receptors which signal through the PI-PLC 
cascade (Dubyak & El-Moatassim, 1993; Burnstock, 1996) (Figure 1.2b).  
1.3.6 Distribution of P2-receptors 
It has gradually become apparent that several P2-receptors are often present on 
the same tissue and even the same cells. Thus the observed responses of these 
cells and tissues are the combined effect of activating several P2-receptor 
subtypes by ATP or its analogues. The distribution of P2X and P2Y receptors in 
tissues has been studied by cDNA probes used in Northern blot analysis of 
mRNA isolated from various tissues, or sense or antisense olignucleotide cRNA 
probes used for in situ hybridisation techniques on cryosections (Barnard et al, 
1996; Collo et al, 1996).  
1.3.6.1  P2X receptor distribution 
Functional studies show that P2X receptors are located on excitable cells, such as 
neurones of both the central, peripheral and autonomic nervous system, 
neuroendocrine cells, smooth muscle cells of vasculature and viscera, cardiac 
myocytes, embryonic myoblasts and myotubes, but not adult skeletal muscle cells 
(Burnstock, 1996; Dubyak & El-Moatassim, 1993). The distribution of individual 
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P2X receptor subtypes is now being mapped and generally correlates with 
functional studies. The P2X1 gene is identical to the RP-2 gene found in 
apoptotic thymocytes and was expressed in thymus and spleen, as well as various 
excitable tissues (Table 1.1) (Valera et al, 1994). Recently, the P2X1 receptor 
was identified in differentiated HL-60 leukocytes, a myeloid leukaemic cell line 
(Buell et al, 1996). The P2X2 receptor gene isolated from PC-12 cells has 
sequence similarity to the RP-2 gene and was expressed predominantly in 
excitable tissues. (Brake et al, 1994). The tissue distribution of the various P2X 
subtypes is listed in Table 1.1. 
1.3.6.2  P2Y receptor distribution 
P2Y receptors have been identified in most tissues with the P2Y2 receptor 
(previously P2U) being the most widely distributed of the known P2-subtypes 
(Barnard et al, 1996). Features and distribution of P2Y receptor subtypes are 
shown in Table 1.2.  
1.3.6.3  Co-expression of P2-receptors 
Given the widespread and overlapping distribution of P2-receptor subtypes, it is 
not surprising that most cells which express these receptors, co-express several 
different subtypes. Endothelial cells show functional responses which indicate 
that both P2Y1 and P2Y2 receptors co-exist on these cells (O’Connor et al, 1991). 
The proportion of each of these receptor subtypes present depends on the 
particular blood vessel. Similarly, P2Y1 and P2Y2 receptors are found on 
hepatocytes (Keppens, 1993) and folliculated Xenopus oocytes, which means that 
only defolliculated oocytes should be used for P2-receptor mRNA expression of 
cloned receptors (King et al, 1996). P2X and P2Y receptors are co-expressed on 
neurones and rat aortic smooth muscle making interpretation of functional 
studies difficult, since they are activated by the same agonists (Kitajima et al, 
1994; Surprenant, 1996). Leukocytes also co-express several P2-receptor 
subtypes and while mast cells express P2Y1 and P2Z receptors (Cockcroft & 
Gomperts, 1979b; Osipchuck & Cahalan, 1992), macrophages express P2Y2 and 
P2Z (Nuttle et al, 1993). In contrast, lymphocytes from patients with chronic 
lymphocytic leukaemia only express P2Z receptors (Wiley et al, 1992, 1993). 
Another complicating factor altering P2-receptor expression is the  in vitro 
desensitisation of P2Y and P2X1 receptors on endothelial cells and differentiated 
HL-60 leukocytes, respectively, from continued exposure of these cultured cells  
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to ATP, released into the culture medium from other dying cells (Barnard et al, 
1996; Buell et al, 1996). 
1.4  Functions of P2X and P2Y Receptors 
The biological effects of extracellular ATP have been documented in most 
organs and tissues of the body, where ATP has a key role in cell-cell 
communication. These functional effects observed for extracellular ATP reflect 
the sum of effects on P2-receptor subtypes expressed in those tissues (Section 
1.3.6.3) (Dubyak & El-Moatassim, 1993). Understanding and further 
clarification of the functional role of individual receptor subtypes is at an 
exciting stage, now that cloning and expression of new receptor subtypes is 
occurring at a great pace. These studies should provide much information, which 
may eventually lead to new treatment modalities for a number of 
pathophysiological conditions.  
1.4.1  P2X Receptors 
Numerous early studies clearly showed that extracellular ATP mediated smooth 
muscle contraction of isolated muscles from a variety of organs and tissues, such 
as vas deferens, intestine, blood vessels and urinary bladder (Burnstock, 1972). 
In the autonomic nervous system, extracellular ATP acts as a cotransmitter at 
neuroeffector junctions, where it acts on smooth muscle P2X receptors. In 
sympathetic nerves, ATP and noradrenaline are released together in synaptic 
vesicles (Burnstock, 1990) and, although the relative contribution of ATP and 
noradrenaline mediating vasoconstriction varies greatly between blood vessels, it 
is ATP that mediates the more rapid transmission component (Kennedy et al, 
1996). ATP is also co-released with acetylcholine to control urinary bladder 
function, and also with various neuropeptides, including vasointestinal peptide 
and neuropeptide Y (Burnstock, 1996). Extracellular ATP also acts as a fast 
excitatory neurotransmitter between neurones in autonomic ganglia (Evans et al, 
1992) and in the central nervous system (Edwards et al, 1992).  
P2X receptors appear to have a role in some pathophysiological situations. For 
example, extracellular ATP causes pulmonary hypertension, hypersensitivity of 
the detrusor muscle in neurogenic bladder and has a role in the pathophysiology 
of interstitial cystitis (Abbracchio & Burnstock, 1994).  
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1.4.2  P2Y Receptors 
Smooth muscle relaxation has been the hallmark of P2Y stimulation and 
differentiated this receptor from P2X receptors. (Burnstock, 1990). In blood 
vessels, stimulation of endothelial P2Y1 and P2Y2 receptors leads to the 
activation of two enzymes, cytoplasmic phospholipase A2 (cPLA2) and nitric 
oxide synthase, and their resultant products (prostacyclin and nitric oxide 
respectively) cause vascular smooth muscle relaxation and vasodilatation 
(Boarder et al, 1995). Stimulation of P2Y receptors activates other enzymes, 
which include some in the glycogenolytic (P2Y2), steroid synthetic and 
eicosanoid producing pathways (Boarder et al, 1995). In addition, P2Y receptors 
upregulate surface adhesion molecules (Altieri et al, 1990) influencing the 
inflammatory response.  
P2Y receptors modulate synaptic transmission in some sympathetic ganglia 
(Brown, 1988) and may also have this function in the central nervous system. 
Stimulation of P2Y receptors mediates secretory responses in endocrine and 
paracrine cells, including pancreatic β cells, chromaffin cells, alveolar type II 
pneumocytes, airway goblet cells, leukocytes and mast cells (Dubyak & El-
Moatassim, 1993). P2Y receptors have trophic effects and are involved in 
embryonic development, wound healing, growth, smooth muscle proliferation 
and differentiation for a variety of cell types (Burnstock, 1996).  
P2Y receptors also stimulate ion transport in thyroid, intestinal, renal and 
pulmonary epithelial cells (Dubyak & El-Moatassim, 1993). The ability of P2Y2 
receptors to stimulate chloride transport in airway epithelium has been exploited 
for therapeutic purposes in patients with cystic fibrosis. Thus, inhaled UTP is 
given to raise cytosolic Ca2+ and to stimulate Ca2+-dependent Cl- secretion and 
bypass the defective chloride transporter, (CFTR), with alleviation of disease 
symptoms (Mason et al, 1991; Boarder et al, 1995). 
1.4.3  Functional Effects due to the Interaction of Multiple P2-receptor 
Subtypes 
Extracellular ATP has complex effects on the cardiovascular system, since P1, 
P2X and P2Y receptors are present in heart, as well as blood vessels. Thus ATP 
contributes to the maintenance of vascular tone and regional blood flow through 
P2X-mediated contractile responses, while vasodilatation is promoted by P1 and 
P2Y receptors. These P2Y responses also protect against thrombosis, since 
prostacyclin and nitric oxide inhibit platelet aggregation (Boarder et al, 1995).  
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Burnstock & Wood, (1996) have postulated that a combination of P2X receptor 
subtypes may be involved in pain sensation. It is likely that the P2X3 receptors of 
small nociceptive sensory neurones (Table 1.1) have a key role. Any tissue 
damage in the periphery would liberate ATP in the region of P2X3-expressing C-
fibres, which synapse with P2X4 and P2X6-expressing sensory neurones of the 
spinal cord, which in turn synapse with neurones in the nocicentre of the brain 
(Burnstock & Wood, 1996). Vascular pain may also involve interacting P2-
receptors. For example, reactive hyperaemia in migraine follows reactive 
vasospasm, and may be due to P2Y stimulation from ATP released in large 
quantities from endothelial cells in this condition. The nitric oxide generated 
causes vasodilatation. ATP may also diffuse from the microcirculation to 
nociceptive endings of sensory fibres and activate P2X3 receptors and set in train 
the events described above. Increased platelet aggregation, which also occurs 
during migraine, releases more ATP from platelet granules, contributing to the 
response (Burnstock & Wood, 1996).  
It needs to be emphasised that in all these responses, adenosine formed from 
ATP breakdown may modulate the effects of P2-receptor stimulation, through 
activation of ubiquitously expressed adenosine receptors.  
1.5 Signal Transduction by P2-receptors 
1.5.1  Receptors and Signal Transduction Pathways 
Receptors can be broadly categorised into 3 main groups based on their structure 
and mechanism of transducing signals.  
• Multisubunit ligand-gated ion channels that open briefly and conduct ions 
in response to binding of a ligand, which is usually a small organic 
molecule, such as a neurotransmitter.  
• G protein-linked receptors where agonist binding causes interaction 
between an associated heterotrimeric G protein and an effector enzyme, 
such as adenylate cyclase or PI-PLC (PLC-β), with the production of 
second messenger molecules, cAMP or inositol trisphosphate (IP3) and 
diacylglycerol (DAG), respectively.  
• Cytokines and growth factor receptors, which have either intrinsic enzyme 
activity or are linked to kinase enzymes. These receptors initiate a series 
of protein-protein interactions and phosphorylation cascades which relay 
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most signals to the nucleus, altering the pattern of gene expression and 
hence cell behaviour.  
Structural (Section 1.3.4) and functional studies indicate that P2 receptors 
transmit signals through the first 2 pathways (Dubyak & El-Moatassim, 1993). 
1.5.2 Signalling Pathways of P2-receptors 
1.5.2.1  P2X receptor signalling pathway 
The binding of ATP to P2X receptors rapidly (milliseconds) opens a cation 
channel permeable to both Na+ and K+ (Benham & Tsien, 1987) and in some 
cases to larger cations, such as choline+ and Tris+ (Bean, 1992) (Figure 1.3). 
Electrophysiological studies show these ion channels to be Ca2+-selective with a 
relative Ca2+/Na+ permeability of 4:1. However, only 8% of the current evoked 
by ATP is carried by Ca2+ because of the relative extracellular concentrations of 
Na+ and Ca2+. In some cells, single channel currents have been measured in the 
10-20 pS range (Benham & Tsien, 1987; Bean, 1990). Unlike voltage-gated ion 
channels, opening of the P2X ion channel is independent of membrane potential 
(Bean, 1992). P2X receptor inactivation is very rapid for P2X1 and P2X3 
receptors (5 milliseconds) and relatively slow for most other P2X receptors (2 - 
10 s) (Surprenant, 1996). As with other ionotropic receptors, P2X receptors are 
opened by the binding of several (2 or more) agonist molecules, which is 
consistent with a multisubunit structure for the receptor (Bean, 1990). Diffusible 
second messengers cannot be involved in P2X signalling because of the rapid 
kinetics of channel opening (Harden et al, 1995). Thus stimulation of neuronal 
P2X receptors with ATP causes a rapid influx of Ca2+ and Na+, depolarisation of 
the cell membrane, subsequent activation of voltage-gated Na+ channels and 
production of an action potential. In smooth muscle cells, P2X receptor-induced 
depolarisation activates voltage-gated Ca2+ channels increasing cytosolic Ca2+ 
concentration ([Ca2+]i) and mediating smooth muscle contraction through a 
Ca2+/calmodulin (Ca2+/CaM) dependent activation of myosin light chain kinase 
as described in Section 1.5.3. (Harden et al, 1995). 
1.5.2.2  P2Y receptor signalling pathways 
ATP stimulation of P2Y receptors, which are coupled to heterotrimeric G 
proteins, activates the PI-PLC signalling pathway where the hydrolysis of 
phosphatidylinositolbisphosphate (PIP2) results in the simultaneous production of 
two second messengers, DAG and IP3. DAG activates protein kinase C (PKC),  
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and IP3 binds to IP3 receptors of endoplasmic reticulum, releasing Ca2+ from 
those stores and thus raising [Ca2+]i (Berridge, 1993). Different P2Y receptor 
subtypes show specificity in the PI-PLC signalling pathway (Boarder et al, 1995; 
Harden et al, 1995) by coupling to specific α or βγ G protein subunits, which in 
turn activate certain isoforms of PI-PLC (Cockcroft & Thomas, 1992). Thus 
P2Y1 receptors couple to the pertussis toxin insensitive Gq α subunit, which 
activates the PI-PLC-β1 isoform, while evidence suggests that P2Y2 receptors 
couple to βγ subunits of pertussis toxin sensitive Gi, which activate PI-PLC-
β2/β3 isoforms (Boarder et al, 1995). The actions of second messengers in 
effecting P2Y-mediated responses is discussed in Sections 1.5.3 and 1.5.4.  
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Figure 1.3 Signalling pathways of P2-receptors 
Adapted from Dubyak & El-Moatassim (1993) 
1.5.3   Ca2+ signalling 
A rise in cytosolic Ca2+ concentration is one of the most ubiquitous of second 
messenger pathways. In order for an increase in [Ca2+]i to act as a second 
messenger, cytosolic [Ca2+] must be tightly controlled at very low levels of ≈ 100 
nM (Vogel, 1994). This is maintained by the activity of plasma membrane Ca2+- 
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ATPases, which pump Ca2+ to the exterior of the cell and by the endoplasmic 
reticulum Ca2+-ATPases, which return cytosolic Ca2+ to stores. Cell activation 
raises bulk [Ca2+]i to about 1 μM, although subplasmalemmal levels may rise to 
10 μM or more (Augustine & Neher, 1992). Stimulation of P2-receptors on most 
cell types rapidly elevates cytosolic Ca2+ concentration, by either influx from the 
extracellular medium (P2X) or from mobilisation of intracellular Ca2+ from the 
endoplasmic reticulum stores (P2Y) (Figure 1.3). With P2Y signalling, there is 
an associated Ca2+ influx through the refilling channel in response to Ca2+ store 
depletion, which is referred to as “capacitative Ca2+ entry” (Putney, 1986). The 
action of Ca2+ in mediating P2X functional effects has already been described 
(Section 1.5.2.1). The rise in [Ca2+]i associated with P2Y receptor stimulation 
mediates its effects through  
• activation of Ca2+-dependent ion channels 
• stimulation of Ca2+-dependent exocytosis 
• translocation of cytosolic proteins to the plasma membrane increasing 
their activity eg protein kinase C (PKC) 
• binding to intracellular Ca2+ binding proteins, which include calmodulin 
(see below) and phospholipases (Section 1.5.4). 
Neuronal P2Y receptors probably act much like other slow metabotropic 
receptors by modulating the function of neuronal ion channels, such as activating 
Ca2+-dependent K+ or Cl- channels, which in turn regulate membrane potential 
and excitability of these cells (Hille, 1992). In non excitable cells, P2Y2 receptor 
stimulation regulates Cl- and other ion transport in epithelial cells through Ca2+ 
activation of these ion channels (Dubyak & El-Moatassim, 1993). P2Y receptor-
stimulated exocytosis is mediated by [Ca2+]i which promotes granule vesicle 
fusion with plasma membranes, a complex process also involving phospholipase 
D (PLD) (Section 1.7.6). However, many other effects of P2Y stimulation are 
mediated by calmodulin (CaM).  
Calmodulin is a universal and versatile intracellular Ca2+ receptor, with the 
capacity to sense a 10 fold increase in [Ca2+]i and translate that rise into a 
physiological response. In the cell CaM is mainly in the free state, but rapidly 
binds Ca2+ as [Ca2+]i rises. CaM has 4 helix-loop-helix Ca2+ binding domains, 
which bind Ca2+ molecules in a cooperative manner in the presence of a target 
protein, enabling CaM to act as an on/off switch over a narrow range of [Ca2+]i 
(Vogel, 1994). Many of CaM targets exist in a deactivated state, because they 
contain an inhibitory peptide domain which masks the active site. Binding of  
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Ca2+/CaM produces conformational change in this region, unmasking the active 
site. A classical example is the activation of Ca2+/CaM-dependent protein kinase 
II (CaMKII) by Ca2+/CaM, which exposes the active phosphorylating site 
(Hidaka & Kobayashi, 1992). Ca2+/CaM targets associated with P2Y signalling 
include nitric oxide synthase (Bredt & Snyder, 1990) and the plasma membrane 
Ca2+-ATPase pump. This pump is activated several seconds after receptor 
mediated rises in [Ca2+]i and functions to remove excess Ca2+ and restore Ca2+ 
homeostasis. The subsequent fall in Ca2+ concentration results in dissociation of 
Ca2+/CaM, followed by the release of the target protein and termination of the 
signal (Carafoli, 1994). Some Ca2+/CaM targets are enzymes associated with 
gene expression and cell proliferation and these may have a role in P2Y mediated 
trophic responses. Such enzymes include Ca2+/CaM-dependent endonucleases, 
some transcription factors and those associated with phosphorylation 
dephosphorylation cascades: CaMKII and calcineurin (Vogel, 1994). 
1.5.4  Secondary signalling pathways 
In addition to activating CaM-dependent pathways, P2Y-mediated increase in 
[Ca2+]i stimulates a number of Ca2+-dependent phospholipases, such as PC-
specific PLC, PLD and PLA2. Protein kinases, including PKC and mitogen 
activated protein kinases (MAPK) are also activated through P2Y receptor 
stimulation (Dubyak & El-Moatassim, 1993; Davis, 1993). There is often a 
complex interplay between the products and enzymes of these pathways. 
1.6  The P2Z receptor 
1.6.1  History of P2Z receptors 
In cells of the immune system, ATP activates pore-forming receptors, although 
other P2-receptors of P2X or P2Y class may also be present. Earliest reports of 
the permeabilising effect of extracellular ATP appeared in the late 1960’s, when 
Hempling et al, (1969) showed volume changes in Ehrlich ascites tumour cells 
and Parker & Snow (1972) found similar effects in dog erythrocytes. These 
reports were followed by others, which showed the permeabilising effect of 
extracellular ATP on rat mast cells and transformed fibroblasts (Dahlquist & 
Diamant, 1974; Rozengurt, et al, 1977). In 1979, it was first proposed that rat 
mast cell permeabilisation was due to receptor activation, and that the ATP4- 
species was the agonist (Cockcroft & Gomperts, 1979a). In 1986, Gordon  
22 
 
proposed that these receptors be designated P2Z, since their properties are 
distinct from P2X and P2Y receptors. This classification has since been endorsed 
by the IUPHAR committee (Fredholm et al, 1994). The permeabilising effect of 
extracellular ATP was then used to alter the intracellular ionic and nucleotide 
composition of susceptible cells (Gomperts & Fernandez, 1985; Weisman et al, 
1989). The first indications of the possible role extracellular ATP in the immune 
system came from studies showing that ATP modulated lymphocyte proliferation 
(Gregory & Kern, 1978), NK cell-dependent cytotoxicity (Schmidt et al, 1984) 
and macrophage phagocytosis (Sung et al, 1985). This possible relationship led 
to detailed investigations in the mid 1980’s by both the Dubyak & Silverstein 
groups. 
1.6.2  Pharmacological Profile 
1.6.2.1  Agonist potency profile 
Early in the history of the P2Z receptor it was recognised that only the ATP4- 
species could open the P2Z ion channel (Cockcroft & Gomperts, 1980). Many 
other studies have shown that extracellular Mg2+ and Ca2+ blocked P2Z-mediated 
responses by converting ATP4- to either, MgATP2- or CaATP2- (Steinberg & 
Silverstein, 1987; El-Moatassim et al, 1990; Alonso-Torre & Trautmann, 1993; 
Wiley et al, 1990). Reducing extracellular pH diminished responses to ATP, 
since the inactive HATP3- species formed (Redegeld et al, 1991). The 
requirement for ATP4- species explains why μM to mM ATP concentrations are 
required to stimulate the P2Z receptor in physiological solutions compared with 
nM to μM ATP for P2X and P2Y receptors (Dubyak & El-Moatassim, 1993). 
The P2Z receptor has a pharmacological profile of agonist potencies which is 
distinct from that of P2X and P2Y receptors (Fredholm et al, 1994). The P2Z 
response is very sensitive to alterations in ATP structure and few synthesised 
analogues stimulate the receptor (Tatham et al, 1988; Wiley et al, 1994). 
Benzoylbenzoic ATP (BzATP) (Figure 1.4) was considered to be selective for 
the P2Z receptor, since it caused Ca2+ influx without triggering release of internal 
Ca2+ in murine macrophages and rat parotid acinar cells, which also express P2Y 
receptors (El-Moatassim & Dubyak, 1992; McMillian et al, 1993). However, 
BzATP is a weak and partial agonist for the human macrophage P2Y2 receptor 
(Blanchard et al, 1995) and a variety of native and cloned P2X receptors 
(Surprenant, 1996). Thus BzATP is a useful agonist for studying P2Z responses 
in murine but not human macrophages co-expressing P2Y receptors, or in P2X-  

  
Table 1.3 Distribution and some properties of P2Z receptors 
Cells Species Agonists Pore Size Features Selected References 
mast cells rat ATP4- ≈ 900 Da sigmoid kinetics of pore opening  Cockcroft & Gomperts, 1979b;  
Tatham & Lindau, 1990 
macrophages mouse  BzATP>>ATP ≈ 900 Da biphasic inward current: small rapid 
followed by large delayed 
Steinberg et al, 1987;  
Nuttle & Dubyak, 1994 
 rat ATP4- ≥200 Da subconductance states for small current Naumov et al, 1996a,b 
microglial 
cells 
mouse BzATP>>ATP ≈ 900 Da selected a clone which ATP depolarises, 
but does not permeabilise 
Di Virgilio et al, 1996 
macrophages human BzATP>>ATP ≈ 900 Da IFNγ-treatment increases P2Z expression  Blanchard et al, 1991;  
Hickman et al, 1994; 
thymocytes mouse ATP4- < 300 -  
≈ 450 Da 
sigmoid kinetics of pore opening Pizzo et al, 1991; 
El-Moatassim et al, 1990; 
NK cells human BzATP>>ATP ≈ 350 Da  Chen, 1995 
HPB-TALL human BzATP>>ATP ≈ 350 Da  Chen, 1995 
B cells mouse ATP ?  Di Virgilio et al, 1989 
B cells 
leukaemic 
human BzATP>>ATP ≈ 350 Da low  level on normal, but increased in 
CLL: CD19+, CD20+, CD5+, sIg (weak) 
Wiley & Dubyak, 1989;  
Wiley et al, 1994 
fibroblasts mouse BzATP>>ATP < 1 kDa  Saribas et al, 1993;  
Erb et al, 1990 
acinar cells rat 
mouse 
BzATP>>ATP 
ATP4- 
< 300 Da 
? 
parotid cells 
lacrimal cells 
Soltoff et al, 1992; 
Sasaki & Gallacher, 1992  
NK, natural killer; CLL, chronic lymphocytic leukaemia; HPB-TALL, human peripheral blood T cell acute lymphoblastic leukaemia cell line; 
CD, cluster differentiation antigen; sIg, surface immunoglobulin 
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1.6.2.2  Antagonists 
Only recently has a specific, reversible and potent antagonist become available 
for the P2Z receptor (Section 3.4 of this thesis). Suramin (Figure 1.5), which 
inhibits most P2-receptors, also antagonises the P2Z receptor, although its 
inhibitory potency towards the lymphocyte P2Z receptor is weak (IC50 60 μM) 
compared to that for P2X receptors (IC50 1-10 μM) (Wiley et al, 1994; 
Surprenant, 1996). Reactive blue 2 inhibits the P2Z receptor with a similar, but 
low potency (IC50 70 μM).  
Among the more potent inhibitors of the P2Z receptor are the amiloride 
analogues, such as 5-(N,N,-hexamethylene) amiloride (HMA) (Figure 1.5), 
which inhibits permeant fluxes in human lymphocytes and Xenopus oocytes 
injected with murine macrophage mRNA (Wiley et al, 1990, 1992; Nuttle & 
Dubyak, 1994). However, high concentrations of HMA (40 - 100 μM) only 
block P2Z-mediated ion fluxes by 70 - 85%, despite IC50 values of 2 - 10 μM 
(Wiley et al, 1990, 1993). This incomplete inhibition has been attributed to 
existence of two conductance states of the P2Z receptor (Section 1.6.6.2), which 
show differential sensitivity to HMA (Nuttle & Dubyak, 1994).  
The best known inhibitor of the P2Z receptor is oxidised ATP (ox-ATP), the 
2′,3′-dialdehyde of ATP (Figure 1.5), which reacts with lysine residues at ATP 
binding sites to form a covalent Schiff base. This reaction gave total and 
irreversible inhibition of P2Z receptors on mouse macrophages, while ox-ATP 
was without effect on co-expressed P2Y1 and P2Y2 receptors (Murgia et al, 
1993). Similarly, P2Z responses in human lymphocytes were irreversibly 
blocked, provided cells were preincubated with ox-ATP for 60 min prior to 
addition of agonist (Wiley et al, 1994). However, ox-ATP also irreversibly 
inhibits P2X responses in chick myotubes under the same preincubation 
conditions (Thomas et al, 1991), but reversibly inhibits other native and cloned 
P2X receptors, when shorter preincubation times are used (≈ 15 min) 
(Surprenant, 1996). Another irreversible inhibitor of many ATP-requiring 
enzymes, 5′fluorosulphonylbenzoyl adenosine (FSBA), also inhibited P2Z-
mediated ion fluxes but the maximum inhibition attained was only 60 - 90% 
(Wiley et al,  1994). 
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anionic), but not trypan blue (961 Da) (Steinberg et al, 1987) while human 
lymphocyte P2Z passes ethidium+ but not propidium+ (414 Da) (Wiley et al, 
1993). Mouse thymocytes showed variable responses to fluorescent dyes, 
permeable to TMA-DPH (468 Da) in one study (El-Moatassim et al, 1990), but 
only to methylglucamine+ (NMG+) (190 Da) in another (Pizzo et al, 1991). In 
contrast, rat parotid cells were not permeable to fluorescent dyes (Soltoff et al, 
1992), while mouse fibroblasts became permeable to phosphorylated metabolites 
and large macromolecules, including fluorescein isothiocyanate-dextran (9 kDa) 
Weisman et al, 1984; Saribas et al, 1993). These differences in size pass of 
permeants for the lymphocyte and macrophage P2Z ion channel may reflect 
different isoforms of the channel or may be due to different conductance states of 
the channel in different cells (Wiley et al, 1996) (Section 1.6.3.3).  
1.6.3.1  Measurement of ion channel activity 
Early techniques of examining ion channel activity relied on measurement of 
ionic fluxes using radioisotopes eg. 45Ca2+, 22Na+, 42K+, 86Rb+ and 36Cl-. 
Ca2+ flux studies have been revolutionised by the introduction of fluorescent, 
membrane permeant, Ca2+-sensitive reporter molecules. These Ca2+ indicators are 
modelled on the structure of the Ca2+ chelator, EGTA, and have selectivities 5 - 6 
orders of magnitude greater for Ca2+ than for Mg2+. Their Ca2+ buffering capacity 
is also in the physiological range (10 nM to several μM) (Tsien (1980). These 
dyes are readily introduced into the cell in a non-disruptive manner, since their 
acetoxymethyl esters are membrane permeant. Once inside the cell, these Ca2+ 
indicators are de-esterified by cellular esterases and thus trapped. When Ca2+-
indicators bind to free Ca2+, their spectral properties change and this can be 
monitored by a fluorescence recording device. Several fluorescent Ca2+ 
indicators are available, but fura-2 is the most widely used, since it is less Mg2+ 
sensitive, less subject to photobleaching, has a higher KD (224 nM) for Ca2+ and 
can be used in the ratio mode. The fluorescence excitation maximum of fura-2 
shifts from 360 nm for the Ca2+-free form to 340 nm for the Ca2+-bound form, 
with negligible shift in the emission maximum, 510 nm. Changes in bulk 
cytosolic [Ca2+] are thus measured using an excitation wavelength of 340 nm, 
while for ratiometric analysis 340 and 380 nm are used, since they conveniently 
lie on either side of the isosbestic point (360 nm) (Thomas & Delaville, 1991). 
Agonist-stimulated internal release of Ca2+ from cell stores can be distinguished 
from agonist-stimulated Ca2+ influx through plasma membrane ion channels. 
When fura-2 loaded cells are suspended in Ca2+-free solutions containing EGTA, 
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any [Ca2+]i increase must be due internal Ca2+ release. Any rise in [Ca2+]i, which 
occurs in Ca2+-, but not EGTA-containing solutions, must be due to Ca2+ influx. 
The fura-2 technique can be used to measure initial rates of Ca2+ or Ba2+ influx, 
and thus monitor ATP-stimulated cation uptake (Wiley et al, 1994). Ba2+ is a 
convenient surrogate for Ca2+, since both are good permeants of the P2Z-
operated ion channel (Section 1.6.3.3). Moreover, Ba2+ has some advantages over 
Ca2+, since Ba2+-fura-2 has similar spectral properties to Ca2+-fura-2 and once 
inside the cell, Ba2+ is neither pumped or sequestered by transport ATPases 
(Schilling et al, 1989; Wiley et al, 1994). 
Electrophysiological methods, including patch clamping provide information 
about the kinetics of channel opening, the direction and amplitude of currents in 
whole cells or individual channels (unitary conductance), the selectivity of 
conducting ions and their permeability ratios as well as conductance states of the 
ion channel.  
Permeabilisation can be assessed by incubating individual cells or cell 
populations with ATP4- in the presence of small fluorescent dyes, which on entry 
into the cell combine with cellular components and their fluorescent properties 
are altered. Uptake of fluorescent dyes into cells can be observed microscopically 
(Steinberg et al, 1987), spectrophotometrically (Gomperts, 1983) or by time 
resolved flow cytometry (Wiley et al, 1993). The advantages of the flow 
cytometric technique are that thousands of cells are assessed from very small 
samples, only cell associated fluorescence is measured and quantitation of 
uptakes can be accurately assessed.  
1.6.3.2  Kinetics of channel opening 
Electrophysiological studies on cells expressing P2Z receptors show that 
application of ATP4- rapidly induces an inward, depolarising current carried by 
Na+, with an opening time of 0.2 s or less, confirming that there is an associated 
ion channel (Tatham & Lindau, 1990; Brettschneider et al, 1995). This inward 
current is distinguishable from the outward, desensitising Ca2+-activated K+ 
current resulting from ATP stimulation of P2Y receptors, which are also present 
with P2Z receptors on macrophages (Coutinho-Silva et al, 1996). ATP4--induced 
currents do not desensitise even if ATP is present for up to 30 min (Buisman et 
al, 1988). These currents are fully reversible on removal of ATP by washing or 
by complexing ATP4- with molar excess Mg2+ (Tatham & Lindau, 1990; 
Steinberg et al, 1987). ATP-induced permeant fluxes of Ba2+ or ethidium+ in 
human lymphocytes are also rapidly reversed on addition of Mg2+ (Wiley, et al, 
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1993). However, the large, delayed BzATP-induced current carried by both 
organic and inorganic cations, which was identified by Nuttle & Dubyak (1994) 
(Section 1.6.3.3) did not reverse when ATP was washed away or Mg2+ added. As 
with most ligand-gated ion channels, sigmoid kinetics have been demonstrated 
for the effect of ATP on the permeability responses in mast cells and 
lymphocytes, with Hill coefficients of ≈ 2.0. Thus, the P2Z ion channel may be 
composed of several subunits that bind two or more ATP molecules in a co-
operative manner to open the P2Z ion channel (Tatham & Lindau, 1990; Wiley et 
al, 1990, 1992, 1993, 1994, Pizzo et al, 1991).  
1.6.3.3  Cation selectivity  
Stimulation of the P2Z receptor on lymphocytes, macrophages and mast cells 
opens a nonselective cation channel, which conducts a range of inorganic and 
organic cations. In lymphocytes, ATP increased the fluxes of K+, Rb+, Na+, Li+, 
Ca2+, Sr2+, Ba2+, Mn2+, choline+, N-methylglucamine+ (NMG+) as well as the 
weak bases, NH4+, monomethylamine+ and dimethylamine+ (Wiley & Dubyak, 
1989; Wiley et al, 1990, 1992, 1993, Pizzo et al, 1991; El-Moatassim et al, 1990; 
Chen et al, 1994). In the macrophage cell line J774, ATP stimulated fluxes of K+, 
Rb+, Na+ and Ca2+ (Steinberg & Silverstein, 1987; Steinberg et al, 1987). 
Patch-clamp studies on lymphocytes, mast cells and macrophages confirm that 
ATP stimulates an inward, nonselective cation current with reversal potentials of 
around 0 mV for physiological saline solutions (Brettschneider et al, 1995; 
Tatham & Lindau, 1990; Buisman et al, 1988). In one study of Xenopus oocytes 
injected with macrophage mRNA (Nuttle & Dubyak, 1994) and subsequently 
stimulated with BzATP, two conductance states were discerned. There was a 
rapidly activated inward current, which could be carried by small inorganic 
cations such as Na+, K+ or Li+, followed one minute later by a large, inward 
current carried by the larger organic cations (NMG+ or Tris+) as well as Na+, K+ 
and Li+. Unlike the initial rapid conductance, this second phase was temperature 
and HMA sensitive. It was proposed that these two conductance states 
represented the initial opening of an ion channel and subsequent formation of a 
pore (Nuttle & Dubyak, 1994). Similarly, Naumov et al, (1995a) also 
demonstrated two phases of an ATP4- induced current in rat macrophages, the 
first phase showing a conductance of 3.5 - 4.5 pS with 4 subconductance levels, 
while the second large inward current, which could be carried by Tris+ only 
appeared when the ATP4- concentration was above 500 μM. Others have 
reported whole cell conductances ranging from 5 - 10 pS in macrophages 
30 
 
(Buisman et al, 1988) and 35-70 pS in mast cells (Tatham & Lindau, 1990), but 
have not resolved single channel currents. However, single channel conductances 
of 2 - 10 pS have been measured in lymphocytes (Brettschneider et al, 1995), and 
macrophages (Coutinho-Silva et al, 1996). These single channel conductances 
are much smaller than expected for a pore capable of conducting molecules up to 
900 Da and may correspond to the first phase conductance described by Nuttle & 
Dubyak (1994). This general inability to detect a conductance compatible with 
ATP-induced pore formation has led to several hypotheses to accommodate the 
available data. Thus it has been suggested that the small ATP4--induced current 
and permeabilisation to small solutes are separate phenomena, perhaps mediated 
by two P2Z receptor isoforms (Coutinho-Silva, et al, 1996). It is also possible 
that the same receptor activates two channels of different size or alternatively, the 
continued presence of ATP leads to the recruitment of ion channel subunits to 
form a pore of varying size. This would explain the temperature dependency of 
the large ATP-gated pore (Steinberg et al, 1987; Tatham & Lindau, 1990; Nuttle 
& Dubyak 1994). 
One common feature of P2Z ion channels is their considerable selectivity for 
Ca2+ over monovalent cations. Thus ATP-induced whole-cell currents in human 
B lymphocytes studied by the voltage-clamp technique showed a permeability 
ratio of PCa:PK:PNa = 35:2:1 (Brettschneider et al, 1995). Flux studies, in which 
various cations were added to inhibit ethidium+ as permeant, gave a permeability 
ratio of Ca2+:Na+ = 30:1 (Wiley et al, 1996). Similarly, a permeability ratio of 
PCa:PK:PNa = 68:4:1 was measured by electrophysiology in rat macrophages 
(Naumov et al, 1995b). Thus, in both macrophages and lymphocytes the P2Z ion 
channel shows a greater selectivity for Ca2+ over monovalent cations than P2X 
receptors, where the permeability ratio is PCa:PNa is 4:1 (Bean, 1992). 
The entry of various permeants through P2Z ion channel is attenuated when cells 
are suspended in extracellular NaCl media compared with Na+-free media 
containing KCl, choline chloride or NMG Cl. This inhibitory effect of 
extracellular Na+ has been shown for both human leukaemic lymphocytes (Wiley 
et al, 1992, 1993, 1994) and mouse thymocytes (Pizzo et al, 1991) and with 
many permeants, Ca2+, Ba2+, Rb+ and ethidium+. Some of this inhibitory effect 
may result from competition between Na+ and other ions for passage through the 
channel. However, Na+ may also interact with modifying sites on the P2Z 
receptor to inhibit occupancy of the receptor or channel opening (Wiley et al, 
1996). 
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1.6.4  Distribution 
P2Z receptors are found mainly on cells of immune and haemopoietic origin. 
Functional studies indicate that P2Z receptors are expressed in mast cells, 
macrophages, including microglial cells and epidermal Langerhan’s cells, some 
lymphocyte subsets, fibroblasts, some transformed cells and acinar cells of some 
salivary glands (Table 1.3). Most cells expressing P2Z receptors generally co-
express either P2Y1 receptors (mast cells) and/or P2Y2 receptors (macrophages) 
(Osipchuck & Cahalan, 1992; Nuttle et al, 1993; Alonso-Torre & Trautmann, 
1993). However, lymphocytes from patients with chronic lymphocytic leukaemia 
only express P2Z receptors and since this receptor has been well characterised 
(Wiley et al., 1990, 1992, 1993, 1994), these lymphocytes are an ideal cell type 
for the study of the functional effects of extracellular ATP.  
1.6.5 Relationship to P2X receptors 
P2Z and P2X receptors are often expressed on different cell types and have 
distinct pharmacological profiles. While both P2X and P2Z receptors are ligand-
gated ion channels and share other common features, there are some attributes 
which are different. Differences in Ca2+-selectivity have already been described 
(Section 1.6.3.3) (Brettschneider et al, 1995; North, 1996). While the P2Z ion 
channel is unique in its permeability to small fluorescent dyes, P2X1 ion channels 
are also permeable to Tris+ and NMG+, suggesting a diameter of 0.9 - 1 nm based 
on molecular sizes (North, 1996). P2X receptors function in neurotransmission 
but they may also have a role in apoptosis, since P2X1 receptor cDNA is identical 
to the RP-2 gene cDNA (Valera et al, 1994), which was cloned by subtractive 
hybridisation between apoptotic and nonapoptotic thymocytes (Owens et al, 
1991). There are also suggestions that the P2Z receptor may have a role in the 
cell death response (Section 1.6.6.1) (Di Virgilio et al, 1996). P2X receptors 
have a putative topology of two transmembrane segments, which is analogous to 
the structure of the mechanosensitive ion channel of the nematode 
Caenorhabditis elegans and functions in neurodegeneration (North, 1996). 
Recently, upregulation of P2X1 receptors was demonstrated in immature mouse 
thymocytes during dexamethasone-induced apoptosis (Chvatchko, et al, 1996), 
suggesting that P2X and P2Z receptors may have some common properties in the 
nervous and immune systems. 
A close relationship between the P2X and P2Z receptors was recently confirmed 
by the successful cloning of a P2-receptor from rat brain, which showed typical 
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P2Z receptor pharmacology and permeability properties (Surprenant et al, 1996). 
The first 395 amino acids were shown to have 35 - 40% homology with P2X 
receptors and this new receptor was designated P2X7 on the basis of this 
homology. The P2X7 receptor has a much longer carboxyl terminal domain than 
other P2X subtypes, which was shown to confer the unique permeability of the 
P2X7 channel to large cations such as fluorescent dyes (Surprenant et al, 1996). 
Electrophysiological studies on this cloned receptor showed a reversal potential 
around 0 mV without rectification and current amplitudes that were dramatically 
potentiated in the absence of divalent cations. This is typical of P2Z receptors, 
but not of other P2X receptors (North, 1996). Furthermore, when the cloned 
P2X7 receptor was stimulated by BzATP, it could produce 2 distinct currents, 
similar to those described by Nuttle & Dubyak (1994) (Section 1.6.3.3). Thus, 
the transient, HMA-insensitive current was carried by small inorganic cations 
while the sustained current was carried by both inorganic and organic cations, the 
latter representing the nonselective pore. However, this latter current could only 
be evoked on repeated or prolonged exposure to ATP in the absence of divalent 
cations and its sensitivity to HMA was not tested. It was proposed that this 
second current may be a novel Ca2+-independent mechanism responsible for 
P2Z-mediated cell death (Surprenant, et al, 1996). For this thesis, the lymphocyte 
P2Z receptor will be treated as a separate class, since this receptor does not share 
all the features of the cloned P2X7 receptor. 
1.6.6  Possible functions 
Currently, the precise function of the P2Z receptor-operated ion channel in 
immune and haemopoietic cells is unknown. However, as indicated earlier 
(Section 1.6.5) there is evidence suggesting that the P2Z receptor may have a role 
in cell death (Di Virgilio et al, 1996).  
1.6.6.1  Cell death/apoptosis 
ATP appears to mediate both apoptosis and necrosis, depending on the target cell 
type and the concentration of ATP used (Zanovello et al, 1990; Zheng et al, 
1991), suggesting the possibility that both P2X and P2Z receptors may be 
involved (Chvatchko et al, 1996). Apoptosis is a long term process involving 
gene expression and protein synthesis, which is characterised by cell and 
chromatin shrinkage and DNA fragmentation, but maintenance of membrane 
integrity. In contrast, necrosis occurs rapidly, with cellular and organelle swelling 
and early membrane rupture (Zheng et al, 1991). In EL-4 cells (mouse thymoma 
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cell line), low concentrations of ATP induce DNA fragmentation and 
morphological changes consistent with apoptosis, but higher ATP concentrations 
release 51Cr, indicative of necrosis (Zheng et al, 1991) 
Other evidence that P2Z receptors mediate cell death come from studies on ATP 
resistant and ATP sensitive clones. For example, ATP resistant ATPR G6 cells, 
derived from the ATP sensitive J774 macrophage cell line, are unresponsive to 
ATP-induced permeabilisation and lysis, unlike the parent line (Greenberg et al, 
1988). In another cell line, ATP induced permeabilisation and cell lysis of 
L929/R fibroblasts, but the parent line, L929 were not permeabilised to dyes, 
although ATP still produced a nonselective inward current (Pizzo et al, 1992). 
These experiments directly link permeabilisation with cell death. 
The cytokine, IFN-γ, upregulates the expression of P2Z receptors on human 
monocytes/macrophages, and this increased expression correlated with P2Z-
induced permeabilisation and cytolysis or DNA fragmentation (Blanchard et al, 
1991; Falzoni et al, 1995; Molloy et al, 1994). In some of these studies, 
treatment of macrophages with ATP for only 15 min was sufficient to initiate the 
lytic pathway, since there was an increase in 51Cr release or DNA laddering, 4 to 
6 h later (Blanchard et al, 1991; Molloy et al, 1994). The lytic response could be 
inhibited by the calmodulin antagonists, trifluoperazine (TFP) and KN-62 
(Blanchard et al, 1995). In macrophages chronically infected with viable BCG1 
bacteria, ATP4- stimulated macrophage apoptosis and subsequent killing of the 
intracellular parasite (Molloy et al, 1994). Thus inflammatory cytokines may 
upregulate the expression of P2Z receptors on immune effector cells, and after a 
brief exposure to extracellular ATP released at sites of tissue 
damage/inflammation, these cells may then undergo cell death along with the 
infecting agent (Di Virgilio et al, 1996). 
Additional evidence linking activation of P2Z receptors and cell death comes 
from the observation that interleukin-1β converting enzyme (ICE) is activated in 
monocytes/macrophages during ATP stimulation (Hogquist et al, 1991; 
Perregaux & Gabel, 1994; Laliberte et al, 1994). ICE is an intracellular cysteine 
protease, which has a key role in tumour necrosis factor-α (TNF-α) and Fas-
induced apoptosis in mammalian cells (Enari et al, 1995; Miura et al, 1995). In 
lipopolysaccharide-stimulated macrophages, ICE cleaves immature IL-1β to 
form mature IL-1β. Some evidence suggests that ATP-stimulated release of 
                                              
1 bacillus Calmette-Guérin, a form of Mycobacterium bovis 
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mature IL-1β is due to P2Z-mediated K+ efflux, since the K+ ionophore nigericin 
also has this effect (Perregaux & Gabel, 1994; Di Virgilio et al, 1996). BzATP, 
but not UTP induces release of mature IL-1β from lipopolysaccharide-treated 
macrophages (Laliberte et al, 1994). Kinetics of ATP-stimulated release of 
mature IL-1β from lipopolysaccharide-treated macrophages parallel those of 
ATP-induced apoptosis (Hogquist et al, 1991). Thus several lines of evidence 
suggest a relationship between P2Z activation, release of IL-1β and apoptosis. 
1.6.6.2  Other functions 
Several reports indicate that ATP activation of P2Z receptors mediates 
membrane remodelling events. Extracellular ATP stimulates granule exocytosis 
in rat mast cells (Cockcroft & Gomperts, 1979a; Osipchuck & Calahan, 1992) 
increases vesicle formation in murine macrophages (Cohn & Parks, 1967) and 
promotes fusion of macrophages to form multinucleate giant cells (Falzoni et al, 
1995). These effects of ATP may result from phospholipase D activation, which 
may produce the necessary membrane remodelling required for fusion events 
(Section 1.6.7) 
Extracellular ATP, acting via P2Z receptors modulates proliferative responses in 
a variety of immune cells. Thus ATP, together with PMA stimulates DNA 
synthesis in murine thymocytes (El-Moatassim et al, 1987) while ATP or BzATP 
synergise with T cell mitogens in stimulating DNA synthesis in human T 
lymphocytes (Baricordi et al, 1996). In contrast, extracellular ATP inhibits the 
growth of erythroleukaemia cells (Chahwala & Cantley, 1984). 
Another physiological role for extracellular ATP may be the modulation of 
adhesion molecules expressed on the surface of lymphocytes. In human 
leukaemic lymphocytes, BzATP and ATP stimulated shedding of the surface 
adhesion molecule, L-selectin through occupancy of P2Z receptors (Jamieson et 
al, 1996). L-selectin2 shedding involves the proteolytic cleavage by a membrane 
metalloproteinase (Kishimoto et al, 1989) which can be activated by ATP, but it 
is not known whether a phospholipase D with GPI specificity is responsible 
(Section 3.5). L-selectin shedding also occurs during lymphocyte transmigration 
through endothelium (Ager & Wood, 1994) following adhesive interactions 
between lymphocytes and endothelial cells. Endothelial cells release ATP to the  
                                              
2 L-selectin is an integral protein held in the plasma membrane by its either TM domain or by a GPI 
anchor (Bazil, 1995). 
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medium under conditions of fluid flow and it is likely that high local 
concentrations of ATP may be achieved in the microenvironment of adherent 
lymphocytes (Hassessian et al, 1993). Thus extracellular ATP may have a 
physiological role in lymphocyte-endothelial interactions as a modulator of L-
selectin expression and thus influence lymphocyte trafficking (Jamieson et al, 
1996). 
1.6.7 Signalling 
Activation of P2Z receptors opens an associated ion channel and causes influx of 
Ca2+, which raises [Ca2+]i in the absence of other second messengers (El-
Moatassim & Dubyak, 1993). There is no evidence that the PI-PLC signalling 
cascade is activated by ATP interaction with P2Z receptors (El-Moatassim et al, 
1987; McMillian et al, 1988). However, in patch clamp studies of rat 
macrophages, GTPγS applied to the cytoplasmic face of the patch mimicked the 
effect of ATP applied to the external membrane, in the size of the current and 
their subconductance levels (Naumov et al, 1995b). In contrast, internal GDPβS 
had no effect on current stimulated by ATP in rat parotid cells (McMillian, et al, 
1988). 
In a study on murine BAC1.2F5 macrophages, El-Moatassim & Dubyak (1992) 
showed that a phosphatidylcholine specific PLD was activated by ATP or 
BzATP. Certain features suggested that PLD activation was mediated by P2Z, 
but not by P2Y2 receptors: 
• rank order of agonist potency BzATP >> ATP > ATPγS, while UTP, ADP 
and adenosine inactive 
• enhancement in Ca2+- and Mg2+-free medium, indicating that ATP4- was 
the agonist  
• inhibition by extracellular Na+ 
• inhibition by ox-ATP. 
ATP-stimulated PLD activity in these cells was directly related to agonist 
occupancy of the P2Z receptor, rather than the subsequent effects of P2Z 
receptor stimulation. Thus, PLD activation was not a response to membrane 
depolarisation, since the ionophore gramicidin did not initiate activity, nor was it 
due to general membrane permeabilisation, since digitonin had no effect. Ca2+ 
influx produced by the Ca2+ ionophore, ionomycin, had no effect on PLD nor did 
Ca2+ mobilisation, since platelet activation factor (PAF), an agonist of a G- 
36 
 
protein coupled receptor, was also without effect. An unusual feature was that a 
significant component of ATP-stimulated PLD activity occurred in the absence 
of extracellular Ca2+ (El-Moatassim & Dubyak 1992). ATP-stimulated PLD 
activity was inhibited when the cells were suspended in medium where Na+ was 
replaced by iso-osmotic choline+. It was proposed that choline+ entered the cell 
through the P2Z pore to prevent PLD activation by end product inhibition (El-
Moatassim & Dubyak, 1993). Choline+ did not prevent ATP-stimulated 
membrane depolarisation or Ca2+ influx, and it was suggested that PLD 
activation and pore formation were mediated by separate but closely related 
receptors. The effects of choline+ on longer term events eg. ATP-induced uptake 
of fluorescent dyes was not assessed. In this context, the ATP-mediated lactic 
dehydrogenase release from J774 mouse macrophages was inhibited by choline+ 
(Murgia et al, 1992). 
1.7 Phospholipase D 
1.7.1  History  
Phospholipase D (PLD) activity was first described in plant tissues in 1948 when 
Hanahan and Chaikoff showed that an enzyme in carrot roots and cabbage leaves 
catalysed the degradation of phosphatidylcholine (PC) to phosphatidic acid (PA) 
plus choline. PLD activity in plant tissues has been well characterised and has 
been reviewed by Heller (1978). Although PLD activity is also present in 
bacteria and fungi (Heller, 1978), it was not realised that it also occurred in 
mammalian tissues until PLD activity was demonstrated in solubilised membrane 
preparations from rat brain (Saito & Kanfer, 1973) and in human eosinophils 
(Kater et al, 1976). The first report of receptor-mediated PLD activity was by 
Cockcroft (1984), who demonstrated that fMet-Leu-Phe stimulation of 
neutrophils generated PA directly from phospholipid hydrolysis, rather than from 
phosphorylation of DAG. Soon after a kinetic analysis of DAG and PA 
production in vasopressin-stimulated hepatocytes showed that PA was generated 
prior to DAG (Bocckino et al, 1987). Furthermore, HPLC analysis of the fatty 
acid composition of the generated PA and DAG indicated the source 
phospholipids were PC and PIP2 respectively, indicating that vasopressin 
stimulated PLD activity. More direct evidence came from two studies of water 
soluble products released from [3H]choline-labelled lymphocytes stimulated by 
IL-1 (Rosoff et al, 1988) and ATP-stimulated bovine pulmonary aortic 
endothelial cells (Martin & Michaelis, 1989). Both studies showed that 
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[3H]choline, but not [3H]phosphorylcholine was released, consistent with the 
notion that PLD hydrolysed PC. Subsequently, agonist-stimulated PLD activity 
has been reported in many cells and for a wide variety of agonists including 
neurotransmitters, growth factors, antigens, and adhesion molecules (Exton, 
1994). 
1.7.2 Enzymology 
Receptor-mediated hydrolysis of membrane phospholipids is catalysed by a 
variety of phospholipases with distinct phospholipid specificities. Phospholipase 
D (EC 3.1.4.4) catalyses the hydrolysis of phospholipids at their terminal 
phosphodiester bond producing PA and the polar headgroup, choline (Figure 1.6) 
(Cockcroft, 1992). PLD attacks the phospholipid substrate to form a transient 
phosphatidyl-PLD intermediate. When water is the acceptor, PA is the product. 
However in the presence of other nucleophilic acceptors such as primary 
alcohols, PLD catalyses the transphosphatidylation reaction, which was first 
demonstrated in plant tissues by Yang et al (1967) and in mammalian tissues by 
Kobyashi and Kanfer (1987). In this reaction, PLD preferentially transfers the 
phosphatidyl moiety to the alcohol to form a stable end product, 
phosphatidylalcohol (Figure 1.7) (Billah, 1993), which is only slowly 
metabolised by cellular enzymes (Metz & Dunlop, 1990a). This reaction has 
proven an extremely useful tool for the detection of PLD activity (Billah, 1993). 
In contrast to phosphatidylalcohols, PA is readily metabolised to DAG by PA 
phosphohydrolase, while PA can be generated by other pathways, such as de 
novo synthesis and phosphorylation of DAG by DAG kinase (Liscovitch & 
Chalifa, 1994). 
Membrane PC is the preferred phospholipid substrate for PLD, since analysis of 
the fatty acid composition of PA or phosphatidylbutanol (PBut) corresponded to 
that of PC rather than phosphatidylinositol (PI) or phosphatidylethanolamine 
(PE) (Bocckino, 1987; Heung & Postle, 1995). Purified PLD from pig lung also 
showed strict specificity toward PC, since it hydrolysed PC but not PE or PI 
(Okamura & Yamashita, 1994). However, there are some forms of PLD with 
broader substrate specificity that also hydrolyse PE and PI (Kiss & Anderson, 
1990; Balsinde et al, 1989). While PC comprises ≈ 40% of the total phospholipid 
content of plasma membranes, the majority is distributed in the outer leaflet, with 
only 26% of PC (10% of total lipids) in the inner leaflet (Graham, 1992). 
Significant changes to the inner  leaflet  phospholipid  composition  occurs  when  
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Figure 1.6  Hydrolysis of phosphatidylcholine by phospholipases  
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PLD is activated, since an estimate of 2.8% of the total PC pool was hydrolysed 
during a 20 s stimulation of neutrophils with fMet-Leu-Phe (Cockcroft, 
1992).There is an absolute requirement for the acidic phospholipid, PIP2 in in 
vitro assays of PLD activity using exogenous radiolabelled PC vesicles as 
substrate (Brown et al, 1993) and for GTPγS-stimulated PLD in permeabilised 
cells (Whatmore et al, 1994). PIP2 also dramatically increased the activity of 
partially purified, membrane PLD activity (Liscovitch et al, 1994). PIP2 
promotes the exchange of GDP for GTP on the small G protein, ADP 
ribosylation factor (ARF) and regulates GTPγS-stimulated PLD activity 
(Whatmore et al, 1994). Thus PIP2 is an essential cofactor for PLD activity, 
although there is evidence suggesting that sodium oleate can substitute for PIP2 in 
certain PLD forms. (Massenburg et al, 1994; Cockcroft, 1996). 
The above evidence suggests that there are at least two isoforms of agonist-
stimulated PLD activity: a membrane bound form with specificity for PC, which 
is activated by PKC, and a cytosolic, Ca2+-dependent form that hydrolyses PC, PI 
and PE (Liscovitch & Chalifa, 1994). Other evidence for the presence of several 
PLD isoforms come from several studies. In one study two peaks of PLD activity 
were obtained from detergent-solubilised preparations of rat brain, one peak 
activated by oleate, but insensitive to GTPγS and ARF (Section 1.7.4.3), while 
the second peak was an ARF-dependent PLD activity (Massenburg et al, 1994). 
Another study of HL-60 cells showed a membrane bound and a cytosolic PLD 
activity, which could be distinguished by their Ca2+ sensitivities (Siddiqi et al, 
1995). While both forms were GTPγS-dependent, they were differentially 
regulated by two small G proteins, ARF and Rho. 
Base exchange enzymes, which constitute the only enzymes for synthesis of 
phosphatidylserine (PS) in mammalian cells, have sometimes been confused with 
PLD, but they are two different groups of enzymes. While PLD and the base 
exchange enzymes are phosphatidyltransferases, only PLD is a hydrolase, and 
only PLD can produce PA or phosphatidylalcohols (Liscovitch & Chalifa, 1994). 
A PLD enzyme with specificity for the GPI moiety of GPI-anchored membrane 
proteins (GPI-PLD), cleaves phosphatidic acid releasing the protein from the cell 
surface (Metz et al, 1994). 
1.7.3 Structure 
Molecular techniques have only recently been applied to PLD research, since this 
membrane associated enzyme has been difficult to purify. Both castor bean  
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(Wang et al, 1994) and mammalian PLD (Okamura & Yamashita, 1994; 
Hammond et al, 1995) have been purified and cloned. The cDNA for plant PLD 
codes for a 92 kDa protein with an N-terminal Ca2+-dependent phospholipid 
binding C2 domain3 (Ponting & Parker, 1996). The human PLD1 gene codes for 
a 1071 amino acid protein, with a predicted mass of 124 kDa. This PLD product 
shows specificity for PC, catalyses transphosphatidylation of primary alcohols, is 
dependent on GTPγS, rARF and PIP2 for activity and associates with membranes 
in transfected cells (Morris et al, 1996). There is little homology between plant, 
yeast and human PLD sequences, although each has 4 small homologous regions. 
There is some homology with PS synthase and cardiolipin synthase, suggesting a 
common active site, since all are phosphatidyltransferases (Morris et al, 1996). 
1.7.4  Regulation 
Multiple mechanisms are involved in the regulation of receptor-mediated PLD 
activity. Initially agonist-stimulated PLD activity was thought to be mediated by 
PKC following PI-PLC activation, since some evidence showed that PI-PLC 
activity is detected prior to PLD activity (Billah & Anthes, 1990). However, 
many other reports have provided evidence suggesting that PLD was also 
regulated independently of PI-PLC, and that Ca2+, G proteins or tyrosine 
phosphorylation pathways may be involved in regulating PLD activity (Exton, 
1994). 
1.7.4.1 Ca2+ dependence 
It is well known that Ca2+ has a role in the activation of PLD in many cell types, 
since calcium ionophores and many calcium mobilising agonists stimulate this 
enzyme. In most studies of intact cells extracellular &/or intracellular Ca2+ 
chelators prevent both agonist-stimulated rises in cytosolic [Ca2+] and PLD 
activity, irrespective of prior PI-PLC activation (Purkiss & Boarder, 1992; Wu et 
al, 1992; Lin & Gilfillan, 1992). In many of these studies however, it is not clear 
whether Ca2+ is regulating PI-PLC or PLD, since both enzymes are often 
activated (Section 1.7.4) (Exton, 1994). In contrast, a similar increase in Ca2+ 
concentration, approximating intracellular values (0.1 - 1 μM), does not stimulate 
PLD activity in subcellular fractions of rat liver plasma membranes, broken 
                                              
3 A C2 domain has an amino acid sequence which forms an 8-stranded β sandwich structure containing 4 
aspartic acid residues, which interact with Ca2+ and allow binding to phospholipids of membranes. PLC, 
PLA2, and all but the atypical PKC isoforms also contain C2 domains (Ponting & Parker, 1996). 
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human neutrophils or permeabilised HL-60 cells (Olson et al, 1991; Xie and 
Dubyak, 1991; Siddiqi & Exton, 1992; Whatmore et al, 1994). The results 
reported in Section 3.2 help explain the discrepancy between intact and broken 
cells in their Ca2+ requirement for PLD activation. 
1.7.4.2 PKC 
In most cell types studied, PMA, a membrane permeant and irreversible activator 
of PKC (Nishizuka, 1992), also activates PLD, implicating PKC as a regulator of 
this activity (Cockcroft, 1996). Notable exceptions are BAC1.2F5 macrophages, 
(El-Moatassim & Dubyak, 1992) normal human T lymphocytes and some T cell 
leukaemic lines (Kinsky et al, 1989). The kinetics of PMA-activated and agonist-
stimulated PLD activity are quite different. PMA produces a linear increase in 
PA or PEt for up to an hour, while receptor agonists often produce a rapid peak 
within one minute followed by a gradual decline over time (Metz & Dunlop, 
1990b; Cockcroft, 1992). There is additional evidence that PKC is responsible 
for PLD activation, namely that exogenous DAG activates PLD (Billah et al, 
1989) and PKC inhibitors attenuate PLD activity (Purkiss & Boarder, 1992) 
although the specificity of PKC inhibitors is suspect (Wilkinson & Hallam, 
1994). Downregulation of cellular PKC activity by prolonged incubation (24 h) 
of cells with PMA generally abrogates both PMA- and agonist-stimulated PLD 
activity (Liscovitch & Chalifa, 1994). It has been suggested that PKC promotes 
ARF translocation to the membrane. This would account for the observation that 
pretreatment of cells with PMA immediately prior to permeabilisation prevented 
the usual loss of GTPγS-stimulated PLD activity as cytosolic components were 
lost from the cell (Whatmore et al, 1994; Cockcroft, 1996). Thus a stable, PLD 
signalling complex appears to form on the inner plasma membrane.  
Attempts have been made to determine which of the numerous PKC isoenzymes 
regulate PLD activity. Overexpression studies have implicated PKC-β1 in 
regulating PMA- and agonist-stimulated PLD activity in haemopoietic cells 
(Liscovitch & Chalifa, 1994) and PKC-ε in rat mesangial cells (Pfeilshifter & 
Merriweather, 1993), while antisense mRNA for PKC-α blocked PLD activity in 
fibroblast membranes (Conricode et al, 1994). In those cells where receptor 
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agonists, but not PMA stimulate PLD activity, a phospholipid-insensitive 
isoform of PKC4 (eg PKC-ζ) may regulate PLD. 
1.7.4.3 G proteins 
There is considerable evidence indicating that G proteins regulate agonist-
stimulated PLD activity. Thus GTPγS is a potent agonist for PLD activation in 
permeabilised cells and membrane preparations (Cockcroft, 1992; Kusner & 
Dubyak, 1994). However, GTPγS can activate other signalling pathways which 
may impact on PLD activation, including PI-PLC, PLA2 and 
phosphatidylinositol 3-kinase (PI 3-kinase) (Cockcroft, 1996). Indeed, in many 
systems it is clear that PLD activation is downstream of PI-PLC activity 
(Sections 1.5.4 & 1.7.4.2). PLD activity does not appear to be under direct 
control of a separate, heterotrimeric G protein, since AlF4-, which activates large, 
but not small G proteins (Kahn, 1991) rarely activates PLD in cell-free systems 
(Liscovitch & Eli, 1991; Bowman et al, 1993). Pertussis toxin, which ADP-
ribosylates Gi, rarely inhibits receptor-stimulated PLD activity in intact cells 
(Liscovitch & Chalifa, 1994). However, a role for small cytosolic G proteins is 
suggested by the need for cytosolic factor(s) for enzyme activity in cell free 
assays or in permeabilised cells, which could be satisfied by the addition of 
exogenous ARF (Brown et al, 1993; Cockcroft et al, 1994) or permeabilising the 
cells in the presence of GTPγS (Kusner & Dubyak, 1994). Thus ARF 
translocates to the plasma membrane on exchange of GDP for GTP and regulates 
GTPγS-mediated PLD activity in a PIP2-dependent manner, forming a stable, 
active PLD signalling complex (Whatmore, et al 1994; Kusner & Dubyak, 1994). 
Several recent studies suggest that other small G proteins such as Rho, which 
mediates stress fibre formation, may also be involved in the regulation of PLD 
activity (Bowman et al, 1993; Siddiqi et al, 1995). However, in intact cells, it is 
ARF rather than Rho that is the physiological regulator of GTPγS-mediated PLD 
activity (Martin et al, 1996). It is yet to be determined whether ARF regulates 
receptor-mediated PLD activation (Cockcroft, 1996). It is also possible that in 
those cases where PLD activity occurs downstream of PI-PLC, PKC activation 
regulates ARF, which in turn controls PLD activity (Cockcroft, 1996). 
                                              
4 DAG acts by translocating cytosolic PKC to the plasma membrane in a Ca2+-dependent or Ca2+-
independent manner. 
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1.7.4.4 Tyrosine phosphorylation 
A large number of growth factors and cytokines, with intrinsic tyrosine kinase 
activity stimulate PLD activity (Exton, 1994). Often, but not always, these 
agonists activate PKC, since they are coupled to PLC-γ (Ahmed et al, 1994). 
Receptor tyrosine kinase activation can be bypassed by the use of vanadates, 
which promote tyrosine kinase activity by inhibiting tyrosine phosphatases. 
Vanadates stimulate PLD activity in leukocytes, and this effect could be inhibited 
by the tyrosine kinase inhibitors, genistein and herbimycin, suggesting a role for 
tyrosine phosphorylation in the activation of PLD (Kusner et al, 1993). 
Furthermore, there was evidence of an interaction between tyrosine 
phosphorylation and G protein activation. However, it is not known if PLD or 
one of its regulators is a substrate for receptor tyrosine kinases, or whether 
another kinase in the phosphorylation cascade stimulated by these receptors, 
activates PLD (Exton, 1994).  
1.7.5 Measurement 
PLD activity can be assayed in whole cells or in cell free conditions by 
measuring the natural products, choline or PA. However, both choline and PA 
are subject to rapid conversion to other products by cellular enzymes. Thus 
choline is converted to phosphorylcholine by choline kinase, and PA to DAG by 
PA phosphohydrolase. Furthermore, choline and PA can be generated from the 
products of PI-PLC activity (phosphorylcholine and DAG) by choline 
phosphatase and DAG kinase, respectively. Thus assays of the natural products 
of PLD activity are difficult to interpret because only net quantities are measured 
(Shukla & Halenda, 1991).  
In contrast, the transphosphatidylation assay is quite specific, since the 
phosphatidylalcohol end product only forms as a result of PLD activity, and is 
only metabolised slowly (Metz & Dunlop, 1990a). In this technique cells are 
prelabelled with radiolabelled phospholipid precursors. Tritiated or [14C]-labelled 
fatty acids may be used to metabolically label phospholipids. [3H]oleic acid is 
commonly used, since it labels phospholipids in the sn-2 position and these are 
the most common species of PC attacked by PLD (Heung & Postle, 1995). 
[3H]myristic acid is also used because it preferentially labels PC compared to 
other fatty acids (Liscovitch & Chalifa, 1994). One of the problems with fatty 
acid labelling is that the specific activity of the label is reduced in serum or 
bovine serum albumin (BSA) because of the fatty acid content of the proteins. 
Tritiated glycerol incorporates during phospholipid synthesis and has been used 
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for transphosphatidylation assays. Lysophospholipids, such as 1-O-alkyl-2-
hydroxyl-sn-glycerophosphocholine, incorporate particularly well into 
neutrophils, but not many other cells, where they are readily acylated by cellular 
enzymes. [32P]orthophosphate has been used, but the labelling and enzyme assay 
must be performed in low phosphate medium to achieve high specific activity 
(Bonser & Thompson, 1992). The radiolabelled phosphatidylalcohols produced 
by PLD activity are extracted from cells into organic solvents, separated by thin 
layer chromatography, identified by autoradiography and quantitated by 
scintillation spectrometry. 
Recently a method was described for measuring PLD activity, based on 
converting choline into a luminescent product. In this reaction, choline is 
oxidised to betaine and hydrogen peroxide (H2O2) on addition of choline oxidase. 
The H2O2 generates luminescence from luminol in the presence of horseradish 
peroxidase (Lucas et al, 1995). However, while this method is much less time 
consuming than radioactive methods described above, it suffers the 
disadvantages mentioned above for the measurement of choline production. 
Cell free assays of PLD activity rely on the use of radiolabelled phospholipids, 
either as prelabelled membranes as already described, exogenous [14C]PC or PC 
conjugated to a fluorescent ligand, such as BODIPY (Ella et al, 1994). These 
assays require the presence of cytosol or rARF plus PIP2 (Section 1.7.2). 
1.7.6 Functions 
The physiological significance of receptor-stimulated PLD activity is not clear. 
Only recently has PLD been purified and a mammalian gene cloned (Section 
1.7.3), which should rapidly advance knowledge and understanding of PLD 
function. Much effort has been directed at establishing a function for PA, 
although in the brain, PLD-generated choline is an important source of choline 
for the resynthesis of acetylcholine (Klein et al, 1995). PA is normally present in 
membranes at very low concentrations and levels rise briefly during agonist-
stimulated PLD activity. Much evidence implicating a role for PA in cellular 
processes is indirect and based on: 
• kinetic and pharmacological correlations of PA production and cellular 
responses 
• the use of ethanol or butanol to inhibit cellular responses, by diverting PA 
production into the metabolically inert products PEt or PBut, an 
incomplete reaction because some PA always forms  
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• addition of exogenous PA or PLD to cells to raise PA levels in a receptor 
independent manner. Although it has been postulated that a PA receptor 
exists (English, 1996), in its absence, this PA must translocate to the inner 
membrane for effect 
• use of propanolol, as a PA phosphohydrolase inhibitor, to prolong the 
effects of PA (Liscovitch & Chalifa, 1994). 
The effects of PA production are likely to be localised. There is evidence that 
PLD activation occurs not only at the plasma membrane, but also at the nuclear 
(Balboa et al, 1995) and Golgi membranes (Ktistakis et al, 1995).  
Many studies focus on examining the role of PA as a second messenger in 
enzyme activation, particularly in neutrophils. Evidence from these studies has 
established a role for PA in receptor-stimulated NADPH oxidase activity and 
subsequent superoxide production (Liscovitch & Chalifa, 1994). There is also 
some evidence that the activity of several other enzymes may be regulated by 
PA. These include PI-4-P 5-kinase, a protein tyrosine phosphatase, PLCγ, PKCζ, 
several GTPase activating proteins (GAP), including ARF.GAP and 
serine/threonine kinase (Cockcroft, 1996). In addition, PA itself is a source of 
other second messengers, such as DAG and arachidonic acid.  
Receptor mediated PLD activity alters the lipid composition of membranes, 
replacing inner leaflet PC with PA, an anionic phospholipid with a smaller 
headgroup. These changes may produce regions with altered lipid packing and 
promote membrane fusion (Park  et al, 1992). Thus PLD-induced membrane 
remodelling of cell membranes may promote secretory responses. A correlation 
was demonstrated between PLD activity and granule secretion in HL-60 cells 
(Xie et al, 1991; Cockcroft, 1992). Similarly, IgE-linked receptors on mast cells 
stimulated PLD activity with a concomitant release of histamine and arachidonic 
acid (Lin et al,  1991), and exogenous PLD added to pancreatic islets generated 
PA and stimulated insulin secretion (Metz & Dunlop, 1990b). PLD activation 
may also have a role in remodelling events of internal membranes. It has been 
suggested that ARF-stimulated PLD activity may be involved in membrane 
trafficking, where ARF plays a key role (Cockcroft, 1996).For example, 
brefeldin A, an inhibitor of ARF nucleotide exchange and secretory responses 
also inhibited ARF-induced PLD activity in Golgi membranes (Ktistakis et al, 
1995; Cockcroft, 1996).  
Some evidence suggests that growth factor-mediated PLD activity may be 
involved in long term responses such as cell proliferation. PA or PA-derived 
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DAG may translocate certain PKC isoforms (PKC-ε, PKC-ζ) (Ha & Exton, 
1993; Limatola et al, 1994) to the plasma membrane, thus initiating 
phosphorylation cascades (Exton, 1994). The identification of a gene (SP014) 
essential for meiosis in yeast as a PLD, lends some support for the role of PLD in 
proliferative responses (Morris et al, 1996). Finally some oncogenes regulate or 
are regulated by PLD (Exton, 1994). 
Recent evidence suggests that receptor-mediated PLD activity may influence the 
cytoskeleton and have a role in cell movement (Morris et al, 1996). Some studies 
indicate that the small G protein Rho, which has a dynamic role in regulating the 
cytoskeleton, may also activate PLD (Bowman et al, 1993; Siddiqi et al, 1995), 
while others show that PLD activity stimulates actin stress fibre formation via 
Rho (Ha et al, 1994; Cross et al, 1996). Another study shows an interaction 
between the actin binding protein, gelsolin and PLD (Steed et al, 1996). 
Although insufficient data is available at this stage, it is possible that PLD 
activity may be involved in cytoskeletal rearrangements and membrane 
deforming events, through interactions with cytoskeletal proteins, to regulate 
secretion, motility and proliferation. 
1.8 Aims of This Study 
The first aim of this study was to investigate the signalling pathways activated by 
extracellular ATP in human lymphocytes, in particular to find out whether the 
stimulation of the P2Z receptor activated PLD. 
A second aim was to investigate whether it was the rise in cytosolic [Ca2+] or 
Ca2+ influx produced by ATP that activated PLD and to examine whether Ba2+ 
and Sr2+, which are permeants for the P2Z ion channel, have any effects on ATP 
-stimulated PLD activity. 
A third aim was to determine whether ATP-stimulated PLD activation could be 
implicated in ATP-induced apoptosis by examining the effect of several 
calmodulin inhibitors, known to inhibit P2Z-mediated lysis in macrophages, on 
both these actions of ATP. 
A fourth aim was to ascertain whether KN-62, a CaMKII inhibitor and KN-04, 
its inactive analogue were direct and selective inhibitors of P2Z-mediated 
responses.  
The fifth aim was to examine a possible role of ATP-stimulated PLD activity in 
mediating L-selectin shedding from the lymphocytes by examining the effects of 
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inhibitors of both GPI-PLD and the metalloproteinase associated with L-selectin 
shedding. 
A sixth aim was to determine if ATP, the natural ligand for the P2Z receptor, was 
a partial agonist, in comparison to BzATP, which previous observations showed 
to stimulate a greater Ba2+ influx. These experiments would also establish 
whether only one P2-receptor was expressed on human leukaemic lymphocytes. 
A final aim was to find out whether ATP-stimulated PLD activity was implicated 
in the permeability changes associated with P2Z activation and cell death, by 
examining the effects of choline+ and pre-exposure to ATP. 
Methods 
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2.1 Materials 
2.1.1 Radiochemicals 
The following radiochemicals were obtained from Amersham, Buckinghamshire, 
UK: [9,10-3H]oleic acid (10 Ci/mmol), 1,2 di [1-14C]palmitoyl L-3 
phosphatidylcholine (112 mCi/mmol) and [methyl-14C]choline (55 mCi/mmol). 
133Ba2+ (3 mCi/mg) was from Dupont, Boston MA, USA. 
[14C]phosphatidylbutanol ([14C]PBut) standard was prepared by PLD hydrolysis 
of [14C]PC according to the method of Bonser & Thompson (1992). Briefly, 1 
μCi [14C]dipalmitoylPC (25 μCi/ml, specific activity 152 μCi/mg) was 
solubilised in 5 mM sodium dodecyl sulphate in 0.1 M sodium acetate buffer, pH 
5.6 by sonication, 375 mM CaCl2, 7.5% butanol-1-ol and 100 units cabbage PLD 
(Sigma Chemical Co, St Louis, MO, USA) were added in a total volume of 1 ml 
and incubated for 4 h at 30°C with constant sonication. The reaction was 
terminated by addition of 3 ml chloroform:methanol (1:2 vol/vol) and the phases 
split by addition of 1 ml each of 1 M NaCl and chloroform. The lower phase was 
removed and evaporated to dryness under a stream of N2, the lipids reconstituted 
in 100 μl chloroform: methanol (95:5 vol/vol) and [14C]PBut purified by TLC, 
using the solvent system for separation of [3H]PBut (Section 2.4). The [14C]PBut 
was eluted from TLC plates in chloroform:methanol (2:1), the solvent evaporated 
and the dried lipid films were stored under anhydrous conditions at -20°C.  
2.1.2 Chemicals 
Nucleotides and nucleosides. ATP, BzATP, ADP, oxidised ATP (ox-ATP), 
adenosine, UTP, FSBA, were from Sigma Chemical Co, St Louis, MO, USA. 
α,β-methylene ATP, 2-methylthio-ATP were from Research Biochemicals Inc., 
Natick, MA, USA. ATPγS was from Boehringer-Mannheim, Sydney, Australia. 
Stock solutions of ATP (100 mM) were prepared in HEPES buffered KCl 
medium and neutralised (pH 7.0) with trimethylammonium hydroxide (TMA). 
P2Z receptor inhibitors. Suramin was a gift from Bayer (Sydney, Australia), and 
the amiloride analogue, 5-(N,N-hexamethylene) amiloride (HMA) was from 
Research Biochemicals Inc. 
Lymphocyte preparation and cell culture materials. Ficoll-Paque (density 1.077) 
and dextran T-500 were obtained from Pharmacia, Uppsala, Sweden. Fetal calf 
serum and powdered RPMI-1640 medium, were obtained from Flow 
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Laboratories, North Ryde, Australia. Gentamicin sulphate was from Roussell, 
Castle Hill, Australia.  
Solvents. TLC solvents were chromatography or HPLC analytic grade and all 
other solvents were reagent grade. Ethylacetate and chloroform were from 
Mallinckrodt, Clayton, Australia. Glacial acetic acid and trimethyl 2,2,4 pentane 
(iso-octane) were from Rhóne Poulenc, Clayton, Australia. Butanol (n-
butylalcohol) and toluene (Pronalys A.R. grade) were from May & Baker, West 
Footscray, Australia and methanol was from Biolab Scientific, Clayton, 
Australia. 
Isoquinolinesulphonamides. KN-62 (1-[N, O-bis(5-isoquinolinesulphonyl)-N-
methyl-L-tyrosyl]-4-phenylpiperazine) was from Research Biochemicals, Inc. 
and KN-04 (N-[1-[N-methyl-p-(5 isoquinolinesulphonyl)benzyl]-2-(4 
phenylpiperazine)ethyl]-5-isoquinoline sulphonamide) was from Seikagaku, 
Tokyo, Japan. Stock solutions were made in DMSO and stored at 4°C. 
Miscellaneous. Unlabelled PC (L-α-lecithin), PE (L-α-cephalin) and PA (1,2, 
diacyl-sn-glycero-3 phosphate, sodium salt) were used as standards for the 
separation of phospholipids by TLC and were from Sigma Chemical Co as were 
the following chemicals: ethidium bromide, propidium iodide, barium chloride, 
magnesium chloride, ethylene glycol-bis-(β-amino-ethyl ether) N, N′-tetra acetic 
acid (EGTA), phorbol ester (phorbol 12-myristate 13-acetate: PMA), iodine, 
digitonin, 1,10 phenanthroline monohydrate, sterile dimethylsulphoxide 
(DMSO), TMA and bovine serum albumin (BSA). Calcium chloride and glucose 
(D+) were from Merck, Darmstadt, Germany; strontium chloride from Fisher 
Scientific, Fairlawn, NJ, USA; and choline chloride was from British Drug 
Houses, Poole, UK. NaCl, KCl and ammonium chloride were from May and 
Baker, Melbourne, Australia. Thapsigargin was from Research Biochemicals Inc. 
HEPES and Tris were from Boehringer-Mannheim. Fura-2-AM and BAPTA-
AM were from Molecular Probes, Eugene, OR, USA. TLC plates (LK6D) were 
from Whatman, Maidstone, UK; En3Hance from Dupont and Hyperfilm MP was 
from Amersham International. Triton-X100 and 2,5-diphenyloxazole (PPO) were 
from Packard Instrument Co., Zurich, Switzerland. L-selectin monoclonal 
antibody (CD62L) was from the DREG.55 clone from Bender Medsystems, 
Vienna, Austria and anti-IgD antibody (sheep anti-human, IgG fraction) was 
from Silenus Laboratories, Hawthorn, Australia. The phthalate oil mixture used 
to separate cells from the incubation medium was a blend of di-n-butyl-phthalate 
(DBP) (d = 1044 g/ml) from British Drug Houses, Poole, England and di-n-
octyl-phthalate (DOP) (d =0.986 g/ml) from Ajax Chemicals Ltd, Sydney, 
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Australia, 7:3 (vol/vol). Trifluoperazine HCl (TFP) was from Smith, Kline & 
French Laboratories, Philadelphia, PA, USA. ARL-67156 (6-N,N-diethyl-D-β,γ-
dibromomethylene ATP) was a gift from Dr. P. Leff, Astra Charnwood, 
Loughborough, UK. Ro-31-9790 (Mr 315.4) was a gift from Dr A. Ager, 
National Institute for Medical Research, Mill Hill, London, UK and stock 
solutions were made in DMSO (30 mM) and used within 2 months. 
2.1.3 Buffers and Solutions 
Buffered medium used for washing cultured, [3H]oleic acid-labelled cells or 
lymphocytes separated from whole blood was HEPES buffered saline composed 
of 145 mM NaCl, 5 mM KCl, 10 mM HEPES, 5 mM glucose, 1 mM Ca2+ and 
0.1% BSA, pH 7.4 (referred to as HEPES buffered saline medium). Incubation 
media were either HEPES-buffered 150 mM KCl, 150 mM NaCl, or 150 mM 
choline Cl plus 5 mM glucose and 0.1% BSA. In some media, 0.2 mM EGTA or 
1 mM of either Ca2+, Ba2+ or Sr2+ was also added. In the fluorometry studies, the 
final concentration of divalent cations added was adjusted to give uptake slopes 
which could be accurately measured under the conditions of a given experiment.  
2.1.4 Cells 
Peripheral blood lymphocytes were obtained from 14 patients with B-cell chronic 
lymphocytic leukaemia (CLL cells). All patients were diagnosed from 
morphology of blood and bone marrow specimens as well as cell typing by flow 
cytometry. The peripheral blood leukocyte counts ranged from 32 - 100 x 109/l 
(normal range 4 - 12 x 109/l), of which 85 -99% were leukaemic lymphocytes. 
Patients ranged in age from 45 - 80 years. Consent was obtained from patients 
prior to withdrawal of blood samples, under the guidelines, and with approval of 
the Committee of Human Ethics in Research, Austin & Repatriation Medical 
Centre (formerly Austin Hospital) for project Nos. 52/92H and 33/93H. Some 
blood samples were obtained from normal human donors under the same 
guidelines as described above. 
2.2 Cell Preparation From Whole Blood 
2.2.1 Lymphocytes  
Venous blood (20 ml) from patients or normal donors (50 ml) was added to 
heparin anti-coagulant and diluted with either 2 vol of HEPES buffered RPMI-
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1640 medium or HEPES buffered saline medium. Mononuclear cells were 
separated from whole blood by density gradient centrifugation as described 
previously (Wiley & Dubyak 1989). Briefly, diluted blood was underlaid with 
Ficoll-Paque and centrifuged at 400 g for 30 min. Lymphoyctes were harvested 
from the interface of the medium and Ficoll-Paque, washed twice and 
resuspended in HEPES buffered saline medium or RPMI-1640 medium. 
Contaminating monocytes were removed by incubation of the cells in plastic 
culture flasks for 60 min at 37°C. Cytocentrifuge preparations showed that >98% 
of cells were small mature lymphocytes, whose phenotype was CD5+, CD20+. 
2.2.2 Neutrophils 
Venous blood (50 ml) from normal human donors was added to heparin anti-
coagulant and mononuclear cells removed as described above. Neutrophils 
passed through the Ficoll-Paque and formed a buffy layer over the red cell pellet. 
Red cells were removed by dextran sedimentation, by resuspending the red cell 
pellet in 5% dextran T-500 in saline to the original volume and incubating for 30 
min at 20°C. The leukocyte rich supernatant was removed, washed twice in 
HEPES buffered saline medium, contaminating red blood cells were removed by 
hypotonic lysis in 135 mM ammonium chloride buffered with 17 mM Tris, pH 
7.4 and the remaining neutrophils washed twice in HEPES buffered saline 
medium. Cytocentrifuge preparations showed that >99% of cells were 
neutrophils. 
2.2.3 Preincubation of Cells with Inhibitors 
Washed lymphocytes were incubated with TFP, KN-62 or KN-04 for 5 - 15 min 
at 37°C prior to addition of agonist and permeant cations and remained present 
during ATP stimulation. Preincubation of the above inhibitors with [3H]oleic 
acid-labelled cells suspended in 3 ml aliquots (1.1 x 107/ml) in HEPES buffered 
KCl medium was for 5 - 15 min at 37°C for TFP and isoquinolinesulphonamides, 
respectively, then 900 μl aliquots were removed into 100 μl butanol (final 
concentration 30 mM) warmed to 37°C for a further 5 min, then incubated with 
agonist and [3H]PBut measured as described in Section 2.4. Basal [3H]PBut, 
measured in the absence of agonist, but in the presence of maximal 
concentrations of inhibitor, was subtracted from each measurement.  
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2.3  Analytical Procedures 
2.3.1 Liquid Scintillation Counting 
Scintillant. Two scintillants were prepared. The scintillant for organic samples 
(phospholipids) was made by dissolving PPO (4 g/l) in toluene, while the 
cocktail for aqueous samples (cell pellets) was a mixture of toluene: triton X-100 
(2:1) containing PPO (4 g/l).  
Sample preparation. Phospholipid samples were scraped directly from TLC 
plates into 4.5 ml scintillant in 7 ml polyethylene counting vials and vigorously 
vortexed. Silica gel from the smaller [3H]PBut spots produced no quenching, 
while ≈ 5% was observed for the larger phospholipid spots. This was considered 
acceptable, since counts for these spots ranged between 100,000 - 150,000 c.p.m. 
and were similar for all phospholipid samples in a given experiment. Cell pellets 
(≈ 107/ml) were solubilised in 500 μl 5% triton X-100 for 1 h at 20°C and 450 μl 
of the lysate thoroughly mixed with 4.5 ml of scintillant to form a clear emulsion. 
Alternatively, cell pellets were dissolved in 500 μl 0.5 M NaOH overnight at 
20°C, vortexed and 450 μl transferred to counting vials containing 4.5 ml 
scintillant. The NaOH was neutralised with 50 μl concentrated HCl (11 N) to 
abolish chemiluminescence.  
Scintillation counting. Samples containing [3H]-labelled phospholipids or 
[14C]choline were counted in a window of 0 - 19 and 4 - 156 keV, respectively, 
on a Packard Tri Carb 300C liquid scintillation system with automatic efficiency 
correction (AEC) turned off. The quench indicating parameter (QIP), obtained 
from the energy spectrum of an external standard (226Ra), was used to monitor 
quenching due to sample variation. 
2.3.2 Flow Cytometry 
Optical Light Path. A Coulter Elite flow cytometer (Coulter Electronics, Hialeah, 
FL, USA.) fitted with an air cooled argon laser with an excitation wavelength of 
488 nm was used. The fluorescence emissions were collected at 90° to the 
incident beam using a series of dichroic mirrors, bandpass filters and 
photomultiplier tubes (PMTs) (Figure 2.1). The 488 nm side scatter light was 
separated from fluorescence emissions by a 488 nm dichroic mirror and a 
blocking filter (488 nm). This side scatter (90°) of the incident light was passed 
through a 488 nm band pass filter and collected in the side scatter detector.  
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4.00 (Coulter Electronics). Histograms of forward versus side scatter were 
collected for each run and used to gate out fluorescence signals associated with 
cell debris. 
Calibration. The flow cytometer was calibrated daily with Immunocheck 
alignment beads (Coulter Electronics) and minor adjustments to the laser 
alignment were made for maximal signal detection in all PMTs.  
3.3.3 Calculations of ATP4- Species Concentration 
Calculation of the relative concentrations of ATP4-, BaATP2-, and free Ba2+ or, 
for ATP4-, CaATP2-, and free Ca2+ for solutions containing varying 
concentrations of ATP and Ba2+ or Ca2+, respectively, were calculated using an 
updated version (3.0) of a previously published program, Bound and Determined 
(Brooks and Storey, 1992). Likewise, the concentrations of ATP required to give 
either 230 or 260 μM ATP4- were calculated for solutions of varying divalent 
cation composition and are shown in Appendix 2. Since the dissociation 
coefficients are unknown for BzATP, they were assumed to be the same as for 
ATP in this study. 
2.4   Phospholipase D Assay 
Phospholipase D assay. Lymphocytes, (107/ml) were cultured at 37°C for 18 - 24 
h in RPMI-1640 medium supplemented with gentamicin (40 μg/ml), 10% heat 
inactivated fetal calf serum, and [3H]oleic acid (2 - 5 μCi/ml, specific activity 10 
Ci/mmole) to label membrane phospholipids. Under these conditions, 61 ± 2.5% 
and 22 ± 4.2% (± S.D., n = 9) of the phospholipids labelled were PC and PE 
respectively. Labelled cells were washed twice in chilled HEPES buffered saline 
medium (Section 2.1.3) followed by a final wash in HEPES-buffered 150 mM 
KCl, 150 mM NaCl, or 150 mM choline Cl medium. One ml aliquots containing 
107 cells were warmed to 37°C in the presence of 30 mM butanol (Appendix 1) 
with or without 1 mM CaCl2 in glass culture tubes for 5 min prior to addition of 
agonist, and then incubated for 15 min with gentle mixing. In some experiments, 
0.2 mM Ca2+ was used instead of 1 mM (Appendix 2). The PLD reaction was 
terminated by addition of 1 ml of cold 20 mM MgCl2, since Mg2+ complex  
ATP4-, then the mixture was centrifuged at 1000 g for 5 mins and 1.0 ml ice-cold 
methanol added to the pellet. In some experiments, eppendorf tubes were used 
for PLD assays; the assay volume was 250 μl and the cell count 2 x 107/ml to 
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ensure adequate counts in the phospholipid spots. Cell viability after incubation 
with ATP was > 95 % by trypan blue exclusion. 
Lipid extraction and analysis. Membrane lipids were extracted by the method of 
Bligh and Dyer (1959) as modified by Metz and Dunlop (1990b). Briefly, 2 ml 
acidified chloroform (chloroform/HCl, 200:1, vol/vol) was added to cells in 
methanol, the sample vigorously vortexed and lipids extracted overnight at 4°C 
under N2. Phase separation was achieved by the addition of 0.75 ml 2M KCl 
containing 50 mM EDTA. After vortexing and centrifugation at 1000g for 5 min, 
the lower organic phase containing lipids was removed and the chloroform 
evaporated under a stream of N2. The lipid film was reconstituted in 20 μl 
chloroform/methanol (2:1, vol/vol), vortexed and 10 μl samples applied to heat 
activated (110°C, 15 min) TLC plates. Phospholipids were separated using the 
solvent system, ethyl acetate/iso-octane/acetic acid/water (13:2:3:10, v/v) under 
saturating conditions. Ten microlitres of PC, PE, PA standards (10 mg/ml in 
chloroform) and [14C]PBut standard (Section 2.1.1) were spotted on adjacent 
lanes. Standard and sample spots were located by I2 vapour and autoradiography 
of En3Hance sprayed TLC plates. The RF value obtained for sample spots of 
[3H]PBut was 0.43 ± 0.01 (n = 16). The [3H]phosphatidylbutanol ([3H]PBut) and 
[3H]phospholipid spots (including PC, PE, PS, PA and minor phospholipids) 
were scraped into scintillant fluid, vortexed and counted in a liquid scintillation 
counter as described (Section 2.3.1). The quantity of [3H]PBut was reported as a 
percentage of total [3H]labelled-cellular phospholipids for each sample lane of 
the TLC plate. PLD assays were performed in triplicate and data are expressed as 
the mean ± s.e.m. of n experiments.  
2.5   Cytosolic Ca2+, Ba2+ and Sr2+ Measurements by 
Fluorometry 
2.5.1   Technique 
Fura-2-AM purchased in 50 μg vials was reconstituted in 50 μl dry DMSO to 
make a 1 mM solution. Washed lymphocytes suspended in HEPES buffered 
saline medium were loaded with fura-2 (final concentration 2 μM) by incubation 
at 37oC for 20 min in the dark. Cells were then washed twice in HEPES buffered 
saline medium and incubated a further 5 - 10 min at 37oC for cellular esterases to 
complete removal of the AM groups. Cells (≈ 108/ml) were kept in the dark at  
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20°C, diluted to 2.0 x 106/ml in 3 ml of Ca2+-free 150 mM KCl HEPES buffered 
medium (Section 2.1.3) and warmed to 37°C in a stirred cuvette. The divalent 
cation of interest, either Ba2+, Sr2+ or Ca2+ was added as BaCl2, SrCl2 or CaCl2 to 
produce final concentrations ranging between 0.25 - 1.0 mM and was followed 
by the agonist, 30 s later. In some experiments, 0.2 mM EGTA was added in 
place of divalent cations. Changes in cellular fluorescence, which reflected 
changes in cytosolic Ca2+ or Ba2+ concentrations, were monitored by a Johnson 
Foundation Fluorometer with excitation at 340 nm and emission at 500 nm 
(Dubyak & De Young, 1985).  
Essentially the same protocol was used for measuring changes in cytosolic [Ca2+] 
in neutrophils, except these cells were diluted to 1.0 x 106/ml in 3 ml of Ca2+-free 
HEPES buffered saline medium for fluorometric analysis. Either 1 mM Ca2+ or 
0.2 mM EGTA was added 30 s prior to the agonist.  
2.5.2   Calibration and Calculation of Cytosolic Ca2+ Concentration 
The binding of intracellular Ca2+ to fura-2 is measured by fluorometry. Measured 
changes in fluorescence intensity are proportional to the change in concentration 
of the fura-2-Ca2+ complex. According to the mass action equation, at 
equilibrium: 
 KD = [products][reactants]  
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where KD is the dissociation constant for the fura-2 Ca2+ complex. In a solution 
containing a mixture of free and bound fura-2 species, the total fluorescence 
intensity F is given by the following: 
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where Fmax and Fmin are the fluorescence intensities at saturating and zero Ca2+ 
concentrations respectively. Rearranging equation (2) and substituting into 
equation (1) yields the Grynkiewicz equation (Grynkiewicz et al, 1985) shown 
over (3): 
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2.5.3   Initial Rates of Divalent Cation Uptake 
Initial rates of Ba2+ or Ca2+ influx were calculated by obtaining the slope of the 
trace immediately after agonist addition. The calibration procedure was also 
conducted on these samples to ensure reproducibility during an experiment by 
maintaining constant F1, Fmax and Fmin values. 
2.6   Ion Flux Measurements by Radioisotopes 
2.6.1   Uptake of 133Ba2+ 
133Ba2+ (0.5 mCi/ml, specific activity 3 mCi/mg) was used to measure Ba2+ influx 
into lymphocytes stimulated with ATP. BaCl2 solutions (0.4 - 4.0 mM, 1 or 2 
μCi/ml) in Ca2+ free HEPES buffered KCl medium were equilibrated at 37°C and 
then added to equal volumes of washed lymphocytes suspended in KCl medium 
at 37°C (final concentration of 1.25 x 107 cells/ml) just prior to addition of 230 
μM ATP4- at time zero in a total volume of 4 ml. 133Ba2+ influx was determined 
by removing 800 μl aliquots of reaction mixture after 0, 15, 30, and 45 s and 
mixing with 200 μl ice cold 50 mM MgCl2 in HEPES buffered medium layered 
over 250 μl phthalate oil mixture (DBP:DOP, 7:3, vol/vol) (Wiley et al, 1985) in 
Eppendorf tubes. The tubes were immediately centrifuged at 8000 g for 30 s to 
separate the cells from the medium. Subsequently, the medium was aspirated, the 
tube walls washed three times with distilled water, oil aspirated and cell pellets 
were counted in a window of 20 - 1030 keV in a Wallac Wizard 3 Automatic 
Gamma Counter (Australian Emerging Technologies, Clayton, Australia) using 
automatic background correction. Machine calibration was with a 137Cs external 
standard to which 133Ba2+ was normalised for optimal counting efficiency.  
The relative specific activity of 133Ba2+ was measured by counting 5 μl samples 
(5) of reaction mixture to allow the calculation of 133Ba2+ uptake in nmol/107 
cells. Isotope uptake at the zero time point for each Ba2+ concentration was 
subtracted from subsequent time points. Rate of 133Ba2+ uptake (ie. influx) at each 
Ba2+ concentration was calculated by least squares analysis. 
2.6.2  Uptake of [methyl-14C]choline+ 
[methyl-14C]choline (200 μCi/ml, specific activity 390 μCi/mg) was used to 
measure choline+ influx into lymphocytes stimulated with ATP. [methyl-
14C]choline (1 μCi/ml) was added to HEPES buffered 150 mM choline Cl 
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medium, equilibrated at 37°C and then added to equal volumes of washed 
lymphocytes suspended in 150 mM choline Cl medium at 37°C (final 
concentration of 1.25 x 107 cells/ml) just prior to addition of 260 μM ATP4- at 
time zero (total volume 4 ml). [14C]choline+ influx was determined by removing 
800 μl aliquots of reaction mixture after 1, 2, 5 and 15 min and mixing with 200 
μl ice cold 50 mM MgCl2 in HEPES buffered medium layered over 250 μl 
phthalate oil mixture (DBP:DOP, 7:3, vol/vol) in Eppendorf tubes. The tubes 
were immediately centrifuged at 8000 g for 30 s to separate the cells from the 
medium. Subsequently, the medium was aspirated, the tube walls washed three 
times with distilled water, oil aspirated and cell pellets solubilised overnight in 
500 μl 5% Triton X-100 or 0.5 M NaOH. Samples were added to scintillant and 
counted in a scintillation counter as previously detailed (Section 2.3.1). 
The relative specific activity of [14C]choline+ was measured by counting 5 μl 
samples (5) of the reaction mixture to allow the calculation of [14C]choline+ 
uptake in nmol/107 cells, which was converted to mmol/l, assuming that 107 CLL 
lymphocytes have a similar intracellular water space (1.5 μl) to that determined 
for normal lymphocytes (Wiley et al, 1985). Isotope uptake at the zero time point 
was subtracted from subsequent time points. 
2.7 Ethidium Influx Measurement by Time Resolved 
Flow Cytometry 
Washed lymphocytes (108/ml) suspended in HEPES buffered saline medium 
were diluted to 106/ml in 1 ml of Ca2+-free HEPES buffered 150 mM KCl 
medium. Some samples were suspended in HEPES buffered 150 mM KCl 
medium containing 0.2 mM Ca2+. These samples were stirred and temperature 
controlled at 37°C using a water jacketed external port and a time zero module 
(Cytek, Fremont, CA, USA). Unless otherwise indicated, the agonist was added 2 
min prior to addition of 25 μM ethidium+ (Appendix 3). Cell associated 
fluorescence signals were analysed for 5 min using a flow cytometer (Section 
2.3.2) with argon laser excitation at 488 nm and fluorescent emission collected 
using a 590 nm long-pass filter. Data was collected at a rate of 400 - 500 cells/s 
and analysed using Elite software, version 4.0 to produce histograms of 
fluorescence intensity (channel number) at 6 s consecutive intervals (Appendix 
3). The mean channel of fluorescence intensity was then calculated using Excel  
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software for each of the 6 s intervals and plotted against time. Rate of ethidium+ 
uptake was calculated by linear regression analysis of the uptake slopes.  
2.8 L-selectin Measurement 
L-selectin was measured by immunofluorescence using a flow cytometer. 
Lymphocytes (106/ml) were suspended in HEPES buffered 150 mM KCl 
medium and 3 ml aliquots were incubated with KN-62 or KN-04 (1 nM - 500 
nM) or DMSO vehicle for 5 min, followed by a 5 min incubation with ATP (500 
μM) in the continued presence of inhibitor or DMSO. Incubations were 
terminated by addition of 3 ml 20 mM MgCl2 and cells were pelleted and 
resuspended in 100 μl of medium and 5 μl FITC labelled CD62L monoclonal 
antibody (anti L-selectin) was added. After 10 min at 20°C, cells were washed 
once and resuspended in 1 ml medium and analysed by flow cytometry (Section 
2.3.2) with argon laser excitation at 488 nm and a 530 nm band-pass emission 
filter. Non specific staining was analysed by incubating cells for 15 min at 37°C 
with an equivalent amount of non-immune immunoglobulin (Coulter Electronics) 
in place of the L-selectin antibody. Single parameter histograms of fluorescence 
intensity were collected in the linear mode for FITC-labelled cells and the mean 
channel of fluorescence of 5000 cells was obtained. 
2.9 Measurement of Apoptosis by Flow Cytometry 
Apoptosis was measured by flow cytometric analysis of isolated nuclei stained 
with propidium iodide (PI) according to the method of Nicolleti et al. (1991). 
The percentage of hypodiploid nuclei with altered light scattering properties was 
determined (Appendix 4). 
Cell Culture. Washed lymphocytes (2 x 106/ml) suspended in RPMI-1640 
medium were cultured for 18 - 20 h with or without 2 mM ATP in 6 well culture 
dishes at 37°C. Positive controls were obtained by culturing cells with 1 μM 
dexamethasone (9α-fluoro-16α-methylprednisolone, Sigma Chemical Co.) 
instead of ATP under the same conditions as above. Some cell cultures were 
preincubated with 10 μM TFP or 1 μM KN-62 or an equivalent volume of sterile 
buffer or DMSO (vehicle) for 15 min at 37°C prior to addition of ATP or 
dexamethasone. Additions, except DMSO (purchased sterile), were sterilised by  
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filtration through 0.22 μm millipore cellulose acetate filters (Millipore, Bedford, 
MA, USA).  
Flow Cytometric Analysis. Approximately 106 cells (500 μl) were harvested from 
each culture, gently centrifuged (400 g, 5 min), resuspended in 1 ml hypotonic 
propidium iodide solution (75 μM PI in 0.1% sodium citrate and 0.1% Triton X-
100) and incubated at 4°C for 1 - 4 h in the dark. Nuclei were then analysed in 
the flow cytometer (Section 2.3.2) with argon laser excitation at 488 nm and 
fluorescent emission collected using a 590 nm long-pass filter. Since DNA 
content of individual nuclei was measured, a very low data rate (30 nuclei/s) was 
used to ensure that nuclei passed through the laser one at a time. This was 
checked by observing a linear relationship between peak versus integral signals 
displayed in one of the two parameter histograms collected from the third PMT. 
Apoptotic nuclei showed a distinct pattern in the scatterplots (log forward (FS) 
versus log side scatter (SS)), with a decrease in FS and an increase in SS. This 
feature was used to increase the accuracy of determining the percentage of 
apoptotic nuclei. Thus data collected from 10,000 nuclei were analysed in two 
parameter histograms of SS versus PI fluorescence intensity. A typical analysis is 
shown in Appendix 4. Light microscopic changes consistent with apoptosis: 
dark, pyknotic, fragmented nuclei and plasma membrane blebbing were observed 
for dexamethasone- and ATP-treated cells. 
2.10 Data Presentation and Analysis 
Concentration response curves for agonists and inhibitors were obtained by non 
linear regression analysis using the program Flexifit (Guardabasso et al, 1988). 
Hill plots were constructed from these curves using the Hill equation, and Hill 
coefficients calculated by linear regression analysis of slopes from individual 
experiments. Data are presented as mean ± s.e.m. (n). Statistical analysis of data 
was by one-way ANOVA or Student’s t test. 
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3.1 ATP-stimulation of the Lymphocyte P2Z Receptor 
Activates PLD 
3.1.1 Introduction 
Extracellular ATP and other agonists for P2-receptors raise cytosolic [Ca2+] and 
in some cell types, these agonists also stimulate PLD activity (El-Moatassim & 
Dubyak, 1992; Murrin & Boarder, 1992; Purkiss et al, 1992; Nally et al, 1992; 
Pfeilschifter & Merriweather, 1993; Rooney & Gobran, 1993). In some of these 
studies, PLD was activated indirectly through the initial stimulation of P2Y1 or 
P2Y2 receptors, which first activated PI-PLC (Murrin & Boarder, 1992; Purkiss 
et al, 1992; Pfeilschifter & Merriweather, 1993; Rooney & Gobran, 1993). 
However, El-Moatassim and Dubyak (1992, 1993) recently reported that BzATP, 
acting via P2Z receptors, directly activated PLD in murine macrophages, which 
express both P2Y2 and P2Z receptors. In contrast, there is evidence showing that 
human leukaemic lymphocytes express P2Z, but not P2Y receptors (Wiley et al, 
1994). It was of interest to determine whether ATP-stimulated PLD activity also 
occurred in these lymphocytes. If so, the features of ATP-stimulated PLD 
activity would be examined.  
3.1.2  ATP-stimulated PLD Activity in Lymphocytes from Patients with 
Chronic Lymphocytic Leukaemia 
PLD activity was measured in the presence of butanol (Appendix 1), since PLD 
catalyses the transphosphatidylation reaction which yields the stable end product 
[3H]PBut. For the purpose of this study, PLD activity was defined as [3H]PBut 
accumulation over 15 min and reported as a percentage of total 
[3H]phospholipids.  
Extracellular ATP stimulated PLD activity in human lymphocytes in a time 
dependent manner, with [3H]PBut accumulation reaching a maximum by 15 min 
(Figure 3.1). PLD activity increased as the concentration of ATP was raised from 
100 μM, reaching a maximum at 1 mM (Figure 3.2) with an EC50 of 513 ± 48 
μM ATP (113 μM ATP4-). Mean basal [3H]PBut accumulation was 0.13 ± 0.01% 
(n =12). BzATP, another P2Z agonist, was more potent than ATP in stimulating 
PLD activity with an EC50 of 379 ± 36 μM (Figure 3.2).  
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Figure 3.1  Time course of ATP-stimulated PLD activity in human lymphocytes  
[3H]oleic acid-labelled lymphocytes (107/ml) suspended in HEPES buffered 150 mM 
KCl medium with 1 mM Ca2+ were incubated at 37°C with (■, ) and without ( ) 910 
μM ATP (230 μM ATP4-) in the presence (■,  ) or absence () of 30 mM butanol. 
Results are expressed as means ± s.e.m. (n =3) representative of 4 experiments. 
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Figure 3.2  Dose-response curve of nucleotide-stimulated PLD activity 
[3H]oleic acid-labelled lymphocytes (107/ml) suspended in HEPES buffered 150 mM 
KCl medium with 1 mM Ca2+ and 30 mM butanol were incubated at 37°C with ATP ( ) 
or BzATP (■) for 15 min. [3H]PBut was expressed as percentage of the maximal 
response to 1 mM ATP which was taken as 100%; means ± s.e.m. are from 3 - 9 
determinations. 
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3.1.3  PLD Activity Stimulated by ATP Analogues  
Other known agonists for the P2Z receptor, 2-methylthio-ATP and ATPγS, were 
less effective and produced maximal responses which were 34% and 12% 
respectively of the response obtained with ATP. α,β-methylene-ATP, ADP, UTP 
and adenosine did not significantly increased PLD activity (Figures 3.3 and 3.4). 
%
 [3
H
]P
B
ut
(%
 [3
H
]p
ho
sp
ho
lip
id
s)
0
1.0
2.0
3.0
AT
P
Bz
AT
P
2M
eS
AT
P
AT
P γS
α,β
−m
eA
TP UT
P
AD
P
ad
en
os
in
e
4.0
 
Figure 3.4 PLD activation by nucleotides and nucleosides 
[3H]oleic acid-labelled lymphocytes (107/ml) suspended in HEPES buffered 150 mM 
KCl medium with 1 mM Ca2+ and 30 mM butanol were incubated with 1 mM of the 
above agonists (2 mM UTP) at 37°C for 15 min. Basal [3H]PBut (0.22 ± 0.01%) was 
subtracted from each value. Results are mean ± s.e.m. (n=3) from an experiment 
representative of 2. 
3.1.4  Inhibitors of ATP-stimulated PLD Activity 
Both suramin and oxidised ATP, which are inhibitors of the P2Z receptor in 
murine macrophages and human lymphocytes (Murgia et al, 1993; Wiley et al, 
1994), prevented PLD activation by extracellular ATP (Table 3.1). Previous 
work has shown that divalent cation fluxes stimulated by extracellular ATP are 
attenuated by high concentrations of extracellular Na+ (Wiley et al, 1992). When 
K+ was replaced with the same concentration of Na+ (150 mM), ATP-stimulated 
PLD activity was reduced by 77 ± 6.5% (n =14) (Table 3.1; Section3.7, Figure 
3.31). Permeant fluxes through the P2Z ligand gated ion channel were blocked 
when Mg2+ was added in 2-10 -fold molar excess over extracellular ATP  
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(Greenberg et al, 1988; Wiley et al, 1993). Similarly, in the present experiments, 
Mg2+ added to ATP stimulated cells reduced [3H]PBut accumulation to 1.1 ± 1.1 
% of maximal activity (Table 3.1). Paradoxically, other inhibitors, such as FSBA 
and the amiloride analogue, HMA, both of which permeate cells, significantly 
stimulated basal PLD activity, as well as the absolute increment in ATP-
stimulated [3H]PBut accumulation, although the fold stimulation over control 
was not increased (Table 3.2). The two inhibitors were not studied further. 
 
Table 3.1 Inhibition of ATP-stimulated PLD activation in human lymphocytes 
 Conditions [3H]PBut (% of control)  
 KCl medium (Control) 100 (14)  
 oxidised ATP     1.6 ± 1.22 (3)  
 Suramin   15.4 ± 11.8 (3)  
 Mg2+     1.1 ± 1.10 (5)  
 NaCl medium   23.0 ± 6.5 (14)  
[3H]Oleic acid-labelled lymphocytes (107/ml) in HEPES buffered KCl medium 
containing 30 mM butanol and 1 mM Ca2+ were incubated with or without 910 μM ATP 
(230 μM ATP4-) for 15 min and [3H]PBut measured. Some cells were incubated with or 
without 300 μM ox-ATP for 60 min at 37°C in HEPES buffered saline medium, washed 
and then incubated with ATP in KCl medium. Suramin (300 μM) or Mg2+ (10 mM) 
were added to cell suspensions in KCl medium just before ATP. In some experiments, 
cells were suspended in HEPES buffered NaCl medium. Results are expressed as 
percentages of the response of the same cells suspended in KCl medium. Means ± s.e.m. 
for the number of experiments shown in parenthesis. 
3.1.5  Activation of PLD by Other Agents 
Multiple mechanisms are involved in regulating receptor-mediated PLD activity, 
including Ca2+, PKC and G-proteins and in most cell types, phorbol esters and 
Ca2+ ionophores stimulate PLD activity (Exton, 1994). The effects of PMA and 
ionomycin were, therefore examined and compared with those of ATP. All three 
agents significantly increased PLD activity (Table 3.3). The effects of ATP and 
PMA were of similar magnitude, and were 3 - 4 fold greater than the effect of 
ionomycin (P < 0.001, ANOVA). A similar profile of results was also obtained in 
two further experiments when cells were stimulated with BzATP, PMA and 
ionomycin in a HEPES buffered saline medium. 
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Table 3.2 Effect of FSBA and HMA on ATP-stimulated PLD activity 
Inhibitor [3H]PBut 
(% [3H]phospholipids) 
 Control ATP Fold over control 
Untreated   0.23 ± 0.02 1.49 ± 0.04 6.5 
HMA *0.59 ± 0.05 2.60 ± 0.17 4.4 
FSBA *0.71 ± 0.07 3.66 ± 0.04 5.2 
[3H]Oleic acid-labelled lymphocytes (107/ml) in HEPES buffered KCl medium 
containing 30 mM butanol and 1 mM Ca2+ were incubated with or without 910 μM ATP 
(230 μM ATP4-) for 15 min and [3H]PBut measured. Some cells were incubated with or 
without 100 μM FSBA for 60 min at 37°C in HEPES buffered saline medium, washed 
and then incubated with ATP in KCl medium. HMA (100 μM) was added to cell 
suspensions in KCl medium just before ATP. Results are mean ± s.e.m. (n = 3) from an 
experiment representative of 2. *Significantly different from control (P < 0.002; 
Student’s t test) 
 
Table 3.3  PLD Activity in lymphocytes 
 Agonist [3H]PBut (% of [3H]phospholipids)  
 Control 0.21 ± 0.01  
 ATP 3.02 ± 0.08*  
 PMA 3.19 ± 0.03*  
 Ionomycin 0.80 ± 0.09*  
[3H]oleic acid labelled lymphocytes (107/ml) in HEPES buffered KCl medium 
supplemented with 30 mM butanol and 1 mM Ca2+ were incubated with buffer, 1 mM 
ATP (260 μM ATP4-), 100 nM PMA or 5 μM ionomycin at 37°C for 15 min. Cells 
stimulated with ionomycin were suspended in BSA-free medium, since ionomycin 
binds to BSA (Simonsen, 1980). Means ± s.e.m of triplicate determinations for an 
experiment representative of 2 are shown. *Significantly different from control (P < 
0.0001; one way ANOVA). 
Small, but not large G-proteins, generally activate PLD activity in permeabilised 
or broken cell preparations. AlF4- (20 mM NaF and 10 μM AlCl3), an activator of 
large, heterotrimeric G proteins did not stimulate PLD activity in intact human 
lymphocytes. Neither pertussis toxin, an inhibitor of Gi or G0, nor depletion of 
guanine nucleotides by an overnight incubation with the inosine dehydrogenase 
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inhibitor, mycophenolic acid (100 μM) (Rizzo et al, 1990: Metz et al, 1992), had 
any effect on ATP-stimulated PLD activity. 
3.1.5 Discussion 
This study shows that extracellular ATP, acting through the P2Z receptor, 
stimulated PLD activity in human lymphocytes. This conclusion supports that of 
El-Moatassim and Dubyak (1992, 1993) who showed that BzATP, an agonist for 
the P2Z receptor, activated PLD of murine macrophages. However, murine 
macrophages express several types of P2-receptors, in contrast to human 
lymphocytes, which have only the P2Z receptor subclass. This, together with the 
features of the ATP-stimulated PLD activity make it very likely that the effect is 
a P2Z receptor-mediated response. The rank order of potency for purinoceptor 
agonists in producing maximal stimulation of PLD activity BzATP > ATP > 2-
methylthio ATP (P2Y1 agonist) >> ATPγS was very similar to that reported for 
producing Ba2+  influx through the P2Z-operated ion channel (Wiley et al, 1994). 
Furthermore, α,β-methylene-ATP (P2X-specific); UTP (P2Y2-specific); ADP 
(P2T-specific), and adenosine (P1-receptor agonist) did not stimulate PLD 
activity. It is possible that the higher concentrations of ATP and BzATP required 
to stimulate maximal PLD activity compared to maximal Ba+ and ethidium+ 
influx (Wiley et al, 1994; Section 3.6.2) is because initial rates were measured 
for cation fluxes but not for PLD activation. Mg2+ inhibited both ATP-stimulated 
cation fluxes through the P2Z ion channel and ATP-stimulated PLD activity 
indicating that ATP4- was the preferred agonist species. The same antagonists 
were found to inhibit ATP-stimulated cation fluxes and ATP-stimulated 
[3H]PBut accumulation (Table 3.1). These were suramin, a non-specific P2-
receptor antagonist, ox-ATP, an irreversible inhibitor of the lymphocyte P2Z-
operated ion channel and high concentrations of extracellular Na+. Thus 
occupancy of P2Z receptors or influx of Ca2+ through the P2Z-operated ion 
channel leads to stimulation of PLD activity.  
PLD activity was also stimulated in human leukaemic lymphocytes by ATP, but 
PMA and ionomycin (Table 3.3). Thus in human lymphocytes, PLD activity may 
be stimulated by PKC and/or Ca2+ influx. In support of these observations, PMA-
induced PLD activity has also been demonstrated in the human T cell line, Jurkat 
(Stewart et al, 1991). Both human B and T lymphocytes express multiple PKC 
isoforms, including PKC-α, β, δ, ε and ζ (Brick-Ghannam et al, 1994; Fulop et 
al, 1995), some of which are Ca2+-dependent and others Ca2+-independent. In 
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human leukaemic lymphocytes, PMA5 stimulated PLD activity in the presence or 
absence of Ca2+. With the expression of both Ca2+-dependent and -independent 
PKC isoforms in normal human lymphocytes, it is difficult to understand why 
Kinsky et al, (1989) were unable to demonstrate phorbol ester-stimulated PLD 
activity in peripheral blood lymphocytes and several leukaemic lymphocyte cell 
lines, including Jurkat.  
The inability of AlF4- to activate PLD, or of pertussis toxin to block ATP-
stimulated PLD activity in human lymphocytes suggests that this enzyme is not 
linked to heterotrimeric G proteins, as found for most other receptor-mediated 
PLD activity (Liscovitch & Chalifa, 1994). However, in human lymphocytes, it 
remains uncertain whether small G proteins participate in ATP-stimulated PLD 
activity. The failure of the inosine dehydrogenase inhibitor, mycophenolic acid, 
to diminish this PLD activity may have been due to inadequate depletion of 
cellular free GTP content, since the same procedure only reduced GTP by 81% to 
≈ 200 μM in rat islets, a level which is sufficient to activate high affinity, low Km 
G proteins (Metz et al, 1992). 
                                              
5 No comparison was made between Ca2+-dependent and Ca2+-independent PMA-stimulated PLD activity 
in the same experiment. However, in two separate experiments on cells suspended in HEPES buffered 
saline medium either with or without 1 mM Ca2+, 100 nM PMA stimulated the accumulation of  2.03 ± 
0.08 and 4.14 ± 0.12% [3H]PBut, respectively. However, because of the variabiltity between individual 
patients, no comparison can be made. 
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3.2  Activation of PLD by Agonists for the P2Z Receptor 
is Dependent on Divalent Cation Influx 
3.2.1   Introduction 
Calcium ionophores activate PLD in many cell types, supporting the concept that 
PLD activity may depend on cytosolic Ca2+ levels (Shukla & Halenda, 1991; 
Billah, 1993; Exton, 1994). In most studies of intact cells, the use of extracellular 
&/or intracellular Ca2+ chelators indicate that a rise in cytosolic [Ca2+] is 
necessary for both direct or indirect activation of PLD (Purkiss & Boarder, 1992; 
Wu et al, 1992; Lin & Gilfillan, 1992). In many of these studies, it is not certain 
whether Ca2+ is regulating PI-PLC and/or PLD. However, in subcellular fractions 
and for purified PLD, a similar increase in Ca2+ concentration does not stimulate 
PLD activity (Exton, 1994; Okamura & Yamashita, 1994). The reported 
discrepancy between intact and broken cells in their Ca2+ requirement for PLD 
activation is unexplained. 
Extracellular ATP binds to the lymphocyte P2Z receptor and opens a Ca2+-
selective ion channel, producing a rise in cytosolic [Ca2+]. There was a close 
parallel between the effects of ATP on divalent cation influx and the activation of 
PLD in these lymphocytes (Section 3.1). Ionomycin also stimulated PLD activity 
in human lymphocytes (Section 3.1.5). Taken together, these results suggest that 
PLD activation may rely on a rise in [Ca2+]i and/or Ca2+ influx. The relationship 
between ATP-stimulated PLD activity and changes in cytosolic [Ca2+] was 
investigated. 
3.2.2   PLD Activity is Independent of Cytosolic [Ca2+] 
Addition of 910 μM ATP (230 μM ATP4-) to fura-2-loaded lymphocytes 
suspended in Ca2+-containing (1 mM) KCl medium caused a rapid increase in 
cytosolic [Ca2+] to values > 1.0 μM, but no change in cytosolic [Ca2+] was 
observed in Ca2+-free medium containing 0.2 mM EGTA (Figure 3.5a). 
Likewise, 910 μM ATP increased [3H]PBut accumulation 10-fold in Ca2+-
containing medium but only produced a 2-fold increase in Ca2+-free media 
containing EGTA (Figure 3.5a). These results suggested that either a rise in 
cytosolic [Ca2+] or an influx of this cation stimulated PLD activity. These two 
possibilities were  
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3.2.4  Divalent Cation Influx Determines PLD Activity  
In further experiments the relation between PLD activity and divalent cation 
influx through the P2Z-operated ion channel was studied. ATP-stimulated PLD 
activity showed a linear relationship to extracellular [Ba2+] over the range 0 to 2 
mM (Figure 3.9). Furthermore, ATP-induced 133Ba2+ uptake also showed a linear 
relationship to extracellular [Ba2+] (Figure 3.9). 
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Figure 3.9 Extracellular ATP produces a parallel increase in 133Ba2+ 
  influx and PLD activity. 
PLD activity (■) was measured in [3H]oleic acid-labelled lymphocytes suspended in 
HEPES buffered KCl medium with 30 mM butanol and Ba2+ (0 - 2 mM) plus 230 μM 
ATP4- (910 μM ATP) for 15 min at 37°C. Basal [3H]PBut accumulation was 0.13 ± 
0.01% for several concentrations of extracellular Ba2+. Mean values ± s.e.m. (n = 3) are 
shown. In a parallel experiment with cells from the same patient, 133Ba2+ influx ( ) at 
37°C was measured at extracellular Ba2+ concentrations of 0.2 - 2.0 mM plus 230 μM 
ATP4-. Results of a single experiment, representative of 2. 
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The interdependence of PLD activation and divalent cation influx was further 
supported by the observation that, when Mg2+ was added 5 min after 
lymphocytes were stimulated with ATP in either Ca2+-or Ba2+-containing media, 
no further [3H]PBut accumulated (Figure 3.10a, b). Similarly, when excess 
EGTA was added to ATP-stimulated cells, [3H]PBut accumulation also ceased 
(Figure 3.10a). 
3.2.5 Discussion 
3.2.5.1  Role of Ca2+ in ATP-stimulated PLD activity. 
It is well known that Ca2+ has a role in the activation of PLD, since calcium 
ionophores and many calcium mobilising agonists, stimulate this effector 
enzyme. However, the exact role of Ca2+ in agonist-mediated PLD activation is 
not well defined (Cook & Wakelam, 1992; Exton 1994). In broken or 
permeabilised cell preparations Ca2+ does not appear to be responsible for PLD 
activation. For example, concentrations of Ca2+, which approximate intracellular 
values (0.1 - 1 μM), did not stimulate PLD activity in rat liver plasma 
membranes, broken human neutrophils or permeabilised HL-60 cells (Olson et 
al, 1991; Xie & Dubyak, 1991; Siddiqui & Exton, 1992; Whatmore et al, 1994). 
Similarly, Ca2+ was not required for bradykinin stimulated PLD activity in 
subcellular fractions of MDCK cells, but was necessary for the effect of 
bradykinin in intact cells (Huang et al, 1992). Other studies on intact cells have 
confirmed the requirement for extracellular Ca2+ in receptor-stimulated PLD 
activation. For example, P2Y receptor agonists stimulated PLD activity in bovine 
aortic endothelial cells and MDCK cells in the presence of extracellular Ca2+, but 
not when EGTA was present (Purkiss & Boarder, 1992; Balboa et al, 1994). In 
these, and in other studies, calcium dependent stimulation of PLD by calcium 
ionophore or receptor agonists (many of which activate PI-PLC enzymes) was 
attributed to a rise in cytosolic [Ca2+] (Lin & Gilfillan, 1992; Wu et al, 1992). In 
contrast, in this study changes in cytosolic [Ca2+] in human lymphocytes did not 
correlate with PLD activity. Thus, thapsigargin, which raises cytosolic [Ca2+], 
both by release from cellular organelles and by Ca2+ influx through the refilling 
channel, was unable to generate significant [3H]PBut accumulation, despite a 
large increase in cytosolic [Ca2+] and a vigorous Ca2+ influx (Figure 3.5b), 
Similarly, thapsigargin did not stimulate PLD activity in mesangial cells 
(Pfeilschifter & Merriweather (1993) or PC-12 cells (Horwitz et al, 1995).  
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Figure 3.10   Mg2+ and EGTA inhibit ATP-stimulated PLD activation 
[3H]Oleic acid labelled-lymphocytes suspended in HEPES buffered KCl medium with 
(a) 1 mM Ca2+ or (b) 1 mM Ba2+ and 30 mM butanol were incubated with (■, z, ) or 
without ( ) 230 μM ATP4- (910 and 640 μM ATP for Ca2+ and Ba2+, respectively) for 5 
min after which Mg2+ (z) or EGTA () to final concentrations, 2 mM, or an equal 
volume of buffer (■) was added and [3H]PBut measured. Values are means ± s.e.m. (n = 
3) from a single experiment, representative of 4 (a) or 2 (b). 
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B lymphocytes from patients with chronic lymphocytic leukaemia possess 
surface immunoglobulin (IgD) and cross linking this surface IgD activates the PI-
PLC cascade and raises cytosolic [Ca2+] (Figure 3.6b) (Ransom et al, 1986). 
Again, this rise failed to activate lymphocyte PLD. Similarly, El-Moatassim and 
Dubyak (1992) reported that Ca2+ mobilising agonists such as PAF and UTP, 
also coupled to the PI-PLC pathway, did not stimulate PLD activity in murine 
macrophages. Ionomycin, which inserts into the plasma and endoplasmic 
reticulum membranes, releases Ca2+ from internal stores when cells are 
suspended in EGTA-containing medium (Figure 3.6a) (Morgan & Jacob, 1994), 
but failed to increase PLD activity under these conditions in leukaemic 
lymphocytes. Taken together, these results suggest that a release of Ca2+ from 
internal stores does not stimulate PLD activity either in murine macrophages, 
mesangial and PC-12 cells or human lymphocytes. Agonist-stimulated changes 
in cytosolic [Ca2+] can be buffered with the Ca2+ chelator BAPTA, which is 
introduced into the cell as the membrane permeant precursor BAPTA-AM (Lew 
et al, 1982). Loading lymphocytes with BAPTA prevented the ATP-stimulated 
rise in cytosolic [Ca2+], but potentiated rather than inhibited PLD activity (Figure 
3.7). These results contrast with other studies in human neutrophils and 
erythroleukaemia cells, and also in rat mast cells and vascular smooth muscle 
cells , which show that agonist-stimulated PLD activity was reduced in BAPTA-
loaded cells (Kessels et al, 1991, Wu et al, 1992, Lin & Gilfillan , 1992; Freeman 
et al., 1995). Unlike lymphocytes, these cell types either do not possess the P2Z 
receptor, or in the case of mast cells, were not stimulated with P2-receptor 
agonists. While in some cell types, PLD activation appears dependent on IP3-
mediated release of Ca2+ from internal stores, at least in human lymphocytes, 
PLD activity is not responsive to changes in cytosolic [Ca2+], but rather is 
dependent on Ca2+ influx, either through the P2Z-operated ion channel or 
through the action of Ca2+ ionophores (Figures 3.5a and 3.6a). The inability of 
thapsigargin to mimic P2Z receptor agonists and Ca2+ ionophores suggests that 
PLD activation requires a threshold steady-state rate of Ca2+ influx or particular 
cell-surface densities of Ca2+ influx sites. 
3.2.5.2  Ba2+ influx through the P2Z-operated ion channel activates PLD 
The major finding of this study is that PLD activity was directly related to influx 
of Ba2+ through the P2Z-operated ion channel. Ba2+ is a convenient surrogate for 
Ca2+ and has some advantages over Ca2+ in studying the functional effects of 
divalent cations in lymphocytes. For example, Ba2+-fura-2 has similar spectral 
properties to Ca2+-fura-2, so that Ba2+ uptake can be measured fluorimetrically 
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(Figure 3.8) (Schilling et al, 1989). Moreover, the unidirectional Ba2+ influx can 
be readily quantified using 133Ba2+, since once inside the cell, this cation is 
neither pumped nor sequestered by transport ATPases. Ba2+ is a good permeant 
for the P2Z-operated ion channel with values for ATP-stimulated Ba2+ influx 
which approximate those for Ca2+ (Wiley et al, 1993). Furthermore, both Ba2+ or 
Sr2+ share with Ca2+ the ability to support ATP-dependent PLD activity in intact 
lymphocytes (Figure 3.8). Several other enzymes are stimulated by Ba2+. Blache 
and Ciavatti (1987, 1989) showed that thrombin-stimulated PLA2 activity, which 
requires extracellular Ca2+, was stimulated by Sr2+ or Ba2+ in intact rat platelets. 
Furthermore, Ba2+ could substitute for Ca2+ in stimulating two Ca2+/calmodulin-
dependent enzymes: myosin light chain kinase in arterial smooth muscle (Satoh 
et al, 1987) and nitric oxide synthase, both in in vitro assays and in endothelium 
(Yamazaki et al, 1995; 1996). 
The present studies using 133Ba2+ suggest that PLD activation can be related to 
ATP-induced influx of this divalent cation. A good correlation between ATP-
stimulated 133Ba2+ influx and ATP-stimulated PLD activity over a range of 
extracellular Ba2+ concentrations was observed (Figure 3.9). In addition, the 
stimulation of PLD activity ceased immediately after the permeating divalent 
cation was removed, either by addition of excess EGTA, or upon ion channel 
closure by removal of ATP4- ligand with addition of excess Mg2+ (Figure 3.10). 
The observed relationship between ATP-stimulated PLD activity and divalent 
cation influx through the P2Z-operated ion channel, suggests that PLD was 
activated by high local concentrations of these cations which accumulated in the 
subplasma membrane region. Indeed, several investigators (Barry & Cheek, 
1994; Prakriya et al, 1996) have shown that agonist-stimulated Ca2+ influx raises 
Ca2+ concentrations to several micromolar in the subplasma membrane region. 
Such [Ca2+] changes cannot be accurately measured by Fura-2, which largely 
measures concentrations of bulk cytosolic Ca2+. Furthermore, while BAPTA has 
high affinity for Ca2+ and rapid Ca2+-binding kinetics, these undetected 
elevations in [Ca2+] in the microenvironment near the P2Z-operated ion channels 
may occur so rapidly (Etter et al, 1994), that PLD activity is potentiated even 
while total cytosolic [Ca2+] is adequately buffered (Figure 3.7). Chow & Powis, 
(1993) came to a similar conclusion, when they observed potentiation of 
receptor-stimulated PLA2 activity of EGTA-AM loaded fibroblasts, even though 
cytosolic [Ca2+] was buffered. It is also possible, that in ATP-stimulated 
lymphocytes, these local elevations in Ba2+ or Ca2+ near the plasma membrane 
may mediate translocation of PLD or, a putative regulatory G-protein and/or  
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PKC, to the membrane. Furthermore, CaM which binds Ca2+ may also directly or 
indirectly regulate PLD activity through the activation of another kinase, such as 
CaMKII. 
Although PLD activation appears to be tightly coupled to divalent cation influx 
associated with stimulation of the P2Z receptor, a small fraction of Ca2+ (or Ba2+) 
independent PLD activity was usually observed (Figure 3.8). This fraction was, 
however, small in comparison to the predominant Ca2+-insensitive PLD activity 
found in murine macrophages (El-Moatassim & Dubyak, 1992). Thus, both Ca2+-
dependent and Ca2+-independent PLD of human lymphocytes appears to be 
closely associated with or is part of the P2Z receptor and the activation of the 
Ca2+-sensitive PLD seems to be tightly coupled to divalent cation influx 
associated with stimulation of this receptor. 
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3.3 Effect of a Calmodulin Inhibitor on ATP-stimulated 
PLD Activity 
3.3.1 Introduction 
The PLD activity of human leukaemic lymphocytes is stimulated by divalent 
cation influx through the P2Z ion channel or through Ca2+ influx mediated by 
Ca2+ ionophores (Section 3.2). In both conditions, a high concentration of Ca2+ 
accumulates in the subplasmalemmal region (Barry & Cheek, 1994; Prakriya et 
al, 1996), which is likely to be responsible for this increased PLD activity. 
Subplasmalemmal Ca2+ binds to the Ca2+-binding protein, CaM, as demonstrated 
by the activation of Ca2+/CaM-dependent Ca2+-ATPase, which pumps Ca2+ from 
stimulated cells when the [Ca2+] rises above the resting level of ≈ 100 nM (Figure 
3.8) (Carafoli, 1994; Vogel, 1994). Ca2+/CaM activates many other enzymes, 
including kinases, such as CaMKII (Vogel, 1994; Hidaka & Kobayashi, 1992). 
Thus it is possible that ATP-stimulated Ca2+ influx through the P2Z ion channel 
may, via activation of Ca2+/CaM, directly regulate PLD activity or activate a 
kinase that in turn phosphorylates either the receptor or PLD. Alternatively, Ca2+ 
may react directly with the C2 phospholipid-binding domain of PLD and effect 
PLD activation (Ponting & Parker, 1996). 
There is some evidence to support the idea that Ca2+/CaM may regulate receptor-
mediated PLD activity, since this activity could be blocked by several Ca2+/CaM 
inhibitors. The phenothiazine, trifluoperazine (TFP) binds to α helical regions of 
CaM, which only become exposed in the presence of Ca2+, blocking Ca2+ binding 
to these α helices and subsequently preventing activation of Ca2+/CaM-
dependent proteins (Roufogalis et al, 1982; Vogel, 1994). TFP has been shown 
to inhibit PLD activity in rat basophilic leukaemic and osteoblast-like cells 
stimulated by antigen and PGD2, respectively (Kumada et al, 1995; Imamura, et 
al, 1995). The naphthalenesulphonamide, W-7, another Ca2+/CaM antagonist 
(Hidaka & Kobayashi, 1992), inhibited PLD activity in a concentration 
dependent manner in fMet-Leu-Phe-stimulated rabbit neutrophils (Kanaho et al, 
1992), ATP-stimulated mouse osteoblast-like cells (Suzuki et al, 1995) and 
vasopressin-stimulated rat aortic smooth muscle cells (Miwa et al, 1995).  
In other studies, ATP-stimulated cell lysis of IFN-γ-treated human 
monocytes/macrophages, which is mediated through P2Z receptors, was blocked 
by TFP and the CaMKII antagonist, KN-62. The authors concluded that  
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Ca2+/CaM and CaMKII mediated this effect (Spranzi et al, 1993; Blanchard et al, 
1995). CaMKII has the unique property of remembering Ca2+ transients, through 
autophosphorylation and subsequent trapping of Ca2+/CaM. Thus once Ca2+ 
homeostasis has been restored, CaMKII still acts at 20 - 80% of maximal activity 
for many hours (Hidaka & Kobayashi, 1992). The involvement of CaMKII was 
also supported by the finding that a brief exposure (15 min) of IFN-γ-treated 
macrophages to ATP followed by washing, was as effective in mediating cell 
lysis 6 h later, as was continued culture with ATP (Blanchard et al, 1991). In 
human lymphocytes, a short exposure to ATP also stimulated a low level PLD 
activity (≈ 20 - 40% of maximal), which persisted for up to 6 h (Section 3.7.3). 
ATP also induced apoptosis in these lymphocytes, which could be blocked by the 
P2Z inhibitor, ox-ATP6. Taken together, these observations suggest that 
Ca2+/CaM and CaMKII may regulate long term events such as P2Z-mediated cell 
death, and that ATP-stimulated PLD activity may also have a role in this process. 
The effect of the Ca2+/CaM and CaMKII inhibitors, TFP and KN-62 on 
ionomycin- and ATP-stimulated PLD activity and P2Z-mediated apoptosis was 
then examined. 
3.3.2 TFP Inhibits Ionomycin- and ATP-stimulated PLD Activity 
The effect of TFP on ionomycin-stimulated PLD activity was first examined. 
Preincubation of cells with the water soluble HCl of TFP for 15 min at 37°C 
produced a concentration-dependent inhibition of ionomycin-stimulated 
[3H]PBut accumulation (Figure 3.11), with 50% inhibition at 27.3 μM. Maximal 
inhibition was at 200 μM. The effect of TFP on ATP-stimulated PLD activity 
was then studied. TFP inhibited ATP-stimulated PLD activity, with an EC50 of 
3.5 ± 0.6 μM (n = 3) and a maximal inhibitory concentration of 10 μM (Figure 
3.12). 
ATP-stimulated PLD activity, which is dependent on divalent cation influx, can 
be supported by Sr2+ and Ba2+ as well as Ca2+. In addition to Ca2+, other divalent 
cations bind CaM with relative affinities for CaM of Ca2+ > Sr2+ >> Ba2+ (Chao 
et al, 1984). Sr2+ and Ba2+ also substitute for Ca2+ in Ca2+/CaM-dependent 
activation of phosphodiesterase with a similar rank order of potency (Chao et al, 
1984: Habermann et al, 1983). The effect on TFP inhibition of ATP-stimulated 
                                              
6 J. Wiley & G. Jamieson, personal communication 
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PLD activity was then examined when Ca2+ was substituted with Sr2+ or Ba2+. 
Figure 3.12 shows concentration-inhibitory curves for ATP-stimulated PLD 
activity in medium containing either Ca2+, Sr2+ or Ba2+. Half maximal inhibition 
of ATP-stimulated PLD activity was 4.2 and 6.7 μM for Sr2+ and Ba2+ 
respectively. 
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Figure 3.11  Inhibition of ionomycin-stimulated PLD activity by TFP 
[3H]Oleic acid labelled-lymphocytes suspended in BSA-free, Ca2+-containing (1 mM) 
HEPES buffered KCl medium were preincubated with or without TFP for 20 min at 
37°C, butanol (30 mM) was then added, followed by 2.5 μM ionomycin for 15 min and 
[3H]PBut was measured. Basal [3H]PBut was 0.15 ± 0.03%. Results are means ± s.e.m. 
(n = 3) from a single experiment.  
3.3.3 Calmodulin Inhibitors Prevent ATP-Stimulated Long-term PLD 
Activity 
KN-62 is a specific inhibitor of CaMKII, since it binds to the kinase at the 
Ca2+/CaM binding site. However, neither KN-62 nor TFP have any inhibitory 
effect once CaMKII is autophosphorylated and has trapped Ca2+/CaM (Hidaka & 
Kobayashi, 1992). Persistent PLD activity, observed after a short exposure of 
lymphocytes to ATP (Section 3.7.3) could be due to production of 
autophosphorylated CaMKII. Thus the action of TFP and KN-62 on long term  
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Figure 3.12  Inhibition of ATP-stimulated PLD activity by TFP 
[3H]Oleic acid labelled cells suspended in HEPES buffered KCl medium containing 1 
mM Ca2+ (), Sr2+ (z) or Ba2+ () were preincubated with or without TFP for 20 min at 
37°C, 30 mM butanol was added, followed by 260 μM ATP4- (1 mM, 840 & 720 μM 
ATP for Ca2+-, Sr2+- and Ba2+-containing media, respectively) for 15 min, and [3H]PBut 
measured. Results are means ± s.e.m. (n = 3) and expressed as % of maximal ATP-
stimulated PLD activity, which was obtained in the absence of TFP and was 1.54 ± 
0.04, 2.76 ± 0.07 and 4.00 ± 0.18% [3H]PBut respectively for Ca2+, Sr2+ and Ba2+-
containing media. (Basal [3H]PBut was 0.14 ± 0.01, 0.15 ± 0.01 and 0.22 ± 0.05% for 
Ca2+, Sr2+ and Ba2+-containing media, respectively). Results are from a single 
experiment for Sr2+ and Ba2+, but representative of 3 for Ca2+. 
 
PLD activity was examined. When cells were preincubated for 15 min with 1 
mM ATP, Mg2+ added, then washed and resuspended in KCl medium, a 
persistent basal PLD activity of 0.70 ± 0.03% was observed (Figure 3.13a). 
When either 20 μM TFP or 1 μM KN-62 were present during the preincubation 
with ATP, this persistent PLD activity was abolished (Figure 3.13b). However, 
when TFP or KN-62 were added for 15 min after the ATP incubation, but prior 
to and for the duration of the PLD assay, this persistent PLD activity was not 
abolished (Figure 3.13c). 
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Figure 3.13  Effect of calmodulin inhibitors on ATP-stimulated long-term 
   PLD activity 
[3H]oleic acid labelled cells were incubated with or without 1 mM ATP (260 μM ATP4-
) in Ca2+-containing (1 mM) HEPES buffered KCl medium for 15 min at 37°C, 10 mM 
Mg2+ was added, the cells washed and resuspended in the above medium. Butanol (30 
mM) was added after 45 min and cells incubated for 20 min and [3H]PBut measured. In 
some cell suspensions, 20 μM TFP or 1 μM KN-62 was added 15 min prior to (b) ATP 
preincubation or (c) butanol addition. Control cells (not preincubated with ATP) 
showed a basal [3H]PBut of 0.14 ± 0.02% and maximal ATP-stimulated PLD activity of 
1.93 ± 0.26%. *Significantly different from ATP-treated control cells (P < 0.001, 
Student’s t test). Results are means ± s.e.m. ( n= 3) from a single experiment, 
representative of 2. 
3.3.4 Calmodulin Inhibitors Block ATP-induced Apoptosis in Lymphocytes 
The effect of TFP and KN-62 on ATP-induced apoptosis in lymphocytes was 
then examined. Dexamethasone induces apoptosis in leukaemic lymphocytes 
from patients with chronic lymphocytic leukaemia and was used as a positive 
control in these experiments. Lymphocytes, suspended in RPMI-1640 medium 
and incubated with 2 mM ATP or 1 μM dexamethasone for 20 h at 37°C showed 
31.0 and 28.7% apoptotic nuclei, respectively. Spontaneous apoptosis of 
untreated control cells was 18.5% (Table 3.4). Both TFP (10 μM) and KN-62 (1 
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μM) prevented ATP-induced apoptosis, but were without effect on 
dexamethasone-induced apoptosis (Table 3.4). 
Table 3.4 Calmodulin inhibitors prevent ATP-induced apoptosis 
 Inhibitor % Apoptotic Nuclei 
  Control ATP Dexamethasone  
 None 18.5 31.0 28.7  
 TFP 11.8   9.3 36.2  
 KN-62 17.9 15.4 29.4  
Lymphocytes (2 x 106/ml) were cultured in RPMI-1640 with 2 mM ATP, 1 μM 
dexamethasone or vehicle for 20 h at 37°C. TFP (10 μM) or KN-61 (1 μM) were added 
15 min prior to the agonists. 106 cells were harvested and incubated with hypotonic 
propidium iodide solution (75 μM) for 1-4 h and 4 x 104 nuclei (data rate 30-40/s) 
analysed by flow cytometry as described in Section 2.9 and Appendix 4. Results from a 
single experiment, representative of 2. 
3.3.5 TFP Blocks P2Z-induced Cation Fluxes in Lymphocytes 
The effect of TFP on ATP-stimulated cation fluxes was then examined in order 
to determine if TFP was having a non-specific inhibitory effect on the P2Z 
receptor or its associated ion channel. When TFP was preincubated with fura-2 
loaded cells for 15 min, both ATP-stimulated Ba2+ and Ca2+ influx through the 
P2Z ion channel was blocked in a concentration-dependent manner (Figure 
3.14a). In contrast TFP had no effect on ionomycin-stimulated Ca2+ uptake7. TFP 
is fluorescent and raised baseline fluorescence as shown in Figure 3.14a.  
The fluorescent dye ethidium+ is also a permeant for the P2Z receptor-operated 
ion channel of lymphocytes and influx of this cation can be measured by time 
resolved flow cytometry (Wiley et al., 1993). Addition of 500 μM ATP (230 μM 
ATP4-) induced ethidium+ uptake into lymphocytes suspended in a Ca2+-free KCl 
medium, which is shown in Figure 3.14b as an increase in mean channel 
fluorescence, which was linear with time over 4 min. Preincubation of the cells 
 
                                              
7 Ionomycin (2.5 μM) raised cytosolic [Ca2+] from a resting level of 120 nM to 1.1 μM in the presence or 
absence of 10 μM TFP in cells suspended in BSA-free HEPES buffered saline medium containing 1 mM 
Ca2+ (n = 1). Higher concentrations of TFP contributed too much fluorescence to be tested. 
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with TFP (5 μM) for 5 min prior to addition of ATP inhibited ATP-stimulated 
ethidium+ uptake (Figure 3.14b). KN-62 also inhibited ATP-stimulated cation 
fluxes and this effect was examined in Section 3.4. 
3.3.6 Discussion 
This study shows that it is not possible to implicate CaM or CaMKII in ATP-
stimulated PLD activity or ATP-induced apoptosis by using the inhibitors TFP or 
KN-62. Both TFP and KN-62 not only inhibited the above two responses to ATP 
(Figure 3.12, Table 3.4), but they also blocked cation fluxes through the P2Z ion 
channel (Figure 3.14, Section 3.4). Since ATP-stimulated PLD activity is 
dependent on divalent cation influx through the P2Z ion channel (Section 3.2.4), 
the inhibitory effects of TFP and KN-62 on ATP-stimulated PLD activity are 
probably due to block of these cation fluxes. The effect of TFP on ATP-
stimulated PLD activity in the presence of various divalent cations provides 
further evidence suggesting that in this system, the primary action of TFP is 
inhibition of the P2Z receptor or associated ion channel, rather than Ca2+/CaM. 
Similar half maximal inhibitory concentrations were observed for TFP in the 
presence of the three divalent cations (3.5, 4.2 and 6.7 μM respectively for Ca2+, 
Sr2+ and Ba2+, Figure 3.12), which is at variance with a rank order of potencies of 
Ca2+ > Sr2+ >> Ba2+ binding to CaM (Chao et al 1984) and Ca2+/CaM-dependent 
phosphodiesterase activity in the presence of these cations (Habermann et al, 
1983). It is also likely that the inhibitory effect of TFP and KN-62 on ATP-
stimulated apoptosis is due to block of Ca2+ influx through the P2Z ion channel, 
since this effect of ATP only occurs in Ca2+ containing medium8. Furthermore, 
many, but not all triggers of apoptosis, also produce a rise in cytosolic [Ca2+] 
(McConkey & Orrenius, 1994). The inability of both TFP and KN-62 to inhibit 
long term PLD activity once it was established (Figure 3.13) argues for a role of 
autophosphorylated CaMKII, but this lack of effect may also be due to the 
formation of a stable, active PLD enzyme complex at the plasma membrane 
(Kusner & Dubyak, 1994), which is no longer dependent on Ca2+ fluxes. 
Many inhibitors are notoriously non-specific. While TFP has been well studied 
as an inhibitor of Ca2+/CaM (Vogel, 1994), it is also well known for its non-
specific effects on ion channels, receptors and enzymes (Roufogalis et al, 1982).  
                                              
8 J. Wiley & G. Jamieson, personal communication 
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Thus, the P2Z receptor can also be added to the list of receptors inhibited non-
specifically by TFP. For this reason, KN-62 was tested because of its stated high 
selectivity for CaMKII, with little effect on other protein kinases (Tokumitsu et 
al, 1990; Hidaka & Kobayashi, 1992). However, even for this inhibitor, there is 
growing list of ion channels which are non-specifically inhibited by KN-62 
(summarised by Marley & Thomson, 1996), to which can be added the P2Z ion 
channel (Section 3.4). 
Reconstitution studies or demonstration of loss of activity when CaM is blocked 
by antibody are also required to implicate a regulatory role of this intracellular 
Ca2+-binding protein in PLD activity. Recently, Takahashi et al, (1996) 
augmented reconstituted ARF-stimulated PLD activity in cytosol-depleted, 
streptolysin O-permeabilised rabbit neutrophils, by the addition of GTPγS, 
purified CaM and Ca2+, an effect which was inhibited by two Ca2+/CaM 
inhibitors, W-7 and TFP. The inhibitory action of TFP on ionomycin-stimulated 
PLD activity, however, may be due to inhibition of Ca2+/CaM (Figure 3.11). 
Ionomycin produces a Ca2+ influx in the absence of receptors and TFP (10 μM) 
had no effect on this flux (Footnote 7) at a concentration which produced 30% 
reduction in ionomycin-stimulated PLD activity (Figure 3.11). Intrinsic 
fluorescence of TFP prevented testing at higher concentrations. The half maximal 
inhibitory concentration of TFP for ionomycin-stimulated PLD activity was 27 
μM, 8 fold higher than for inhibition of ATP-stimulated PLD activity, and in the 
IC50 potency range (6 - 50 μM) for TFP inhibition of many other Ca2+/CaM-
dependent enzymes (Roufogalis, 1982). Similarly, TFP inhibited A23187-
stimulated PLD activity in rat basophilic leukaemia cells in a concentration-
dependent manner, with an IC50 of ≈ 30 μM (Kumada et al, 1995). Thus 
Ca2+/CaM may regulate PLD activity stimulated by Ca2+ ionophores or ARF in 
permeabilised cells (Kumada et al, 1995; Takahashi et al, 1996), but it remains to 
be determined whether this is the case for receptor-mediated PLD activity. 
The finding that TFP and KN-62 inhibited P2Z-mediated apoptosis of human 
lymphocytes (Table 3.4) agrees with that of Blanchard et al, (1995), who showed 
that these inhibitors prevented ATP-stimulated 51Cr lysis in IFN-γ-treated human 
macrophages. The results described in the present study would suggest that the 
effect of these inhibitors on cell death was related to their effect on cation fluxes 
through the P2Z receptor (Figure 3.14). Blanchard et al, (1995) also tested the 
effect of KN-62 on ATP- and BzATP-stimulated changes in cytosolic [Ca2+], but 
their results contrast to those described in the present study (Section 3.4). They 
reported that micromolar concentrations of KN-62 failed to block ATP- and  
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BzATP-stimulated rises in [Ca2+]i in both Ca2+-containing and Ca2+-free medium 
(containing 1 mM EDTA), and concluded that ATP-induced 51Cr lysis was 
independent of Ca2+ influx or release of Ca2+ from internal stores. These results 
are puzzling, since although ATP caused the expected internal release of Ca2+ 
and a Ca2+ influx due to P2Y and P2Z stimulation, BzATP, unexpectedly 
stimulated Ca2+ release from intracellular stores, an effect which they attributed 
to P2Z stimulation. Others have reported contrary results, since BzATP has been 
specifically used to stimulate P2Z receptors in cells expressing both P2Y and 
P2Z receptors (El-Moatassim & Dubyak, 1992; McMillian et al, 1993; Nuttle & 
Dubyak, 1994; Baricordi et al, 1996). Perhaps, IFN-γ treated human 
macrophages may expresses some other, as yet uncharacterised P2-receptor, not 
found in murine macrophages, and these receptors respond to BzATP by a PI-
PLC signalling pathway. 
While the IC50 for TFP inhibition of ATP-induced PLD activity was in the low 
μM range, that for KN-62 was several orders of magnitude lower (Section 3.4). 
Furthermore, an analogue of KN-62, which had no inhibitory activity on CaMKII 
or any other protein kinase (Ishikawa et al, 1990), was available as a negative 
control. This compound, KN-04, proved very useful in excluding a role for 
CaMKII in ATP-mediated responses in human lymphocytes and studies using 
these isoquinolinesulphonamides support the conclusion that both TFP and KN-
62 have a primary inhibitory locus on the P2Z receptor and/or its ion channel. 
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3.4 KN-62 is a Potent and New Inhibitor of the P2Z 
Receptor 
3.4.1 Introduction 
At present, there are no specific antagonists of the P2Z receptor which are active 
in the nanomolar range. The best known inhibitor of P2-receptors is suramin, 
which inhibits not only the lymphocyte P2Z receptor (IC50 60 μM) but also P2X 
and P2Y receptors (Wiley et al, 1993; Leff et al, 1990). Suramin also inhibits 
receptors for several growth factors (eg bFGF, PDGF, IL-3 etc) and a wide 
variety of enzymes, including ecto-ATPase (Voogd et al, 1993; Crack et al; 
1995). Oxidised ATP inhibits the P2Z receptor but its effect is irreversible and 
requires exposure of cells to high concentrations of inhibitor (≈ 300 μM for 60 
min) (Murgia et al, 1993; Wiley et al, 1994). Amiloride analogues, such as 
hexamethylene amiloride (HMA), are the most potent known inhibitors of the 
P2Z receptor with IC50s of 2-10 μM, but at maximal effective concentrations 
produce only incomplete block (70-85%) of cation fluxes through the P2Z ion 
channel (Wiley et al, 1996). The problems of antagonist potency and non-
selectivity are further compounded by the co-expression of several P2 receptor 
subtypes on many cells. Thus mast cells express P2Y1 and P2Z receptors 
(Cockcroft & Gomperts; 1979b; Osipchuck & Cahalan, 1992) and macrophages 
P2Y2 and P2Z (Nuttle et al., 1993). However, evidence suggests that 
lymphocytes from patients with chronic lymphocytic leukaemia only express 
P2Z receptors and since this receptor has been well characterised (Wiley et al, 
1990, 1992, 1993, 1994), lymphocytes are an ideal cell type in which to evaluate 
the effect of antagonists. 
In order to determine whether P2Z-stimulated responses in human lymphocytes 
were dependent on CaMKII, a study was made of the isoquinolinesulphonamide, 
KN-62 (Section 3.3), a selective and potent inhibitor (IC50 0.9μM) of the kinase 
(Tokumitsu et al, 1990; Hidaka & Kobayashi, 1992). A structural analogue, KN-
04, which has no effect on at CaM-kinase II at 100 μM (Ishikawa et al, 1990) 
was used as a control compound. The structure of these 
isoquinolinesulphonamides is shown in Figure 3.15. KN-62 was found to inhibit 
several ATP-mediated responses, namely apoptosis and long-term PLD 
activation (Section 3.3). In this study, the effect of both KN-62 and KN-04 on 
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other P2Z-mediated responses was investigated in order to determine their 
inhibitory potency and selectivity. 
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Figure 3.15 Structure of the isoquinolinesulphonamides, KN-62 & KN-04 
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3.4.2   KN-62 Inhibits ATP-stimulated Permeant Fluxes  
Fura-2 loaded cells were suspended in KCl medium, preincubated with the 
isoquinolinesulphonamide, KN-62 for 5 min at 37°C and then 0.5 mM Ba2+ was 
added, followed by 260 μM ATP4- (640 μM ATP). KN-62 produced a 
concentration dependent inhibition of ATP-stimulated Ba2+ influx which was 
maximal at 500 nM (Figure 3.16a,b). Analysis of the initial rates of Ba2+ influx 
(Figure 3.16b) gave an IC50 12.7 ± 1.5 nM for KN-62 and maximal inhibition of 
95.9 ± 2.5% (mean ± s.e.m., n = 3 experiments from 3 patients). Hill analysis 
yielded a nH of -1.16 ± 0.14 (n = 3). In fura-2 loaded cells, ATP also stimulated a 
rise in cytosolic [Ca2+] from a resting level of 140 nM to 700 nM, which was 
completely inhibited by 500 nM KN-62. No basal uptake of Ba2+ or Ca2+ was 
observed in the presence or absence of 1 μM KN-62. 
Preincubation of cells with KN-62 (1 - 500 nM) for 5 min prior to addition of 
ATP inhibited ATP-stimulated ethidium+ influx at all concentrations. (Figure 
3.17a). Analysis of KN-62 inhibition of the rates of ethidium+ uptake (Figure 
3.17b) gave an IC50 13.1 ± 2.6 nM with maximal inhibition of the uptake of 97.7 
± 4.0% at 500 nM KN-62 and nH -0.89 ± 0.12 (n = 4). KN-62 (500 nM) had no 
effect on the negligible basal uptake of ethidium+ into lymphocytes. 
3.4.3  KN-04 also Inhibits ATP-stimulated Permeant Fluxes 
The observed inhibitory effect of KN-62 on ATP-stimulated cation fluxes raised 
the possibility that CaMKII may be involved in regulating the P2Z receptor. The 
inhibitory activity of the inactive structural analogue KN-04 was, therefore, 
examined. KN-04 potently inhibited ATP-stimulated Ba2+ influx in a 
concentration dependent manner (Figure 3.16b) with an IC50 17.3 ± 2.7 nM, nH  
-0.94 ± 0.10 and producing maximal inhibition of 91.4 ± 2.7% of the flux at a 
concentration of 500 nM (n = 3). Similarly, KN-04 potently antagonised ATP-
induced ethidium+ uptake with an IC50 of 37.2 ± 8.9 nM, a nH of -0.72 ± 0.06 and 
maximal inhibition of 95.3 ± 5.7% at a concentration of 500 nM (n = 4) (Figure 
3.17b). The activity of KN-04 excludes an involvement of CaMKII in the 
regulation of the P2Z receptor. The effect of these two 
isoquinolinesulphonamides on other P2Z-mediated responses in lymphocytes 
was then studied. 
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Figure 3.17  Inhibition of ATP-stimulated ethidium+ influx by KN-62 & KN-04.  
(a) Lymphocytes, suspended (106/ml) in HEPES buffered KCl medium, were pre-
incubated in the absence (,) or presence of KN-62: 1 ({), 5 (z), 10 (◊), 50 (), 100 
() and 500 (Δ) nM for 5 min at 37°C followed by additions of 500 μM ATP (230 μM 
ATP4-) and 25 μM ethidium+ as indicated. Mean channel cell associated fluorescence 
was measured at 6 s intervals by flow cytometry. (b) Initial rates of ATP-stimulated 
ethidium+ influx were obtained from cells stimulated with ATP in the presence of KN-
62 () or KN-04 () as described above. Results are expressed as a percentage of 
maximal response to ATP in the absence of inhibitor, which was defined as 100% 
response. The curves shown were calculated by non linear regression analyses. Mean 
values ± s.e.m. from 4 experiments on 3 patients are shown. 
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3.4.4   KN-62 and KN-04 Inhibit Other P2Z-mediated Responses 
3.4.4.1  KN-62 and KN-04 Inhibition of ATP-stimulated PLD activity 
To explore the inhibitory specificity of KN-62 and KN-04, the effect of these 
inhibitors on ATP-, ionomycin- and phorbol ester-stimulated PLD activity was 
examined, since the three agonists activate PLD through different signal 
transduction pathways (Exton, 1994). In human leukaemic lymphocytes, 
ionomycin (5 μM) increased [3H]PBut accumulation 8 fold over basal, while 
phorbol ester (100 nM) produced a 3.6 fold increase (Figure 3.18a). Similarly, 1 
mM ATP (260 μM ATP4-) increased PLD activity 3.5 fold over basal. However, 
while both KN-62 (500 nM) and KN-04 (500 nM) completely inhibited ATP-
stimulated PLD activity (P < 0.0001, ANOVA), the inhibitors had no effect on 
phorbol ester- or ionomycin-stimulated PLD activity (Figure 3.18a), even at 
concentrations up to 5 μM9. The concentration dependence of PLD inhibition by 
either KN-62 or KN-04 added 10 min prior to ATP is shown in Figure 3.18b. 
Both compounds antagonised ATP-stimulated PLD activity, over the 
concentration range 1 - 500 nM, producing 50% inhibition at 5.9 ± 1.2 and 9.7 ± 
2.8 nM (n = 3) respectively. The nH were -1.03 ± 0.33 (n = 3) and -0.75 ± 0.09 (n 
= 3) for KN-62 and KN-04, respectively. Neither compound affected basal PLD 
activity. 
3.4.4.2  KN-62 and KN-04 Inhibition of ATP-stimulated L-selectin shedding 
Stimulation of the P2Z receptor by extracellular ATP also causes shedding of the 
surface adhesion molecule, L-selectin (CD62L) by activation of a membrane 
proteolytic activity, which is independent of Ca2+ influx (Jamieson et al, 1996). 
Cells were preincubated with KN-62 or KN-04 (5 - 500 nM) for 5 min at 37°C, 
500 μM ATP (230 μM ATP4-) was added and after another 5 min the cells were 
stained by fluorescein-labelled anti L-selectin antibody and analysed by flow 
cytometry. Again, both KN-62 and KN-04 prevented ATP-stimulated L-selectin  
 
                                              
9 In the same experiment described in Figure 3.18a: 
5 μM ionomycin stimulated 0.75 ± 0.04 and 0.90 ± 0.02% [3H]PBut accumulation in the presence of 5 
μM KN-62 and KN-04 respectively (P = 0.06, ANOVA);  
100 nM PMA stimulated 0.32 ± 0.02 and 0.38 ± 0.01% [3H]PBut accumulation in the presence of 5 μM 
KN-62 and KN-04 respectively (P = 0.06, (n = 1). 
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Figure 3.18 Effect of KN-62 and KN-04 on ATP-, ionomycin- or phorbol 
  ester-stimulated PLD activity.  
[3H]oleic acid-labelled lymphocytes (107/ml) suspended in Ca2+-containing (1 mM) 
HEPES buffered KCl medium were preincubated in the absence ( ) or presence of KN-
62 () or KN-04 () for 5 min at 37°C, 30 mM butanol added, then cells were 
stimulated for 15 min with (a) 1 mM ATP (ATP4- 260 μM), 5 μM ionomycin or 100 nM 
phorbol ester (PMA) and (b) 1 mM ATP (ATP4- 260 μM). (a) KN-62 and KN-04 were 
500 nM. [3H]PBut was expressed as a percentage of total [3H]phospholipids (means ± 
s.e.m., n = 3) after subtraction of basal activity (0.09 ± 0.01%). *Significant difference 
in PLD activity P < 0.0001 (ANOVA). Results shown are from one of 2 experiments.  
(b) Results are expressed as a percentage of maximal response to ATP in the absence of 
inhibitor, which was defined as 100% response. The curves shown were calculated by 
non linear regression analyses. Mean values ± s.e.m. on 3 patients are shown. 
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shedding, IC50 31.5 ± 4.5 and 78.7 ± 10.8 nM (n = 3) respectively. The nH were  
-0.93 ± 0.02 (n = 3) and -0.84 ± 0.10 (n = 3) for KN-62 and KN-04, respectively 
(Figure 3.19). In contrast, 500 nM KN-62 had no effect on PMA-stimulated L-
selectin shedding10. 
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Figure 3.19   KN-62 & KN-04 inhibit ATP-stimulated L-selectin shedding 
Lymphocytes (106/ml) suspended in HEPES buffered KCl medium, were preincubated 
with KN-62 () or KN-04 () for 5 min at 37°C and stimulated with 500 μM ATP 
(ATP4- 230 μM) for 5 min, then stained with FITC-labelled monoclonal anti-L-selectin 
antibody. The mean channel of cell-associated fluorescence was measured by flow 
cytometry. Results are expressed as a percentage of maximal response to ATP in the 
absence of inhibitor, which was defined as 100% response. The curves were calculated 
by non linear regression analyses. Mean values ± s.e.m. on 3 patients are shown. 
3.4.5  Inhibition by KN-62 and KN-04 is Time Dependent and Partially 
Reversible 
KN-62 (15 - 100 nM) had little inhibitory effect on ATP-stimulated Ba2+ influx if 
both the inhibitor and the agonist (ATP, 640 μM) were added simultaneously to 
the lymphocyte suspension at zero time of the assay (data not shown). The onset  
                                              
10 C. Gargett, B. Gu & J. Wiley unpublished observations. 
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of inhibitory action of the isoquinolinesulphonamides was best shown by 
measuring ATP-stimulated ethidium+ influx. In the absence of inhibitor, the 
ATP-stimulated uptake of ethidium+ was linear with time over 5 min, but the 
addition of KN-62 or KN-04 (500 nM) 3 min after ATP (500 μM) produced a 
gradual and substantial slowing of the rate of ethidium+ uptake (Figure 3.20). 
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Figure 3.20 Onset of KN-62 inhibition of ATP-stimulated ethidium+ uptake 
Lymphocytes (106/ml) suspended in HEPES buffered KCl medium, were incubated at 
37°C with ({, z) or without () 500 μM ATP (230 μM ATP4-), followed by 25 μM 
ethidium+ and 500 nM KN-62 ({) as indicated by the arrows. Mean channel cell 
associated fluorescence was measured at 6 s intervals by flow cytometry. Similar results 
were obtained when KN-04 was added to ATP-stimulated cells. Results from a single 
experiment, representative of 2. 
 
The reversibility of KN-62 inhibition was examined by incubating cells with or 
without KN-62 (20 nM) for 10 min at 37°C, washing, and then measuring ATP-
stimulated Ba2+ influx after the KN-62 washing procedure. The inhibitory effect 
of KN-62 was partially reversible, since the Ba2+ influx was restored to 50% of 
that observed for untreated cells when KN-62-treated cells were washed twice in 
medium containing 2% BSA. When 0.1% BSA-containing medium was used for 
washing the cells, 25% of P2Z activity was restored. 
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(Figure 3.21 and Footnote 11), but 500 nM KN-62 completely inhibited ATP-
stimulated Ba2+ uptake in normal lymphocytes (monocytes removed) isolated 
from the same blood sample. Similarly, KN-62 (100 nM) had no effect on ATP-
stimulated contractile responses of guinea pig urinary bladder or anococcygeus 
muscle, both of which contain P2X1 receptors12. 
3.4.6   Discussion 
3.4.6.1  KN-62 and KN-04 are potent inhibitors of the P2Z receptor 
The main finding of this study is that KN-62 and KN-04 are potent inhibitors of 
the P2Z receptor, since all P2Z-mediated responses in human lymphocytes were 
antagonised. Thus both KN-62 and KN-04 inhibited ATP-stimulated permeant 
fluxes (Figures 3.16 and 3.17) through the P2Z ion channel in a concentration-
dependent manner over the same range (1 - 500 nM) that inhibited ATP-
stimulated PLD activity (Figure 3.18b) and ATP-induced L-selectin shedding 
(Figure 3.19). While ATP-stimulated PLD activity is directly dependent on 
divalent cation influx through the P2Z receptor-operated ion channel (Section 
3.2), ATP-induced L-selectin shedding is independent of these fluxes (Jamieson 
et al, 1996). These data show that both KN-62 and KN-04 directly inhibit the 
P2Z receptor rather than simply blocking the associated ion channel. 
Furthermore, the specificity of KN-62 and KN-04 for P2Z-mediated responses 
was supported by the lack of effect of these compounds on ionomycin-stimulated 
rise in cytosolic [Ca2+]13 and ionomycin-stimulated PLD activity (Figure 3.18a). 
It is well documented that PMA, a membrane permeant phorbol ester, activates 
protein kinase C, and stimulates both L-selectin shedding and PLD activation 
(Kishimoto et al, 1989; Exton, 1994). However, neither of these responses, 
which do not involve P2Z receptor activation, were inhibited by the 
isoquinolinesulphonamides (Figure 3.18a, B. Gu, personal communication). 
                                              
12 T. Cocks, personal communication. 
13 Ionomycin (5 μM) increased [Ca2+]i from a resting level of 150 nM to > 1 μM in Ca2+-containing 
HEPES buffered saline medium, in the presence or absence of either 1 μM KN-62 or KN-04. Similarly, 
in Ca2+-free saline medium containing 0.2 mM EGTA, 5 μM ionomycin raised [Ca2+]i from 100 nM to 
520, 515 and 520 nM in the absence and presence of KN-62 and KN-04 respectively (n = 1).  
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3.4.6.2  P2Z-mediated responses are unlikely to involve CaMKII 
This study shows that the inhibitory effect of KN-62 on the diverse effects mediated 
by ATP activation of P2Z receptors present on human lymphocytes is not due to 
CaMKII inhibition. KN-62 has been extensively used as a protein kinase inhibitor, 
which is specific for CaMKII (IC50 of 0.9 μM), since even at 100 μM, it has no 
effect on other protein kinases (Tokumitsu et al, 1990). In this study, it was shown 
that KN-62 inhibited both ATP-stimulated Ba2+ and ethidium+ fluxes in a 
concentration-dependent manner with a potency (IC50 13 nM), which is 100 fold 
greater than its inhibitory action on CaMKII (Figures 3.16 and 3.17). KN-04, a 
structural analogue of KN-62, with no inhibitory effect on CaMKII at 100 μM, has 
been used as a negative control in studies exploring the role of CaMKII. For 
example, KN-62 but not KN-04 inhibits the release of GABA into the cerebrospinal 
fluid of the rat (Ishikawa et al, 1990), decreases the density of voltage-gated Na+ 
channels in chick myotubes (Satoh et al, 1994), and inhibits both glucose-dependent 
release of insulin and cyclic-ADP-ribose-mediated Ca2+ release from ryanodine-
sensitive Ca2+ stores of rat pancreatic islets (Wenham et al, 1992, Takasawa et al, 
1995). In all these studies it was concluded that CaMKII was involved in mediating 
these responses. In the present study, KN-04 inhibited P2Z-mediated responses with 
IC50s of the same order of magnitude as KN-62, which further suggests that CaMKII 
is unlikely to regulate the P2Z receptor. 
3.4.6.3  Specificity of Isoquinolinesulphonamide Antagonism 
In contrast to the potent inhibition by KN-62 and KN-04 of the P2Z receptor, these 
inhibitors had no effect on the P2X1 receptor of urinary bladder (Footnote 12) or on 
P2Y2 receptors (Figure 3.21). While stimulation of P2Z, P2X and P2Y receptors 
results in a rise in cytosolic [Ca2+], the mechanism by which this occurs is quite 
different. The P2X and P2Z receptors are ligand gated ion channels and conduct 
Ca2+ from the extracellular medium into the interior of the cell, without release of 
Ca2+ from intracellular stores (Dubyak & El-Moatassim, 1993; Section 3.2). In 
contrast, P2Y receptors are G-protein-coupled and activate the phosphoinositide 
specific phospholipase C signalling cascade, releasing Ca2+ from internal stores 
(Dubyak & El-Moatassim, 1993; Figure 3.21). P2Y2 receptors, present on human 
neutrophils, respond to ATP and UTP and at much lower concentrations (1 - 10 μM) 
than the concentration of ATP required to stimulate the P2Z receptor (Conigrave & 
Jiang, 1995). KN-62 and KN-04, at concentrations which completely inhibited all 
P2Z-mediated responses, had no effect on the P2Y2-mediated rise in cytosolic  
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[Ca2+], whether the cells were suspended in Ca2+-free or Ca2+-containing medium 
(Figure 3.21 and Footnote 10). In other cell types which express P2Y2 receptors, 
such as thyroid FRTL-5 cells (Dubyak & El-Moatassim, 1993) or biliary 
epithelial cells, KN-62 had no inhibitory effect on ATP-stimulated rise in 
cytosolic [Ca2+] (McGill et al, 1995; Törnquist & Ekokoski 1996). Thus the 
isoquinolinesulphonamide antagonists distinguish between P2Z-, P2X1 and 
P2Y2-mediated responses. 
Recent studies have shown that KN-62 and KN-04 have other effects and are 
equipotent inhibitors of voltage-gated Na+ and Ca2+ channels, as well as receptor-
operated Na+ channels in bovine adrenal chromaffin cells (Marley & Thomson, 
1996; Maurer et al., 1996; Tsutsui et al, 1996). However, the action of the 
isoquinolinesulphonamides on these cation channels requires concentrations 2 - 3 
orders of magnitude greater than those which inhibit the P2Z-mediated responses 
in this study. Furthermore, the maximal effect achieved with 10 μM KN-62 or 
KN-04 was 70 - 80% inhibition of voltage-gated 45Ca2+ or 22Na+ fluxes (Maurer 
et al, 1996; Tsutsui et al, 1996) whereas in the present study, 500 nM 
concentrations of these inhibitors blocked Ba2+ or ethidium+ influx through the 
P2Z ion channel by 91 - 98% (Figures 3.16 and 3.17). However, KN-62 
inhibition of the P2Z receptor and the subsequent lack of cation fluxes is 
probably responsible for inhibition of ATP-stimulated PLD activity, which is 
Ca2+-influx dependent (Section 3.2). 
KN-62 is membrane permeant as shown by its ability to inhibit intracellular 
CaMKII (Hidaka & Kobayashi, 1992). It is also likely that KN-04 is membrane 
permeant, since its structure is almost identical to KN-62 (Figure 3.15) and 
slightly more hydrophobic. It is possible that these isoquinolinesulphonamides 
act intracellularly, conferring specificity by binding to the long intracellular 
carboxyl tail found only on the P2X7 receptor (Surprenant et al., 1996). This 
might explain the 5 - 15 min preincubation required to achieve maximal 
inhibition with KN-62 and KN-04, and also the partial reversibility of their 
inhibitory action after washing with media containing BSA. Longer 
preincubations (30 - 60 min) are necessary for KN-62 antagonism of CaMKII, 
(Wenham et al, 1992; Takasawa et al, 1995) compared to inhibition of the P2Z 
receptor, perhaps due to the higher intracellular concentration of inhibitor 
required for CaMKII inhibition. However, it is possible that both KN-62 and 
KN-04 bind to either the ATP binding site at the putative large external region of 
the P2X7 receptor or close to one of the transmembrane regions and so prevent 
ATP-induced conformational changes associated with ion channel opening. In 
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support of the latter notion is the observation that the isoquinoline ring of the 
protein kinase inhibitor, CK17, mimics the planar structure of adenine, and binds 
to casein kinase I by occupying the cleft that binds ATP (Xu et al, 1996). Hill 
analysis of the KN-62 and KN-04 inhibitory effect on P2Z-mediated responses 
yields, nH of ≈ 1.0, suggesting a single binding site. However ATP-stimulated 
Ba2+ influx produced sigmoid concentration-response curves, and nH values of ≈ 
2, suggesting that several ATP molecules bind to the receptor. Thus it is 
uncertain at present where and how KN-62 and KN-04 act.  
This study shows that KN-62 and KN-04 are the two most potent inhibitors of 
the P2Z receptor described to date. KN-62 and KN-04 are 2-3 orders of 
magnitude more potent as inhibitors of the P2Z receptor than are HMA, oxidised 
ATP, or suramin, all of which require 30 - 300 μM concentrations for maximal 
effect (Wiley et al, 1993, 1994, 1996). Although isoquinolinesulphonamide 
inhibition of P2Z responses is essentially complete after a 5 min preincubation, it 
was noted that at low KN-62 concentrations a 15 min preincubation sometimes 
gave an additional 10% inhibition. In contrast, oxidised ATP requires a one hour 
preincubation. Furthermore, the inhibitory effect of KN-62 and KN-04 on P2Z-
mediated responses is almost complete (91-98%), unlike that of HMA which 
only blocks cation fluxes 70-80% at maximal effective concentrations. 
Currently there are no antagonists that are specific for any single P2-receptor 
subtype or even any that distinguish between ionotropic and metabotropic P2-
receptors. Even, PPADS, which initially emerged as a P2X selective antagonist 
(Lambrecht et al, 1992) has since been shown to inhibit P2Y1 but not P2Y2 
receptors co-expressed on endothelial cells (Brown et al, 1995). Further studies 
will be necessary to check selectivity of the isoquinolinesulphonamides for the 
P2Z receptor, since their effect on P2X2-6 receptors and the cloned P2X7 receptor 
is unknown. The present study suggests KN-62 should prove a useful tool in 
analysing purinergic responses in the many tissues which co-express several P2-
receptor subtypes. 
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3.5 ATP-induced L-selectin Shedding Does Not Involve 
PLD Activity 
3.5.1 Introduction 
The leukocyte surface adhesion molecule, L-selectin, has a role in lymphocyte 
transmigration from the blood stream into peripheral lymph nodes. L-selectin is 
important for the rolling behaviour of lymphocytes and other leukocytes, since L-
selectin interacts with carbohydrate epitopes on endothelial cells and causes 
tethering of these leukocytes, immediately prior to their transmigration into 
normal and inflamed tissues (Tedder et al, 1995). L-selectin is constitutively 
expressed on most classes of B lymphocytes (Bevilaqua & Nelson, 1993), 
including those from patients with chronic lymphocytic leukaemia (Spertini et al, 
1991; Jamieson et al, 1996), although on these cells it is abnormally glycosylated 
(Prystas et al, 1993). Activation of both normal and leukaemic lymphocytes by 
PMA causes rapid shedding of L-selectin (Jung et al, 1988; Prystas, et al, 1993; 
Jamieson et al, 1996). L-selectin down-regulation immediately follows 
lymphocyte binding to high endothelial venules, suggesting that L-selectin 
shedding represents the earliest stages in lymphocyte trafficking (Ager & Wood, 
1994). Evidence supporting this finding is the presence of high levels of soluble 
L-selectin (5 -10 μg/ml) in the plasma (Xie & Low, 1994), suggesting that 
shedding may be a continuous process (Schleiffenbaum et al, 1992).  
L-selectin is largely extracellular and expressed on lymphocytes as an integral or 
GPI-anchored protein (Camerini et al, 1989). Endogenous metalloproteinase or 
GPI-specific PLD of activated cells cleave L-selectin, which is released into the 
plasma (Bazil, 1995). Recently a metalloproteinase that cleaves L-selectin was 
identified, which was distinguishable from other known matrix 
metalloproteinases and designated, L-selectin sheddase (Preece et al, 1996). GPI-
PLD is found in human serum and is also expressed on some cell types (Low & 
Prassad, 1988; Xie et al, 1993), including human and murine 
monocyte/macrophages and myeloid cells and, from some of these cells, the 
enzyme is released into the plasma (Xie & Low, 1994). While plasma GPI-PLD 
is active in in vitro assays, its ability to cleave and thus release GPI-anchored 
cell-surface receptors and adhesion molecules into the medium has not been 
demonstrated on intact cells (Scallon et al, 1991; Bergman & Carlsson, 1994). 
Instead, GPI-PLD hydrolyses GPI anchors from their proteins intracellularly, as 
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they transit to the cell surface (Scallon et al, 1991). The primary structure of 
GPI-PLD reveals four E-F hand like structures, which are Ca2+ binding regions 
similar to those found in CaM and other Ca2+-binding proteins (Scallon et al, 
1991). GPI-PLD binds Ca2+ and Zn2+ (Li et al,  1994) and both divalent cations 
are required for enzyme activity, since the Ca2+ chelators EDTA and EGTA, and 
the Zn2+ chelator, 1,10-phenanthroline, are inhibitory (Low & Prasad, 1988; Xie 
& Low, 1993). 
Stimulation of the lymphocyte P2Z receptor by extracellular ATP also causes 
cleavage of L-selectin (Jamieson et al, 1996). However, it is not known if this 
cleavage is due to GPI-PLD, metalloproteinase or both. Neither is it known if the 
ATP-stimulated PLD activity in murine macrophages and human lymphocytes 
has specificity toward the GPI anchor. The effects of inhibitors of both GPI-PLD 
and the metalloproteinase involved in L-selectin shedding were examined on 
ATP-stimulated PLD activity.  
3.5.2  Effect of GPI-PLD inhibitors on ATP-stimulated on PLD Activity  
Cells suspended in HEPES buffered KCl medium containing 0.2 mM Ca2+ were 
preincubated with 1 mM 1,10 phenanthroline (Xie & Low, 1994) for 20 min at 
20°C, 30 mM butanol was added and the cells then stimulated with 580 μM ATP 
(230 μM ATP4-) for 15 min at 37°C. Since ethanol was the only suitable solvent 
for 1,10 phenanthroline and was present at 1% in the PLD assay medium, 
[3H]phosphatidylethanol ([3H]PEt) was also identified on TLC plates, measured 
and added to the amount of [3H]PBut accumulated for both untreated (vehicle, 
1% ethanol) and 1,10-phenanthroline-treated cells. There was no significant 
difference between ATP-induced [3H]PBut plus [3H]PEt or [3H]PBut 
accumulation in the presence or absence of ethanol respectively (Table 3.5). 
ATP-stimulated PLD activity in human lymphocytes was potentiated rather than 
inhibited by 1,10-phenanthroline (Table 3.5). 
Since ATP-stimulated PLD activity is dependent on divalent cation influx 
through the P2Z ion channel, and was inhibited by extracellular EGTA (Section 
3.2), the effect of EGTA and EDTA as inhibitors of GPI-PLD activity were not 
studied. 
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Table 3.5 Effect of a GPI-PLD inhibitor on ATP-stimulated PLD activity 
Conditions [3H]PBut + [3H]PEt 
(% [3H]phospholipids) 
Fold over 
respective basal 
ATP 1.67 ± 0.16   8.8 
ATP + 1% ethanol 1.46 ± 0.02 10.4 
ATP + 1,10 phenanthroline 2.64 ± 0.06 18.9 
[3H]Oleic acid-labelled lymphocytes (107/ml) suspended in Ca2+-containing (0.2 mM) 
HEPES buffered KCl medium supplemented with 30 mM butanol were incubated with 
or without 580 μM ATP (230 μM ATP4-) for 15 min at 37°C and [3H]PBut and [3H]PEt 
measured. Some cells were incubated with 1 mM 1,10-phenanthroline or 1% ethanol 
(vehicle) for 20 min at 20°C, warmed to 37°C with butanol present, prior to incubation 
with ATP. Basal PLD activity was 0.14 ± 0.03 and 0.19 ± 0.01% [3H]PEt + [3H]PBut 
for cells incubated with or without 1% ethanol, respectively and was subtracted from 
values. ATP-stimulated PLD activity was significantly different from respective 
controls for each condition (P < 0.005; Student’s t test). Results are mean ± s.e.m. (n=3) 
from a single experiment representative of 2. 
3.5.3 Effect of a Metalloproteinase Inhibitor on ATP-stimulated PLD 
Activity 
Recently, the hydroxamic acid-based inhibitor of Zn2+-dependent matrix 
metalloproteinases, Ro 31-9790, was shown to block PMA-induced L-selectin 
shedding in mouse, rat and human lymphocytes (Preece et al, 1996) and ATP-
induced shedding in human leukaemic lymphocytes14. When lymphocytes were 
incubated with 150 μM Ro 31-9790, a concentration which completely blocked 
ATP-stimulated L-selectin shedding, there was no effect on ATP-stimulated PLD 
activity (Figure 3.22). Figure 3.23 shows that Ro 31-9790 also had no effect on 
ATP-induced rise in cytosolic [Ca2+] in fura-2 loaded lymphocytes.  
3.5.4  Discussion 
This study shows that ATP-stimulated L-selectin shedding is independent of two 
other P2Z-mediated responses, ion channel opening and subsequent PLD 
activation. Ro 31-9790 inhibits ATP-induced L-selectin shedding, but had no 
effect on ATP-induced Ca2+ influx or ATP-stimulated PLD activity. These 
 
                                              
14 J. Chen, B. Gu & J. Wiley, personal communication 
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observations, together with reports that ATP-induced L-selectin shedding is 
independent of extracellular Ca2+ (Jamieson et al, 1996) indicate that stimulation 
of the lymphocyte P2Z receptor can result in Ca2+-dependent and Ca2+-
independent responses. The lack of inhibitory effect by 1,10-phenanthroline 
(Table 3.5), which uniformly blocks GPI-PLD activity (Low & Prassad, 1988; 
Xie & Low, 1994), indicates that the PLD present in human leukaemic 
lymphocytes has no specificity for GPI-linked substrates. Recently a human 
PLD1 enzyme was cloned from HeLa cells, which showed no structural 
homology with GPI-PLD (Hammond et al, 1995), thus supporting the above 
conclusion that PC-PLD and GPI-PLD are distinct enzymes with separate 
substrates, but which produce the same end product, PA.   
The unexpected potentiating effect of 1,10-phenanthroline on ATP-stimulated 
PLD activity (Table 3.5) suggests that the lymphocyte PLD enzyme is sensitive 
to contaminating Zn2+, which may have been present in the medium. 
Alternatively, PLD activity may be negatively regulated by Zn2+-dependent 
protein(s). Indeed, a cytoskeletal protein, fodrin, has been identified as one 
negative regulator of PLD activity in HL-60 cells (Lukowski et al, 1996). 
 112
3.6 ATP is a Partial Agonist for the P2Z Receptor 
3.6.1 Introduction 
Agonists for the P2Z receptor show a rank order of potency which clearly 
distinguishes these receptors from other P2-receptors (Section 1.6.2.1). In murine 
macrophages (El-Moatassim & Dubyak, 1992; Nuttle & Dubyak, 1993), human 
lymphocytes (Wiley et al., 1994, 1996) and HEK cells expressing P2X7 receptors 
(Surprenant et al, 1996) BzATP was a far more potent agonist than ATP. Indeed, 
BzATP stimulated Ba2+ influx in human lymphocytes with an EC50 of 8 μM 
compared with 89 μM for ATP (Wiley et al, 1994). In addition to its greater 
potency relative to ATP, BzATP showed greater maximal stimulation of P2Z-
mediated responses such as Ba2+ influx in human lymphocytes (Wiley et al., 
1994), PLD activity in both human lymphocytes and murine macrophages 
(Section 3.1.2; El-Moatassim & Dubyak, 1992) and current amplitude in J744 
macrophages and HEK cells transfected with P2X7 receptors (Surprenant et al, 
1996). Differences in maximal response elicited by other agonists have also been 
reported for both native and cloned P2Y1 receptors, for which and it was 
concluded that ATP acted as a partial agonist (Barnard et al, 1996). Partial 
agonism is a well recognised feature of many agonist-receptor interactions and is 
generally attributed to a diminished ability of the agonist to change receptor 
conformation, which results in lower measured responses, even at maximal 
receptor occupancy (Ross, 1996).  
Cells often co-express several P2-receptor subtypes and thus maximal responses 
to a variety of ATP analogues may be due to the combined responses of these co-
expressed receptors (O’Connor et al, 1991). Lymphocytes from patients with 
chronic lymphocytic leukaemia do not possess P2Y receptors, but the possibility 
exists that another, as yet unrecognised P2X receptor subtype is expressed on 
these cells, and which responds to BzATP, which is a partial agonist for P2X 
receptors (Surprenant, 1996). Moreover, a partial cDNA clone (RP-2) has been 
isolated from apoptotic thymocytes and from base 38 to its end has sequence 
identity to P2X1 receptor cDNA (Owens et al, 1991; Valera et al, 1994). Thus 
the lower maximal responses in human lymphocytes to ATP compared with 
BzATP are not known. In the present study the ability of four agonists to 
stimulate ethidium+ influx through the P2Z receptor-operated ion channel was 
quantitated and compared, in order to determine whether any were partial 
agonists. In addition, competitive inhibition experiments were conducted 
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between ATP and BzATP, in order to determine if ATP is a partial agonist for 
the P2Z receptor and to exclude the presence of another P2-receptor. 
3.6.2 BzATP Produces Greater Maximal Responses than ATP 
The influx of ethidium+ through the lymphocyte P2Z-operated ion channel was 
studied using concentrations of BzATP and ATP known to give maximal Ba2+ 
influx (Wiley et al., 1994). Addition of 500 μM ATP or 50 μM BzATP to 
lymphocytes suspended in Ca2+-free KCl medium induced an uptake of 
ethidium+ which was linear over 5 min (Fig. 3.24). Ethidium+ influx was greater 
for BzATP compared to ATP. Concentration-response curves for BzATP and 
ATP were then analysed. Uptake slopes gave EC50 values of 15.4 ± 1.4 μM (n = 
5 experiments from 4 patients) and 85.6 ± 8.8 μM (n = 5 experiments from 3 
patients), respectively (Fig. 3.25). The maximal response for ATP was only 69.8 
± 1.9 % (n  
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Figure 3.24   BzATP- & ATP-stimulated ethidium+ influx in lymphocytes. 
Cells (106/ml) suspended in HEPES buffered KCl medium were preincubated for 2 min 
at 37°C with either 50 μM BzATP () or 500 μM ATP (z) prior to addition of 25 μM 
ethidium+. Control cells (Δ) were incubated with 25 μM ethidium+ alone. Mean channel 
cell associated fluorescence was measured at 6 s intervals by flow cytometry. Arrows 
indicate the sequential addition of agonist and ethidium+. Results are from a single 
experiment, representative of 6. 
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= 5) of that for BzATP. Hill analysis of the data (Figure 3.26) gave nH values of 
3.17 ± 0.24 (n = 3) and 2.09 ± 0.45 (n = 4) for BzATP and ATP, respectively. 
Similar Hill plots derived from Ba2+ uptake data (Fig. 3.28b, Wiley et al., 1994) 
gave nH values of 3.27 ± 0.43 (n = 3) and 2.36 ± 0.22 (n = 5) for BzATP and 
ATP, respectively. 
 
ATP  S
2MeSATP
BzATP
ATP
100
75
50
25
0
E
th
id
iu
m
+  
In
flu
x
(%
 m
ax
im
al
 re
sp
on
se
 to
 B
zA
TP
)
-6 -5 -4 -3 -2
log Agonist (M)  
 
Figure 3.25 Concentration response curves for ethidium+ uptake stimulat-
  ed by ATP analogues.  
Lymphocytes (106/ml) were suspended in HEPES buffered KCl medium and incubated 
with BzATP, ATP, 2MeSATP or ATPγS for 2 min at 37°C before addition of 25 μM 
ethidium+. Mean channel cell associated fluorescence was measured at 6 s intervals by 
flow cytometry. Initial rates of agonist-stimulated ethidium+ influx were measured and 
results expressed as a percentage of maximal response to BzATP, which was defined as 
100% response. The curves shown were calculated by non linear regression analyses. 
Mean values ± s.e.m. from 3 - 6 experiments on 6 patients are shown. 
3.6.3   Other ATP Analogues are Partial Agonists for the P2Z Receptor 
Our laboratory has previously shown that 2MeSATP and ATPγS are also 
agonists for the P2Z receptor, since both induce Ba2+ influx through the 
associated ion 
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Figure 3.26  Hill plot analyses of BzATP- & ATP-stimulated cation fluxes. 
Data obtained from the concentration-response curves for (a) BzATP- & (b) ATP-
stimulated ethidium+ (Fig. 3.25) & Ba2+ uptake (Fig 3.27 & Fig. 1b, Wiley et al, 1994) 
were analysed by the Hill equation and plots for ethidium+ () and Ba2+ () 
constructed from the means of 3 - 5 experiments. Y is the fractional response, V/Vmax, 
where V is the initial rate of ethidium+ or Ba2+ influx for each agonist concentration & 
Vmax is the rate at maximal agonist concentration. nHs were calculated by linear 
regression analysis of slopes from individual experiments & means ± s.e.m. for n 
experiments are shown. 
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channel (Wiley et al, 1994). Both 2MeSATP and ATPγS induced ethidium+ 
influx into lymphocytes and analysis of the concentration-response curve for 
2MeSATP gave an EC50 value of 77.5 ± 8.0 μM (n = 3). An EC50 was not 
determined for ATPγS, since the response in some experiments did not reach 
maximal at the concentrations shown. Maximal responses of 2MeSATP and 
ATPγS were 34.6 ± 3.5% (n = 3) and 13.1 % (n = 2 of the 4 experiments shown) 
of that observed for BzATP (Fig 3.25). These values were compared to those 
found previously for the efficacy of the four agonists in stimulating Ba2+ influx 
and PLD activity. All four agonists produced the same rank order of maximal 
P2Z responses, with similar relative values, whether measured by ethidium+ 
uptake, Ba2+ influx or phospholipase D activation (Table 3.6.)  
Table 3.6   Maximal P2Z-mediated responses induced by ATP analogues 
Agonist Maximal Response 
 Ethidium+ influx Ba2+ influx§ PLD activity† 
BzATP  100   ± 3.5 (3)      100 ± 6 (3)     100 ± 18 (5) 
ATP 69.8 ± 1.9 (5) 52.9 ± 2 (3) 72.6 ± 7 (5) 
2MeSATP 34.6 ± 3.5 (3) 35.4 ± 2 (3) 28.4 ± 1 (3) 
ATPγS 13.1   (2) 13.2 ± 4 (3) 13.8 ± 1 (3) 
§ derived from data presented in Wiley et al, (1994) and † from Section 3.1.3) 
Maximal responses are expressed as a percentage relative to maximal responses for 
BzATP and are means ± s.e.m. for (n) observations. Maximal rates for ethidium+ influx 
were calculated by non-linear regression analysis of concentration-response curves 
using the program Flexifit (Guardabasso et al, 1988). 
3.6.4  Partial Agonists Produce Ethidium+ Uptake Only After a Delay 
The delay in ethidium+ uptake observed when ATP is added immediately after 
ethidium+, but which is absent when cells are preincubated with ATP (Appendix 
3, Figure A3.3) was also detected for the other partial agonists. Ethidium+ influx 
was then compared between the agonists, when they were added immediately 
after the permeant. Thus cells were incubated with maximal concentrations of the 
agonists added 30 s after 25 μM ethidium+ and the uptake measured (Figure 
3.27a). The delay before maximal ethidium+ influx was reached was then 
calculated for each agonist by drawing a line through the maximal slope and 
finding the time where deviation from this slope occurred. This value was  
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checked for each of the partial agonists by measuring the delay before maximal 
ethidium+ uptake was induced with equiactive concentrations of the more 
efficacious agonists, since the delay was longer at submaximal concentrations of 
all agonists (Figure A3.4). The data showed an inverse linear relationship 
(Pearson’s r = -0.96, P < 0.001) between the length of the delay phase and the 
maximal response for the various agonists (Figure 3.27b). There was little or no 
delay for the most efficacious agonist, BzATP and the delay was longer than 
ATP for both 2MeSATP and ATPγS. 
3.6.5   ATP, a Competitive Inhibitor of BzATP-mediated Responses 
To ascertain whether ATP binds to the same receptor as BzATP, classical 
full/partial agonist interaction studies were carried out, in which the putative 
partial agonist (ATP) was allowed to compete with the “full” agonist (BzATP), 
to find out if the combination reduced the maximal response to BzATP. Cells 
were incubated with increasing concentrations of ATP (50 - 1000 μM) added 
simultaneously with a constant concentration of BzATP (30 μM; EC90) and 
ethidium+ fluxes measured. Concentrations of ATP less than 300 μM added 
concurrently with 30 μM BzATP did not affect the maximal response to BzATP 
(designated 100%) (Fig. 3.28a). However, at concentrations of ATP above 300 
μM, a progressive decrease in the rate of BzATP-stimulated ethidium+ uptake 
was observed, such that the response at 1 mM ATP plus 30 μM BzATP matched 
that of 1 mM ATP alone (Fig 3.28a). 
A similar protocol was used to test ATP/BzATP competitive effects on Ba2+ 
influx. Fura-2 loaded cells, suspended in Ca2+-free KCl medium containing 0.25 
mM Ba2+, were stimulated with ATP alone (50 - 1000 μM), or 30 μM BzATP 
added simultaneously with ATP (50 - 1000 μM). Again, low ATP concentrations 
did not alter the Ba2+ uptake stimulated by BzATP, but increasing the 
concentration of ATP to greater than 150 μM, gradually reduced the rate until it 
approximated that produced by ATP alone (Fig. 3.28b).  
3.6.6  KN-62, a Less Potent Inhibitor of BzATP- than of ATP-mediated 
Responses 
The isoquinolinesulphonamides (KN-62 and KN-04) are potent inhibitors of the 
lymphocyte P2Z receptor, which are active in the low nanomolar range (Section 
3.4). Cells were preincubated with the more potent of these two inhibitors, 
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Figure 3.27 Agonist-induced ethidium+ uptake at maximal concentrations 
(a) Cells (106/ml) suspended in HEPES buffered KCl medium at 37°C were incubated 
with 50 μM BzATP (|), 500 μM ATP (z), 500 μM 2MeSATP () or 2 mM ATPγS 
(), added 30 s after 25 μM ethidium+. Control cells (Δ) were incubated with 25 μM 
ethidium+ alone. Mean channel cell associated fluorescence was measured at 6 s 
intervals by flow cytometry. Results are from a single experiment, representative of 3 - 
4.  
(b) Maximal rates of ethidium+ uptake (Emax) for each agonist calculated as a percentage 
of response to 50 μM BzATP which was taken as 100% were plotted against the length 
of the delay phase of the uptake. Line of best fit through data points from 4 experiments 
was calculated by least squares analysis. Correlation between Emax and length of the 
delay phase was -0.96 (Pearson’s r, P < 0.001).  
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Figure 3.28    Partial inhibition of BzATP-stimulated cation fluxes by ATP. 
(a) Lymphocytes (106/ml) were suspended in HEPES buffered KCl medium and 
incubated with either ATP alone (), or 30 μM BzATP added simultaneously with 
ATP () for 2 min at 37°C prior to addition of 25 μM ethidium+, and ethidium+ uptake 
was measured by flow cytometry. (b) Fura-2 loaded lymphocytes (2 x 106/ml) were 
suspended in HEPES buffered KCl medium at 37°C, 0.25 mM Ba2+ added, followed by 
either ATP alone (), or 30 μM BzATP added simultaneously with ATP (). Initial 
rates of ethidium+ or Ba2+ influx were measured and results expressed as a percentage of 
response to 30 BzATP μM alone, which was defined as 100% response. The 
concentration-response curves were calculated by non linear regression analyses. Mean 
values ± s.e.m. from 3 experiments on 3 patients are shown. 
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KN 62 (5 - 2000 nM) for 15 min at 37°C prior to measurement of ethidium+ or 
Ba2+ fluxes both in the presence and absence of ATP or BzATP. Using 
maximally effective concentrations of these agonists, KN-62 produced much 
greater inhibition of responses to ATP than to BzATP (Fig. 3.29). Similar results 
were obtained with KN-04. Thus, 1 μM KN-04 inhibited ATP-stimulated Ba2+ 
influx by 95%, but only inhibited the BzATP-induced Ba2+ influx from a rate of 
14.6 to 7.7 cm/min (47% inhibition). Similarly, 2 μM KN-04 completely 
abolished ATP-induced ethidium+ uptake, but only reduced BzATP-induced 
uptake from 4.46 to 3.64 mcf15/min (18% reduction). Maximal inhibition of 
BzATP-stimulated cation fluxes was at 1 - 2 μM, and even at 10 μM KN-62, no 
further inhibition could be achieved. However, when BzATP (18 μM) was used 
at a concentration equiactive with a maximally effective ATP concentration, KN-
62 showed the same inhibitory potency. (Figure 3.29). 
3.6.7  Effect of an Ecto-ATPase Inhibitor on P2Z-mediated Responses 
Since B-cell lymphocytes (Barankiewicz et al, 1988; Segel et al, 1985) express 
an ecto-ATPase on the cell surface, it is possible that the lower EC50 observed 
with ATP may be due to its more rapid hydrolysis compared with BzATP. ARL-
67156 (300 μM), a recently described ecto-ATPase inhibitor (Crack et al, 1995), 
 
Table 3.7 Effect of ARL-67156 on ATP- and BzATP-induced Ba2+ influx 
Agonist Ba2+ Influx (% maximal response to BzATP) 
 Untreated ARL-67156 (300μM) Effect of ARL-67156 
ATP 100 μM   51.4 12.0 - 76.7%  
ATP 500 μM   75.3 60.6   - 6.2%  
BzATP 10 μM   65.5 21.1 - 67.7%  
BzATP 30 μM 100 51.4 - 48.6%  
Fura-2 loaded cells (2 x 106/ml) suspended in HEPES buffered KCl medium were 
incubated in the presence or absence of 300 μM ARL-67156 for 5 min at 37°C, 0.25 
mM Ba2+ added, followed by ATP or BzATP. Results are a percentage of the response 
to 30 μM BzATP in the absence of ARL-67165, which was a rate of 14.2 cm/min and 
taken as 100% response. Results are from a single experiment. 
                                              
15mcf: mean channel fluorescence 
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Figure 3.29 Inhibition of ATP- & BzATP-stimulated cation fluxes by KN-
62  
(a) Lymphocytes (106/ml) suspended in HEPES buffered KCl medium, were pre-
incubated in the absence or presence of KN-62 for 15 min at 37°C followed by 
additions of 50 () or 18 () μM BzATP or 500 μM ATP (z) and 25 μM ethidium+ 
and ethidium+ uptake measured by flow cytometry. (b) Fura-2 loaded lymphocytes (2 x 
106/ml) were suspended in HEPES buffered KCl medium, preincubated with or without 
KN-62 for 15 min at 37°C, 0.4 mM Ba2+ added, followed by 50 () or 18 () μM 
BzATP or 500 μM ATP (z). Initial rates of ethidium+ or Ba2+ influx were measured and 
results expressed as a percentage of maximal response to 50 μM BzATP in the absence 
of inhibitor, which was 5.02 mcf/min & 29 cm/min respectively, and defined as 100% 
response. Results from a single experiment are shown, representative of 2. 
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was preincubated with fura-2 loaded cells for 5 min at 37°C and then stimulated 
with ATP or BzATP in the presence of 0.25 mM Ba2+. ARL-67156 inhibited 
both ATP- and BzATP-induced Ba2+ influx (Table 3.7). 
3.6.8   Discussion 
3.6.8.1  ATP is a partial agonist for the P2Z receptor 
This study shows that extracellular ATP, the natural ligand for the lymphocyte 
P2Z receptor, is a partial agonist, while BzATP is a more efficacious agonist for 
this receptor. Several lines of evidence support this conclusion. Firstly, maximal 
responses to ATP were less than BzATP for three different P2Z-stimulated 
responses: ethidium+ uptake, Ba2+ influx and activation of phospholipase D 
(Table 3.6). Secondly, ATP competitively inhibited BzATP-stimulated Ba2+ and 
ethidium+ fluxes (Figures 3.28a and 3.28b), indicating that both agonists bind to 
the same receptor to open the P2Z ion channel. This study assumed that BzATP 
was acting as a full agonist, which can elicit apparent maximal responses when 
only a proportion of receptors are occupied (Ross, 1996). This assumption is 
currently being tested, by substantially reducing lymphocyte P2Z receptor 
reserve by pretreatment with the irreversible P2Z inhibitor, ox-ATP, and then 
measuring BzATP-induced fluxes. BzATP can be regarded as a highly 
efficacious or full agonist for the lymphocyte P2Z receptor if this ox-ATP 
pretreatment depresses and substantially shifts rightward the concentration 
response curve for BzATP-stimulated fluxes (ie produces a curve like ATP) (Leff 
et al, 1993). Competitive experiments similar to those described in Figure 3.28 
have been used to show that 2MeSATP competitively inhibited ADP-enhanced 
responses in mouse macrophages and it was concluded that 2MeSATP was a 
partial agonist (Proctor et al, 1994). ATP is not only a partial agonist for the P2Z 
receptor, but also for the chick brain P2Y1 receptor, for which ATP gives 70% of 
the response elicited by 2MeSATP (Barnard et al, 1996), while for the P2Y 
receptor of rat brain capillary endothelial cells, ATP produced a response that 
was only 55% of that for the full agonist, ADP (Feolde et al, 1995). However, 
ATP is generally a full agonist for cloned and native P2X1-6 receptors, while 
various synthetic ATP analogues such as 2MeSATP, ATPγS and BzATP are 
partial agonists (Surprenant, 1996). 
Sigmoid concentration-response curves for the effects of ATP on the 
permeability responses of mast cells and lymphocytes are well documented, with 
nH ≈ 2 for ATP-induced increments in the permeant influx (Tatham & Lindau, 
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1990; Wiley et al, 1990, 1992, 1993, 1994; Pizzo et al, 1991). Similarly, in this 
study, nH values derived from ATP concentration-response curves for two 
permeants of different size, Ba2+ (135 Da) and ethidium+ (314 Da), were 2.4 and 
2.1 respectively. However, nH values derived for BzATP were clearly greater 
(3.3 and 3.2 respectively) than for ATP, suggesting that in this system, the more 
efficacious agonist exerts a greater positive co-operative effect on binding to the 
P2Z receptor than a partial agonist. An alternative, and less likely explanation for 
the flattened concentration response curve of ATP compared to the steep curve of 
BzATP, is that agonist binding to the P2Z receptor is hyperbolic, while P2Z ion 
channel opening (ie transducer function) is cooperative (Black et al, 1985). 
Either way, the different nHs observed for ATP and BzATP suggest that ATP is a 
partial agonist.  
3.6.8.2  Other partial agonists for the P2Z receptor 
Several other ATP analogues, including 2MeSATP and ATPγS, are capable of 
stimulating P2Z-mediated responses in lymphocytes. A comparable order of 
agonist efficacy was observed with both cation fluxes and with PLD activity 
(Table 3.6), suggesting that 2MeSATP and ATPγS are also partial agonists. The 
rank order of maximal activities shown in this study BzATP > ATP > 2MeSATP 
> ATPγS (Fig. 3.25, Table 3.6) is similar, but not identical, to the rank order 
agonist potency of BzATP >> ATP = 2MeSATP > ATPγS (Fig. 3.25, Wiley et 
al, 1994), and the same as the rank order of the length of delay before ethidium+ 
entry through the P2Z ion channel (Figure 3.27b). The inverse relationship 
between delay in ethidium+ uptake and relative efficacy of the four P2Z agonists 
is typical of a series of agonists which induce submaximal responses at full 
receptor occupancy, and thus supports other evidence that ATP, 2MeSATP and 
ATPγS are partial agonists. Others have reported similar orders of maximal 
activity for P2Z stimulation of NG108-15 cells and rat parotid acinar cells (Kaiho 
et al, 1996; McMillian et al, 1993) and for the rat brain P2X7 receptor transfected 
into HEK cells (Surprenant et al, 1996). However, in human monocyte-derived 
macrophages and transformed fibroblasts, ATP had a similar or greater efficacy 
relative to BzATP or ATPγS (Erb et al, 1990; Hickman et al, 1994). 
3.6.8.3  Factors influencing potencies of P2Z agonists 
The isoquinolinesulphonamide derivative, KN-62, a potent and specific inhibitor 
of the P2Z receptor (Section 3.4), was an incomplete and far less potent inhibitor 
of BzATP-mediated cation fluxes, compared with ATP (Figure 3.29). An 
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unusual observation was that in the presence of high concentrations of KN-62 
there was complete inhibition of BzATP-stimulated Ba2+ influx for the first 5 - 
15 s and BzATP-stimulated ethidium+ influx for 30 - 90 s, and then there was 
linear influx of the cations. Thus, uptakes reported for BzATP were measured on 
the linear part of the trace/plot. This phenomenan of complete initial block was 
not studied further, but raises the question whether KN-62 is a competitive 
antagonist. BzATP is 10 fold more potent than ATP and both are 2 - 3 orders of 
magnitude less potent than KN-62. Thus BzATP may be more effective than 
ATP in competing with KN-62 for the P2Z receptor. Competition between KN-
62 and P2Z agonists has been suggested previously (Section 3.4.6.3), a concept 
which is also supported by the observation that KN-62 showed similar inhibitory 
potency when equiactive concentrations of BzATP and ATP were used (18 μM 
and 500 μM, respectively) (Figure 3.29). 
The accuracy of relative agonist potencies has often been complicated by the 
effect of ecto-ATPase activity (Section 1.3.1). Ecto-ATPase is present on the 
surface of lymphocytes of B-cell origin (Barankiewicz et al, 1988; Segel et al, 
1985), but since this enzyme is Ca2+ and/or Mg2+ dependent (Ziganshin et al, 
1994) and neither of these cations were present in these experiments, it is 
unlikely that hydrolysis contributed to the lower EC50 of ATP compared with 
BzATP. It is difficult to draw conclusions about ecto-ATPase effects on the 
potencies of P2Z receptor agonists, since the ecto-ATPase inhibitor, ARL-67156 
(Crack et al, 1995) did not potentiate ATP-mediated responses, but slightly 
inhibited the P2Z receptor (Table 3.7). Similarly, high concentrations of ARL-
67156 (400 μM) also inhibited P2X receptors (Crack et al 1995). 
3.6.8.4  Human leukaemic lymphocytes only express the P2Z receptor subtype 
A further complication of relative agonist potencies and maximal activities is the 
presence of multiple P2-receptor subclasses, which occurs for most cells 
expressing P2-receptors. In these cells, any observed nucleotide or antagonist 
potency order will depend on the proportions of different types of P2-receptors 
present (Section 1.3.6.3) (O’Connor et al, 1991). Competitive experiments 
between different agonists distinguish true partial agonism from interaction of 
agonists with different classes of P2-receptors. For example, the failure of 
2MeSATP, the putative partial agonist, to inhibit responses of piglet aortic 
endothelium to the full agonists ATP, UTP or ATPγS, aided the discovery of 
coexisting P2Y1 and P2Y2 receptors on endothelial cells (O’Connor et al, 1991; 
Needham et al, 1987). In contrast, a single class of P2-receptors was shown on 
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the B10 clone of rat brain capillary endothelial cells by competitive inhibition of 
ADP responses by the partial agonist, ATP (Feolde et al, 1995). Likewise, the 
data in Figure 3.28 show that only one class of P2-receptor (P2Z class) is 
expressed on human leukaemic lymphocytes. 
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3.7 Intracellular Choline+ Inhibits PLD Activity and the 
Permeabilising Effects of ATP 
3.7.1 Introduction 
Agonist occupancy of the P2Z receptor produces a time-dependent increase in 
permeability of the plasma membrane over many minutes. Thus macrophages, 
mast cells and transformed fibroblasts develop large pores in a time-dependent 
manner following short term exposure to high concentrations of extracellular 
ATP, with influx of solutes ranging up to 900 Da in size (Steinberg et al, 1987) 
and efflux of nucleotides and phosphorylated intermediates from the cytoplasm 
(Cockcroft & Gomperts, 1979b; Weisman et al, 1984). Kinetic aspects of a 
variable conductance state produced by P2Z receptor agonists have been studied 
by Nuttle and Dubyak (1994) in Xenopus oocytes injected with mRNA from 
murine macrophages. Superfusion of BzATP or ATP over voltage-clamped 
oocytes produced a biphasic response where a small rapidly-activated inward 
current carried by monovalent cations (Na+, K+, or Li+) was followed one minute 
later by a larger inward current. This delayed current could be carried by the 
larger organic cations (NMG+ and Tris+) as well as Na+, K+ and Li+, suggesting a 
time-dependent increase in size of the P2Z ion channel. The transition from 
smaller-to-greater conductance states of the P2Z receptor-operated ion channel is 
sensitive to temperature (Steinberg et al, 1987; Saribas et al, 1993; Nuttle and 
Dubyak, 1994), consistent with the involvement of enzymatic activity.  
Electrophysiological studies on Xenopus oocytes injected with human leukaemic 
lymphocyte mRNA and suspended in saline medium showed that ATP evoked a 
rapid initial current of 2 - 10 nA, which after a delay of 1 - 2 min developed into 
large inward currents of 50 - 2000 nA (Figure 3.30)16. This sudden collapse of 
membrane resistance occurred only at negative holding potentials, which 
favoured the influx of divalent cations through the P2Z channel. However, this 
ATP-induced collapse of membrane resistance was not observed for oocytes 
studied in isotonic choline Cl medium (Figure 3.30).   
In lymphocytes, ATP stimulated PLD activity in direct proportion to the influx of 
divalent cations through the P2Z ion channel (Section 3.2.4). However, ATP-  
                                              
16 J. Wiley, B. King and G Burnstock, personal communication 
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3.7.2  Effect of Extracellular and Intracellular Choline+ on PLD Activity. 
Lymphocytes were suspended in iso-osmotic KCl, NaCl and choline Cl media 
containing Ca2+ and incubated for 15 min with BzATP (1 mM) or ATP (1 mM, 
260 μM ATP4-). Figure 3.31 shows that in cells suspended in KCl medium, 
BzATP and ATP stimulated PLD activity 17 and 13 fold over basal, respectively. 
The ATP-stimulated PLD activity was attenuated in both NaCl (Section 3.1.4) 
and choline Cl media (Figure 3.31). BzATP stimulated PLD activity was not 
significantly altered in NaCl medium (P = 0.27, Student’s t test), but was reduced 
in choline Cl medium (Figure 3.31). 
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Figure 3.31   Agonist-stimulated PLD activity in K+, Na+ or choline+ media 
[3H]oleic acid-labelled lymphocytes (0.6 x 107/ml) suspended in HEPES buffered 150 
mM KCl, NaCl or choline Cl medium with 1 mM Ca2+ and 30 mM butanol were 
incubated in the absence () or presence of 1 mM () ATP (260 μM ATP4-) or 1 mM 
( ) BzATP at 37°C for 15 min and [3H]PBut accumulation measured. PLD activity 
significantly different from *ATP- or **BzATP-stimulated PLD activity in KCl 
medium (P < 0.05, Student’s t test). Results are mean ± s.e.m. (n=3) from an 
experiment representative of 2 - 4. 
[14C]choline+ uptake was then measured in lymphocytes suspended in 150 mM 
choline Cl (1 μCi/ml) medium. ATP induced a rapid accumulation of 
[14C]choline+ (60 and 150 μmol/ml intracellular water) in 10 - 15 min (Figure 
3.32a,b) in Ca2+ -containing (1 mM) and Ca2+-free choline Cl medium, 
respectively. Basal uptake of [14C]choline+ was negligible. A significant amount 
of this accumulated [14C]choline+ was retained intracellularly for up to 2 h after 
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removal of ATP by washing and reincubating cells in choline-free medium 
(Figure 3.32b). 
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Figure 3.32   [14C]choline+ accumulates in ATP-stimulated lymphocytes  
(a) ATP- (1 mM, 260 μM ATP4-) induced [14C]choline+ uptake was measured in 
lymphocytes (107/ml) suspended in HEPES buffered 150 mM choline Cl (1 μCi/ml) 
medium containing 1 mM Ca2+ at 37°C. 
(b) The cellular [14C]choline+ content of lymphocytes (107/ml) incubated for 10 min 
with 500 μM ATP (230 μM ATP4-) in Ca2+-free HEPES buffered 150 mM choline Cl (1 
μCi/ml) medium was measured (zero time point). Mg2+ was added to the remaining 
cells, which were washed, resuspended in RPMI-1640 medium, stored at 37°C and 
[14C]choline+ content measured at the times indicated.  
Extracellular water space and basal uptake of 52.1 and 57.3 nmol/107 cells for (a) and 
(b) respectively were subtracted from each time point. Results are means ± s.e.m. (n = 
3) from a single experiment, representative of 3 for (a) and a single experiment for (b). 
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The effect of the above concentrations of intracellular choline+ on PLD activity 
was then examined. Choline+ or K+ were loaded into the cytosol of lymphocytes 
by allowing these cations to flux through the P2Z ion channel, and then trapping 
the cations inside the cells by adding Mg2+ to terminate the effect of ATP. Thus 
cells were preincubated with 500 μM ATP (230 μM ATP4-) in Ca2+-free buffered 
isotonic KCl or choline Cl at 37°C for 10 min (designated choline+- or K+-loaded 
cells, respectively). Control cells were preincubated in KCl or choline Cl medium 
in the absence of ATP (K+- or choline+-control cells, respectively). Cells were 
then washed and resuspensed in KCl medium containing 1 mM Ca2+ and 30 mM 
butanol for subsequent measurement of PLD activity in the presence or absence 
of ATP (1 mM, 260 μM ATP4-). Figure 3.33 shows that ATP-stimulated PLD 
activity was the same in K+-loaded and K+-control cells. In contrast, ATP- 
stimulated PLD activity was significantly inhibited in cells containing high 
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Figure 3.33   Intracellular choline+ inhibits ATP-stimulated PLD activity 
[3H]oleic acid-labelled cells were first preincubated with or without 500 μM ATP (230 
μM ATP4-) in Ca2+-free HEPES buffered media as indicated for 10 min at 37°C, then 10 
mM Mg2+ was added, cells washed twice and resuspended in HEPES buffered KCl 
medium containing 30 mM butanol and 1 mM Ca2+. [3H]PBut was then measured in the 
presence ( ) or absence ( ) of 1 mM ATP (260 μM ATP4-) for 15 min at 37°C. 
Means ± s.e.m (n = 3) are shown. *Significant difference between choline+-loaded and 
choline+-control cells (P = 0.0002, Student’s t test). **Significant difference in basal 
[3H]PBut between cells preincubated with or without ATP in a either medium (P < 0.05, 
Student’s t). Results are from a single experiment, representative of 3. 
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concentrations of intracellular choline+ (P = 0.0002, Student’s t test, for choline+-
loaded versus choline+-control cells) (Figure 3.33). The reduced ATP-stimulated 
PLD activity observed in this experiment for choline+-control cells resuspended 
in KCl medium was not observed in two similar experiments, although ATP-
stimulated PLD activity was consistently abolished in choline+-loaded cells.  
The effect of intracellular choline+ on PLD activity stimulated by BzATP, 
ionomycin and PMA was then compared. The experimental design was that used 
for Figure 3.33, except that the PLD assay was conducted in HEPES buffered 
NaCl medium. PLD activity stimulated by all three agents was significantly 
inhibited by intracellular choline+ (Table 3.8). 
Table 3.8 Intracellular choline+ inhibits BzATP-, ionomycin and PMA- 
  stimulated PLD activity. 
Condition [3H]PBut (% of [3H]phospholipids) 
 BzATP Ionomycin PMA 
Choline+-loaded 0.04 ± 0.02* 0.53 ± 0.08* 0.91 ± 0.02* 
Choline+-control 0.82 ± 0.03 1.53 ± 0.05 1.97 ± 0.13 
Na+-loaded 0.63 ± 0.04 1.29 ± 0.07 2.47 ± 0.08 
Na+-control 0.98 ± 0.01 1.54 ± 0.09 1.96 ± 0.11 
ANOVA <0.001 <0.001 <0.001 
[3H]oleic acid-labelled lymphocytes (107/ml) were first preincubated with or without 
ATP as described in Figure 3.33 in either choline Cl or NaCl medium, Mg2+ was then 
added, the cells washed and resuspended (2.0 x 107/ml) in 250 μl HEPES buffered NaCl 
medium containing 30 mM butanol and 1 mM Ca2+. These pretreated cells were then 
incubated with or without 1 mM BzATP, 100 nM PMA or 5 μM ionomycin at 37°C for 
15 min and [3H]PBut measured. BSA-free medium was used for ionomycin-stimulated 
cells. Basal [3H]PBut was identical for choline+-control and Na+-control cells (0.07 ± 
0.01%), and for choline+-loaded and Na+-loaded cells (0.13 ± 0.01%) and were 
subtracted from respective values. Means ± s.e.m (n = 3) are shown. *Significant 
differences between choline+-loaded cells and the other conditions for each agonist are 
shown. Results are from a single experiment, representative of 2. 
3.7.3  ATP-stimulated PLD Activity Persists after ATP Removal 
Basal PLD activity was significantly higher in cells preincubated with ATP than 
in cells which had never been exposed to ATP, irrespective of the medium used 
in the pretreatment (Figures 3.13 and 3.33). Thus a proportion of the stimulated 
PLD activity persists after ATP removal. The length of time that this suprabasal  
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PLD activity continued was determined by sequential PLD assays on cells which 
had been preincubated with ATP, washed and resuspensed in RPMI-1640 
medium. Figure 3.34 shows that basal PLD activity in cells previously exposed 
to ATP for 15 min at 37°C was twice that observed in control cells (preincubated 
in the absence of ATP). Furthermore, this greater PLD activity was sustained for 
up to 6 h after removal of ATP, when the cells were stored at 20°C (Figure 3.34) 
and for 1 to 2 h for cells stored at 37°C17. 
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Figure 3.34 Brief exposure of lymphocytes to ATP leads to a sustained 
  increase in basal PLD activity.  
[3H]oleic acid-labelled cells were first preincubated with ( ) or without ( ) 1 mM 
ATP (260 μM ATP4-) in KCl medium containing 1 mM Ca2+ for 15 min at 37°C, then 
10 mM Mg2+ added, and cells then washed and resuspended in RPMI-1640 medium at 
22°C. At the times indicated, 30 mM butanol was added and the cells then incubated at 
37°C for 20 min to measure basal (residual) PLD activity. *Significant difference 
between untreated and ATP-treated cells for each time point (P = 0.006; Student’s t 
test). There was no significant decrease in basal PLD activity of control cells over 6 h 
(P = 0.59. ANOVA). Results of a single experiment shown, representative of 2. 
                                              
17 ATP-pretreated cells resuspended in RPMI-1640 produced 0.21 ± 0.001, 0.16 ± 0.02, and 0.08 ± 
0.002% [3H]PBut, 0.25, 1 and 3 h after ATP removal. Basal [3H]PBut in respective untreated control 
cells was 0.07 ± 0.01% for each time point measured.  
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3.7.4 ATP Pre-exposure Alters Ethidium+  Permeability 
Figure 3.34 shows that a brief exposure (15 min) of lymphocytes to ATP resulted 
in a sustained increase in basal PLD activity. The effect of a brief ATP exposure 
on basal permeability of lymphocytes was examined by measuring basal 
ethidium+ uptake by flow cytometry. Cells were preincubated once or twice with 
ATP (600 μM; 260 μM ATP4-) for 10 min at 37°C in HEPES buffered KCl 
medium in the presence of Ca2+ (0.2 mM) (Appendix 2). After removal of ATP 
by addition of Mg2+, which complexes the ATP, and washing the cells, little 
change was observed in ATP-induced ethidium+ uptake (Table 3.9). However, 
ATP exposure increased basal ethidium+ uptake (Table 3.9) and there was an 
immediate increase in fluorescence after ethidium+ addition, which was more 
pronounced after two ATP exposures (Appendix 5, Figure A5.1c). Scatterplots of 
ATP pretreated lymphocytes showed changes typical of swollen cells (Appendix 
5) and a small proportion (≈ 8%) were immediately so highly permeable to 
ethidium+ that they were gated out in the histogram analysis (Appendix 5). The 
effect of intracellular choline+ on basal permeability was then examined. When  
 
Table 3.9  Effect of ATP exposure on subsequent basal ethidium+ influx 
 
Preincubation Conditions 
 
No. of 
Ethidium Influx  
(mean channel fluorescence/min) 
 preincubations Basal ATP-induced 
Expt 1: Preincubation in K+ medium  
Medium (no ATP) 2 0.01 2.39 
ATP 1 0.32 2.31 
ATP 2 0.31 2.12 
Expt 2: Preincubation in K+ medium  
Medium (no ATP) 1 0.01 3.40 
ATP 1 0.23 3.57 
Expt 2: Preincubation in choline+ medium  
Medium (no ATP) 1 0.01 3.48 
ATP 1 0.04 0.28 
Cells (2 x 106/ml) suspended in Ca2+-containing (0.2 mM) HEPES buffered KCl or 
choline Cl medium were first incubated once or twice with or without 600 μM ATP 
(260 μM ATP4-) for 10 min at 37°C, 10 mM Mg2+ was added and cells washed in 
HEPES buffered saline after each incubation, then resuspended in Ca2+-containing (0.2 
mM) HEPES buffered KCl medium (106/ml) and 25 μM ethidium+ added for 
measurement of basal ethidium+ uptake by flow cytometry. For ATP-induced ethidium+ 
uptake, ATP was added 30 s after ethidium+. Results are from a single experiment, 
representative of 4 (experiment 1). 
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lymphocytes were suspended in choline Cl medium during exposure to ATP, the 
subsequent basal permeability to ethidium+ measured in KCl medium was 
decreased, and ATP-stimulated ethidium+ uptake was abrogated (Table 3.9). 
Likewise, the changes observed in the flow cytometry histograms for cells 
pretreated with ATP in KCl medium were much less obvious when cells were 
pretreated with ATP in choline Cl medium (Appendix 5, Figure A5.2b). 
3.7.5   Discussion 
3.7.5.1  Intracellular choline+ inhibits PLD activity 
The results from this study suggest that intracellular rather than extracellular 
choline+ inhibits ATP-stimulated PLD activity. ATP caused a large quantity of 
[14C]choline to rapidly accumulate intracellularly, although it was lower in the 
presence of extracellular Ca2+, suggesting that Ca2+ and choline+ compete for 
passage through the P2Z ion channel (Figure 3.32). These results support the 
findings of El-Moatassim and Dubyak (1993), who showed in murine 
macrophages, that extracellular choline+ inhibited BzATP-stimulated PLD 
activity with an IC50 of 20 mM choline+ and maximal effect at 75 - 100 mM. 
These authors suggested that choline+ entered the cell through the P2Z ion 
channel and inhibited PLD activity by end product inhibition. In the absence of 
specific PLD antagonists, advantage was taken of the permeabilising effect of 
ATP to load the cytosol with choline+ (Figure 3.22b), for subsequent testing of 
its inhibitory effect on PLD activity stimulated by other agents. In human 
lymphocytes, intracellular choline+ blocked PLD activity stimulated by P2Z 
agonists, by ionomycin, and by PMA (Figure 3.33 and Table 3.8). More 
complete inhibition of P2Z-mediated PLD activity (95%) by intracellular 
choline+ compared with its inhibition of ionomycin- and PMA-stimulated PLD 
activity (65 and 54% respectively) suggests that choline+ may also interfere with 
the P2Z receptor (Table 3.8). The inhibitory effect of intracellular choline+ on 
ATP-stimulated ethidium+ uptake (Table 3.9, experiment 2) may, thus, be due to 
its effect on PLD activity as well as an additional effect on the P2Z receptor. 
3.7.5.2  A brief exposure to ATP induces persistent PLD activity and a 
permeability lesion  
The persistence of a proportion of ATP-stimulated PLD activity for several hours 
after ATP removal (Figure 3.34), suggests that an active, stable PLD complex is 
assembled on the plasma membrane, perhaps due to translocation of PLD or its  
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regulator(s). A prolonged elevation in basal PLD activity was also reported in 
U937 monocytes permeabilised in the presence, but not in the absence of GTPγS, 
and this activity persisted for 48 h if preparations were stored at 4°C (Kusner & 
Dubyak, 1994). Likewise, human neutrophils permeabilised after, but not before 
PMA treatment, show an enhanced GTPγS-stimulated PLD activity. This effect 
of PMA was attributed to its ability to translocate ARF to the membrane 
(Whatmore et al, 1994; Cockcroft, 1996).  
Prolonged PLD activity may significantly change the phospholipid composition 
of the plasma membrane. Thus, there could be a substantial decrease in PC 
content, with a concomitant increase in PA. While PA is normally metabolised, 
these increases in PA may be too substantial or prolonged for the relative 
proportions of these phospholipids to be restored. Membrane remodelling events, 
such as vesicle fusion are promoted by similar changes in the phospholipid 
composition of vesicles (Sundler et al, 1981). Increases in the PA content of 
membranes may also promote lysis, since lysis often accompanies Ca2+-
dependent membrane fusion and phospholipid packing defects (Gennis, 1989). 
The fusibility of phospholipid vesicles was greatly enhanced when PLD was 
introduced into them, and it was suggested that the differential distribution of PA 
between the inner and outer monolayers of the membrane contributed to the 
destabilisation of these vesicles (Park et al, 1992). Lymphocytes and 
macrophages briefly exposed to ATP developed large, delayed inward currents, 
which may represent a permeability lesion preceding cell lysis (Figure 3.30; 
Nuttle & Dubyak, 1994). Likewise, in lymphocytes, basal permeability to 
ethidium+, which was distinct from ATP-induced ethidium+ influx through the 
P2Z ion channel, increased after brief exposure(s) to ATP in KCl medium (Table 
3.9). Together these observations suggest that P2Z-mediated PLD activity may 
contribute to increased leakiness of the plasma membrane with the development 
of a prelytic lesion, which may eventually lead to cell death. Surprenant et al, 
(1996) also reported that HEK cells, transfected with the P2X7 receptor, showed 
sustained currents and increased permeability to fluorescent dyes on repeated 
exposures to BzATP. Furthermore, others have shown that brief exposures (15 
min) of IFN-γ-treated human macrophages to extracellular ATP resulted in 
enhanced 51Cr lysis, 6 h after removal of ATP (Blanchard, 1991, 1995). 
3.7.5.3  Intracellular choline+ prevents ATP-induced permeability responses 
The results presented in this study suggest that PLD activity maybe involved in 
the development of a permeability lesion mediated by extracellular ATP, since 
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intracellular choline+ was a powerful inhibitor of this process. The large, delayed 
current induced by ATP in oocytes transfected with lymphocyte mRNA was 
blocked when these oocytes were suspended in choline Cl medium (Figure 3.30). 
Similarly, there was no subsequent basal ethidium+ uptake observed in 
lymphocytes pre-exposed to ATP in choline Cl medium (Table 3.9, experiment 
2). Finally, others have shown that choline Cl medium can substantially inhibit 
ATP-induced lysis of murine macrophages, measured by leakage of lactic 
dehydrogenase from the cells (Murgia et al, 1992). While El-Moatassim and 
Dubyak (1993) found that extracellular choline+ blocked BzATP-stimulated PLD 
activity in BAC1.2F5 macrophages, they came to a different conclusion about 
the effect of choline+ on P2Z-mediated permeability responses. In their study, 
extracellular choline+ had no effect on BzATP-stimulated depolarisation, a 
measure of immediate ion channel activity. Likewise, choline+ had no effect on 
the initial rapid current induced by ATP in transfected oocytes (Figure 3.30). 
However, it would be interesting to examine the effect of intracellular choline+ 
on the large, delayed current observed by this group in BAC1.2F5 macrophage 
mRNA injected oocytes (Nuttle & Dubyak, 1994).  
In conclusion, both macrophages and lymphocytes contain phospholipase D 
which is activated by ATP, at least in part by the influx of divalent cations 
(Section 3.2, El-Moatassim & Dubyak, 1992). Moreover PLD may remain active 
for many hours and produce a localised change in the phospholipid composition 
of the plasma membrane which may cause large permeability increases and 
contribute to cell death. 
 
Conclusions and Significance 
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Conclusions and Significance 
Lymphocytes from patients with chronic lymphocytic leukaemia have proved a 
useful model for studying the characteristics of the P2Z receptor. These 
lymphocytes are present in high concentrations as a monoclonal population, in 
the patient’s peripheral blood and are thus readily accessible for experimentation. 
The lymphocytes from the majority of CLL patients overexpress the P2Z 
receptor in comparison with normal peripheral blood lymphocytes, which are 
composed of both B and T cells and show a lower level of P2Z expression 
(Wiley & Dubyak, 1989). Previous evidence also suggests that information 
obtained from studies on CLL lymphocytes can be applied to normal human 
lymphocytes. Some patients’ cells lacked P2Z expression and on occasions these 
were used as negative controls. P2Z receptor expression is modulated by 
cytokines and other factors, during the various stages of lymphocyte and 
macrophage maturation (Blanchard et al, 1991; Falzoni et al, 1995; Chused et al, 
1996), which may explain the high level of P2Z expression on most CLL 
lymphocytes. High levels of P2Z expression on mouse memory T lymphocytes 
(Chused et al, 1996) and human CLL cells point to a role for the lymphocyte P2Z 
receptor in lymphocyte trafficking (Jamieson et al, 1996). Furthermore, ATP4- 
may be a mediator of cell-cell communication between antigen presenting cells 
and memory lymphocytes via stimulation of P2Z receptors.  
Another advantage in studying CLL lymphocytes is their expression of the P2Z 
receptor in the absence of other P2-receptors, which was confirmed in the present 
study by demonstrating competitive inhibition between ATP and BzATP, the 
partial and more efficacious agonists, respectively, for P2Z receptors (Section 
3.6). Thus human leukaemic lymphocytes are among a rare group of cells which 
only express one P2-receptor subtype, although recent data suggests that 
apoptotic thymocytes may express P2X1 receptors (Chvatchko et al, 1996). A 
search for P2X1 receptor expression in various haemopoietic cells was prompted 
by the discovery of sequence identity between P2X1 and the partial apoptosis 
gene, RP-2, and by the observation that mRNA for P2X1 was expressed in spleen 
and thymus (Valera et al, 1994; Owens et al, 1991). The lymphocyte P2Z 
receptor may also have a role in mediating cell death (Sections 3.3 and 3.7), 
which supports the observations of Zheng et al, (1991), who showed that 
stimulation of P2Z receptors induced Ca2+ influx in murine thymocytes and 
mediated apoptotic cell death, although Ca2+ fluxes alone were insufficient to 
elicit apoptotis. However, it is more likely that the lymphocyte P2Z receptor is 
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related to the rat brain P2X7 receptor (Surprenant et al, 1996), which has similar 
permeability properties, rather than other P2X receptor subtypes. 
A further advantage of the CLL lymphocyte model was that several diverse 
responses are mediated when ATP binds to the P2Z receptor (Figure 4.1). These 
responses could be separated into those dependent on associated ion channel 
activity (eg. Ca2+-dependent PLD activation) and those which are independent 
(eg. L-selectin shedding). This distinction was crucial in determining that KN-62 
and KN-04 were inhibitors of the P2Z receptor and not simply ion channel 
blockers. 
 
ATP P2Zreceptor
Ion channel (cations)
Phospholipase D
Metalloprotease 
Cell death
 
 
Figure 4.1 Responses mediated by the human lymphocyte P2Z 
receptor  
 
The close correlation found between binding of ATP4- to the P2Z receptor, 
opening of a Ca2+-selective channel and activation of PLD in human 
lymphocytes (Section 3.1) and murine macrophages (El-Moatassim & Dubyak, 
1992) suggests that PLD may, in part, mediate functional effects of the P2Z 
receptor. An interesting observation was that other permeants of the P2Z channel, 
such as Sr2+, Ba2+, could also support ATP-stimulated PLD activity (Section 3.2). 
Thus PLD, like PLA2 and two Ca2+/CaM-dependent enzymes, nitric oxide 
synthase and myosin light chain kinase, are among the few Ca2+-dependent 
enzymes which can be stimulated by alkali earth cations other than Ca2+. 
Experiments using isotopic Ba2+ revealed that PLD activity could be directly 
correlated with divalent cation influx through the P2Z receptor-operated ion 
channel (Section 3.2), suggesting that the high levels of divalent cations, which 
accumulate in the subplasma membrane region, stimulate enzyme activity 
(Figure 4.2). Another possible similarity between PLD and cPLA2 is that 
subplasmalemmal Ca2+ may mediate their translocation to the plasma membrane 
through Ca2+-dependent C2 phospholipid-binding domains (Figure 4.2) (Ponting 
& Parker, 1996). Once associated with the plasma membrane, the catalytic 
domains of PLD and cPLA2 (Nalefski et al, 1994) would cleave choline and 
arachidonic acid from their respective substrates. High concentrations of Ca2+ 
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beneath the plasma membrane may also translocate regulatory molecules of PLD 
activity, to allow the assembly of a stable PLD enzyme complex at the plasma 
membrane (Figure 4.2) (Kusner & Dubyak, 1994). This recruitment of 
appropriate cofactors may not be necessary in in vitro cell free assays of PLD 
activity, since they are all provided in the tube and artificially mixed. This would 
explain the dependence of PLD activity on Ca2+ in intact cells, but not in broken 
cell preparations. Future experiments, using permeabilised cells and approaches 
similar to those of Cockcroft (Whatmore et al, 1994) or Dubyak (Kusner & 
Dubyak, 1994) should elucidate which, if any, of the factor(s) shown in Figure 
4.2 regulate ATP-stimulated PLD activity in lymphocytes. 
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Figure 4.2 Mechanism of ATP-stimulated PLD activity 
 
It was not possible to establish a role for calmodulin or CaMKII in ATP-
stimulated PLD activity or in P2Z-mediated apoptosis of human lymphocytes, 
since the two inhibitors tested (TFP and KN-62) both directly inhibited the P2Z 
receptor at concentrations lower than those which inhibit Ca2+/CaM and CaMKII, 
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respectively (Section 3.3). This study highlighted the problem of inhibitor non-
specificity and the inherent danger of relying on the effects of one or two  
inhibitors to assign an effect. Perhaps the conclusions of Blanchard et al, (1995) 
implicating Ca2+/CaM and CaMKII with P2Z activation, could equally be 
explained by a direct effect of both TFP and KN-62 on the macrophage P2Z 
receptor. Several recent studies show that ATP stimulates apoptosis in murine 
lymphocytes and rat thymocytes (Zanovello et al, 1990: Zheng et al, 1991). ATP 
also induces apoptosis in CLL cells (Section 3.3), which is probably triggered by 
Ca2+ influx through the P2Z ion channel, and may involve PLD activation. It is 
possible that subsequent increased PA content of the inner leaflet facilitates 
bidirectional transbilayer movement of phospholipids, resulting in loss of 
membrane asymmetry and the appearance of PS on the outer leaflet (Verhoven et 
al, 1995). Macrophages recognise this exposed PS, an early hallmark of 
apoptosis, and subsequently phagocytose the apoptotic cells (Fadock et al, 1992). 
The data in Section 3.4 shows that the isoquinolinesulphonamides, KN-62 and 
KN-04 are the two most potent and selective inhibitors for the P2Z receptor 
(Section 3.4). KN-62 and KN-04 were of value in testing whether ATP was a 
partial agonist, since both were more effective in blocking P2Z responses 
mediated by the partial agonist, ATP, than the more efficacious agonist, BzATP 
(Section 3.6). The mechanism of action of the isoquinolinesulphonamides on the 
P2Z receptor is uncertain, since Hill analysis suggests that only one molecule 
binds per receptor (nH ≈ 1) and yet two or more ATP and BzATP (nH ≈ 2 and 3, 
respectively) molecules are required to open the ion channel. It is possible that 
the planar structure of one of the isoquinoline rings fits one of the ATP binding 
sites, in a manner analogous to CKI-6 binding to casein kinase I (Xu et al, 1996). 
Some clues about the inhibitory mechanism of KN-62 may come from examining 
the effect of KN-62 on the cloned P2X7 receptor (Surprenant et al, 1996). KN-62 
and KN-04 should also prove invaluable inhibitors for: 
• distinguishing responses in macrophages and mast cells, which co-
express P2Z and P2Y2 receptors, and where in macrophages, KN-62 
has already been shown to block ATP-mediated cell lysis (Blanchard 
et al, 1995)  
• distinguishing responses in haemopoietic cells (HL-60 cells 
differentiated into macrophages, RBL 2H3 basophilic leukaemic cells 
and T lymphocytes), which express either P2Z and/or P2X receptors 
(Buell, et al, 1996; Baricordi et al, 1996; Chused et al, 1996)  
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• radioligand binding studies in order to quantitate the number of P2Z 
binding sites per cell 
 
• testing the hypothesis suggested by the present study, that KN-62 
inhibits the P2Z ion channel but not the delayed permeability response 
associated with PLD-mediated membrane remodelling, using both 
electrophysiological (Nuttle & Dubyak, 1994; Surprenant et al, 1996) 
and flux studies (Section 3.7) 
• examining the role of P2Z receptors in lymphocyte trafficking in the 
whole animal, by infusing KN-62 and KN-04 and tracking tagged 
lymphocytes 
• examining the role of P2Z receptors in the central nervous system in 
an animal model, by intraventricular infusions of KN-62 and KN-04 at 
concentrations below that which inhibit CaMKII (Ishikawa et al 1990). 
Section 3.5 shows that PLD activity was unrelated to L-selectin shedding. While 
ATP-induced L-selectin shedding was sensitive to the effects of the 
metalloproteinase inhibitor, Ro 31-9790, PLD activity was unaffected. It was 
also established that ATP-stimulated PLD activity is not the GPI-specific form of 
PLD (Section 3.5). Thus the two inhibitors, Ro-31-9790 and KN-62 show 
differential inhibitory action on P2Z-mediated responses in lymphocytes. These 
inhibitors could be used in concert, together with ox-ATP, to dissect the role of 
the P2Z receptor and/or P2Z-mediated L-selectin shedding in those multistage 
processes, where L-selectin shedding has already been shown to have a role: 
namely rolling behaviour of leukocytes at high shear rates of blood flow (Finger 
et al, 1996) and lymphocyte transmigration through endothelial monolayers 
(Ager & Wood, 1994; Chen, Gu & Wiley, personal communication). 
The results described in Section 3.7 point to a possible relationship between 
ATP-stimulated PLD activity and the development of a permeability lesion, 
which ultimately leads to cell death. These effects of ATP were all time 
dependent and developed minutes to hours after a brief exposure to ATP. The 
ability of intracellular choline+ to potently inhibit PLD activity provided a 
powerful tool to link PLD activity with the development of both plasma 
membrane leakiness to fluorescent dyes and large delayed currents. Evidence 
from the present study suggests that the lytic effect of ATP is more likely to 
result from alterations to the phospholipid composition of the plasma membrane, 
rather than through the association of P2Z monomers to form large variable sized 
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pores (Tatham & Lindau, 1990; Di Virgilio, 1995). It must be emphasised that 
this leakiness is distinct from the lymphocyte P2Z ion channel, which is 
permeable to ethidium+. The difficulty in obtaining a unitary conductance  
 
consistent with a prelytic lesion, may be explained by the fact that in these 
studies (Couthino-Silva et al, 1996) only the immediate effects of ATP were 
examined and currents were not measured long enough after ATP exposure. The 
question should be asked whether cells with a prelytic lesion survive the 
electrode impalement procedure? The suitability of using ATP-permeabilised, 
Mg2+-resealed cells (Gomperts & Fernandez, 1985; Weisman et al, 1989) for 
examining signal transduction pathways, needs to be questioned, since the 
significant and prolonged activation of PLD has a striking effect on the viability 
of the cell, which is not immediately apparent. However, the ability of brief ATP 
exposures to stimulate irreversible permeability changes which ultimately lead to 
cell death, could be exploited clinically. One possibility is to give patients with 
CLL an occasional intravenous infusion of BzATP to kill a proportion of their 
lymphocytes when their disease becomes more progressive. The advantages of 
BzATP infusions over cytotoxic chemotherapy to control a mild leukaemia, 
which is characterised by an accumulation of long lived lymphocytes in the 
peripheral blood, depend on BzATP having no toxicity problems of its own. The 
effects of BzATP are likely to be short lived due to the action of ubiquitous ecto-
ATPases, increasing its safety as a drug. Furthermore, BzATP has advantages 
over ATP, being the most potent and efficacious agonist of the P2Z receptor 
(Section 3.6) but having little or no effect on endothelial P2Y receptors.  
Physiologically, it is likely that the effects of extracellular ATP on lymphocytes 
are cumulative and thus develop over time. It is also likely that in vivo the P2Z 
receptor is only activated under extreme circumstances, because there are many 
factors which mitigate against P2Z activation. Thus, the high concentrations of 
ATP required, ATP’s partial agonist activity (Section 3.6) and the inhibitory 
effects of extracellular Na+ and divalent cations, protect against P2Z activation. 
The lymphocyte P2Z receptor may only be stimulated at local sites where close 
cell-cell contact is possible and the concentration of extracellular ATP reaches 
relatively high levels, such as inflammatory sites, platelet thrombi and regions of 
turbulent blood flow. In these circumstances, it is the proposed that brief 
exposures of lymphocytes to ATP opens the P2Z ion channel, allowing influx of 
Ca2+, which activates PLD, and promotes the formation of a stable, PLD enzyme 
complex on the membrane. The subsequent changes to the composition of the 
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plasma membrane may have several effects. Thus, phosphatidic acid may be 
generated, which may alter the packing of the phospholipids producing a 
permeability lesion, which in turn leads to cell death several hours later (Figure 
4.3). 
Closed
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Figure 4.3 Mechanism of P2Z-mediated cell death in lymphocytes. 
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Appendix 1 Butanol Concentration for the PLD Assay 
The transphosphatidylation assay for measuring PLD activity uses a primary 
alcohol instead of water as the nucleophilic acceptor of the phosphatidyl moiety. 
Many studies report the use of ethanol at relatively high concentrations (1 - 2%), 
which may damage cell membranes and affect metabolism. However, this 
problem can be avoided by using butanol, which is a more efficient acceptor than 
ethanol (Danin et al, 1993). 
A concentration-response curve for butanol was obtained by incubating cells, 
suspended in HEPES buffered KCl medium, with or without 910 μM ATP (230 
μM ATP4-) in the presence of butanol and 1 mM Ca2+. Figure A1.1 shows that 
ATP stimulated maximal [3H]PBut accumulation at 30 mM (0.27% vol/vol) 
butanol, a concentration ≈ 5 fold less than required for the substrate, ethanol. 
Viability of lymphocytes incubated with 910 μM ATP for 15 min at 37°C in the 
presence of 30 mM butanol was > 95% as determined by Trypan blue exclusion. 
Thus 30 mM butanol was used in all PLD transphosphatidylation assays. 
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Figure A1.1  Butanol concentration-response curve for ATP-stimulated 
    PLD activity. 
[3H]oleic acid-labelled lymphocytes (107/ml) suspended in HEPES buffered 150 mM 
KCl medium were equilibrated for 5 min at 37°C with butanol, then incubated with 910 
μM ATP (230 μM ATP4-) for 15 min. Mg2+ (2 mM) was added to terminate the reaction 
and [3H]PBut measured. Values are mean ± s.e.m. (n =3) from a single experiment, 
representative of 3. 
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Appendix 2  Effect of Extracellular Ca2+ on ATP-
induced PLD Activity 
The Bound and Determined program, version 3.0 (Brooks & Storey, 1992) was 
used to calculate the concentration of ATP required to produce constant 
concentrations of ATP4- species over the range 0 - 2 mM extracellular [Ca2+] 
(Table A2.1) (see Section 3.7).  
 
Table A2.1 Concentration of ATP species at various extracellular [Ca2+] 
 Extracellular 
Ca2+  mM 
ATP4- 
uM 
CaATP2- 
uM 
Free Ca2+ 
mM 
ATP 
uM 
 
    0 230     0       0   500  
 0.1 230   41 0.06   540  
 0.2 230   81 0.12   580  
 0.5 230 230 0.29   700  
 1.0 230 389 0.57   910  
 1.5 230 572 0.83 1120  
 2.0 230 740 1.10 1320  
Values were calculated by an updated version of the program, Bound and Determined, 
3.0 (Brooks & Storey, 1992). 
Cells suspended in HEPES buffered KCl medium were incubated with or without 
230 μM ATP4- (Table A2.1) in the presence of 30 mM butanol and Ca2+ for 15 
min at 37°C. Similar levels of [3H]PBut accumulated when cells were incubated 
with 0.1 - 1.0 mM extracellular [Ca2+], which corresponds to free [Ca2+] 60 μM 
to 0.57 mM. Maximal ATP-stimulated PLD activity occurred at 0.2 mM 
extracellular [Ca2+] (Figure A2.1). The diminished PLD activity seen at 2.0 mM 
[Ca2+] was probably due to the high concentration of [CaATP2-] (Table A2.1), 
which may compete with the agonist, ATP4-, for the P2Z receptor. Extracellular 
[Ca2+] of 1.0 mM was generally used in PLD assays. However, in certain 
experiments, where it was necessary to lower extracellular [Ca2+] to lessen its 
competition with other ions (eg ethidium+ uptake in the presence of Ca2+) or 
prevent precipitation of insoluble salts (eg NaF and AlCl3, since CaF2 has low 
solubility), 0.2 mM extracellular [Ca2+] was used. 
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Figure A2.1  Effect of extracellular Ca2+ on ATP-stimulated PLD activity 
[3H]Oleic acid-labelled lymphocytes (107/ml) suspended HEPES buffered KCl medium 
with 30 mM butanol and Ca2+ as indicated were incubated with or without 230 μM 
ATP4- for 15 min at 37°C and [3H]PBut was measured. Results are mean ± s.e.m. (n=3) 
from a single experiment representative of 4. 
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maximal rate of ethidium+ uptake was not observed in BzATP-stimulated cells at 
maximal concentrations (30 - 50 μM), but became apparent at suboptimal 
concentrations (Figure A3.4). For ATP and other P2Z agonists, the delay before 
maximal rate uptake was also concentration dependent, the lower the 
concentration of agonist, the greater the delay (Figure A3.4). Similarly, Chused 
et al, (1996) found a concentration-dependent delay in ATP-stimulated ethidium+ 
uptake in murine thymocytes. Preincubation of cells with agonist for 2 min at 
37°C prior to addition of ethidium+ abolished the delay phase, producing linear 
ethidium+ influxes (Figure A3.3). Thus ATP and other agonists were added 2 
min prior to ethidium+, unless otherwise stated. 
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Figure A3.3  ATP-stimulated ethidium+ uptake in human lymphocytes 
Cells (106/ml) suspended in HEPES buffered KCl medium were either preincubated for 
2 min at 37°C with 500 μM ATP (260 μM ATP4-) prior to addition of 25 μM ethidium+ 
(solid arrows) or ATP was added 30 s after ethidium+ (hollow arrows) and mean 
channel cell associated fluorescence was measured at 6 s intervals by flow cytometry. 
Control cells were incubated with 25 μM ethidium+ alone. Results from a single 
experiment, representative of 3. 
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Figure A3.4  BzATP-stimulated ethidium+ uptake  
Cells (106/ml) suspended in HEPES buffered KCl medium at 37°C were incubated with 
BzATP added 30 s after ethidium+ and mean channel cell associated fluorescence was 
measured at 6 s intervals by flow cytometry. Control cells were incubated with 25 μM 
ethidium+ alone. Results from a single experiment, representative of 3. 
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nuclei, in addition to a small, tetraploid peak of nuclei in G2/M phase, which 
would have been at > 1000 in Figure A4.1. Scatterplots of PI stained nuclei were 
collected in log mode and displayed a distinct pattern of normal and apoptotic 
nuclei. The latter are characterised by a loss of FS and an increase in SS (Figure 
A4.2). Others have noted a similar changes in the light scattering properties of 
apoptotic nuclei (Darzynkiewicz et al, 1994). This feature has been used in the 
present study to produce two parameter histograms of PI stained nuclei, thereby 
increasing the accuracy of the technique. Thus, the percentage of apoptotic nuclei 
was estimated from histograms of log SS versus linear PI staining (Figure A4.2, 
lower histogram). Apoptotic nuclei were located in the large rectangular gate, H 
(actually H minus I (H-I)), while normal nuclei were in the small gate, I. The 
percentage apoptotic nuclei was obtained by subtracting the percentage of nuclei 
in gate I from those in gate H (Figure A4.2). A backgating strategy confirmed 
that nuclei in gate I1 showed normal FS and SS (gate C, Figure A4.3a), while 
those in gate H-I showed decreased FS and increased SS (gate B, Figure A4.3b). 
This method was more accurate than single parameter histograms of PI staining, 
since it was noted some ATP- or dexamethasone-induced apoptotic nuclei, 
showed normal or increased PI staining, producing a shoulder to the right of the 
G0/G1 peak. Nuclei in this region were difficult to estimate and backgating 
showed that they were located in gate B (low FS, high SS) of the scatterplot 
(Figure A4.3b). It is suggested nuclei with low FS, high SS and increased PI 
staining represent early stages of apoptosis, the increased PI staining due to 
loosening of the chromatin, providing greater access for PI binding to DNA. This 
hypothesis has been recently confirmed in irradiated and growth factor-deprived 
peripheral blood mononuclear cells (Ferlini et al, 1996). 
                                              
1 While gate names have changed (ie I is now G or L; H is E or F) in Figure A4.2, due to the insertion of 
new gates used in the backgating strategy, they are located in the same region on the histograms as in 
Figure A4.1. 
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Appendix 5  Effect of a Brief ATP Exposure on 
Subsequent Basal Lymphocyte Permeability: 
Flow Cytometric Analysis 
Pre-exposure to ATP altered the appearance of lymphocytes in scatterplot 
histograms generated from ethidium+ uptake assays. Cells suspended in HEPES 
buffered KCl or choline Cl medium containing 0.2 mM Ca2+ were first 
preincubated once or twice with or without 600 μM ATP (260 μM ATP4-) for 10 
min at 37°C. Mg2+ (10 mM) was added and the cells were then washed twice in 
HEPES buffered saline medium, resuspended in Ca2+-containing HEPES 
buffered KCl medium and 25 μM ethidium+ added for measurement of basal 
ethidium+ uptake by flow cytometry. Figures A5.1 and A5.2 depict two separate 
experiments on cells from two patients as described in Table 3.9. After a single 
pre-exposure to ATP, many lymphocytes in the scatterplot show a loss of FS and 
an increase in SS (Figures A5.1b and A5.2c). These changes are typical of 
swollen cells, which paradoxically show an increase in SS and decrease in FS, 
because the refractive index of the cytosol now resembles more closely that of 
the suspending medium. A second exposure to ATP exacerbated these changes in 
light scattering properties of the lymphocytes (Figure A5.1c). However, these 
changes were not observed for control cells incubated twice in KCl or once in 
choline Cl medium in the absence of ATP (Figures A5.1a and Figure A5.2a). 
These changes were not normally observed for the standard ATP-stimulated 
ethidium+ uptake (Figure A3.1) and they were largely prevented when cells were 
suspended in choline Cl medium during ATP pre-exposure (Figure A5.2b). Cells 
in the region below gate A (Figure A5.2c) are considered non-viable by flow 
cytometrists and were not included in the analysis. 
Further evidence that preincubation of cells with ATP alters basal permeability 
was observed in histograms of ethidium+ intensity versus time. A proportion of 
cells were immediately so permeable to ethidium+ that they registered in the 
highest channel, appearing at the top of the histogram (arrows, Figure A5.1b,c) 
and were excluded from the data analysis in Excel. Many other cells showed 
ethidium+ intensity above basal levels and registered throughout the histogram 
(Figures A5.1b,c and Figure A5.2c). These changes were not observed in control 
preincubated cells (Figure A5.1a and Figure A5.2a) nor in cells preincubated 
with ATP in choline Cl medium (Figure A5.2b). The data presented in this 
appendix support the conclusion of Section 3.7, that a pre-exposure to ATP 
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causes a permeability lesion, which can be prevented by incubation in a choline 
Cl medium. 
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